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ABSTRACT 
 
Through-bond Energy Transfer Cassettes for Multiplexing and 
Development of Methods for Protein Mono-labeling. 
 (May 2009) 
Yuichiro Ueno, B.S., Fukuoka University, Japan; M.S., Fukuoka University, Japan  
Chair of Advisory Committee: Dr. Kevin Burgess 
 
A set of three through-bond energy transfer cassettes based on BODIPY as a donor 
and cyanine dyes as acceptors has been prepared via Sonogashira couplings, and their 
photophysical properties were examined.  These cassettes fluoresce around 600 to 800 
nm and are resolved by approximately 100 nm.  This property is an important factor for 
multiplexing study in cellular imaging.  Several useful fluorescent probes such as 5- and 
6-carboxyfluorescein, water-soluble BODIPY, and water-soluble Nile Blue dyes, have 
also been synthesized and their photophysical properties studied. 
We have also attempted to develop a method for protein mono-labeling via a solid-
phase approach.  The labeling of protein with one fluorescent dye facilitates 
quantification and single molecule imaging in biological applications.  Various solid-
supports such as PEGA, CPG, and BSA-coated CPG, were tested.  Photolabile and 
chemically cleavable linkers were prepared to connect solid-supports and fluorophores.  
Unfortunately, our approach to the fluorescent mono-labeling of native proteins did not 
give us any conclusive results.  
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NOMENCLATURE 
  
BOC  tert-butoxycarbonyl 
BODIPY 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene 
BSA  Bovine Serum Albumin 
CE  capillary electrophoresis 
CH2Cl2 dichloromethane 
CH3CN acetonitrile 
CPG  control pore glass 
Cy  cyanine 
DIC  N,N’-diisopropylcarbodiimide 
DMAP  4-dimethylaminopyridine 
DMF  N,N-dimethylformamide 
EDCI  1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride 
ETE  energy transfer efficiency 
EtOAc  ethylacetate 
EtOH  ethanol 
FAM  carboxyfluorescein 
FRET  fluorescence resonance energy transfer 
MeOH  methanol 
NHS  N-hydroxysuccinimide 
ONB  o-nitrobenzyl 
PCC  pyridinium chlorochromate 
PEG  polyethylene glycol 
PEGA  polyethylene glycol polyacrylamide 
TBAF  tetrabutylammonium fluoride 
TBET  through-bond energy transfer 
TFA  trifluoroacetic acid 
THF  tetrahydrofuran
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CHAPTER I 
 
INTRODUCTION 
 
1.1 Fluorescence and Phosphorescence 
Luminescence takes place from electronically excited states to ground states.  It is 
categorized in terms of fluorescence and phosphorescence, and the mechanism of those 
emissions are explained by the Jablonski diagram (Figure 1.1).  For fluorescence, the 
electron is usually excited to singlet states S1 or S2 levels from the ground states by the 
absorption of photons.  The electron occasionally rapidly relaxes to lower level, S1, and 
this process is called internal conversion and the general rate is 10–12 s or less.  When the 
electron relaxes to ground states, fluorescence occurs by releasing light energy and the 
rate is 10–8 s.  The electron of S1 level can also go to triplet state (T1) via spin conversion 
(called intersystem crossing).  The emission from T1 level to ground state is known as 
phosphorescence, and this emission process is usually observed at relatively longer 
wavelengths.  The rate of phosphorescence is therefore slower than that of fluorescence.  
The heavy atoms such as halogens are known to facilitate intersystem crossing and this 
process also involves the fluorescence quenching mechanism. 
 
S0
S1
S2
0
1
2
T1
h!A h!A h!F h!P
absorption
internal
conversion
fluorescence
phosphorescence
intersystem
crossing
 
Figure 1.1.  Jablonski diagram.1 
____________ 
This dissertation follows the style of The Journal of Organic Chemistry. 
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1.2 Fluorescence Resonance Energy Transfer (FRET) 
Fluorescence resonance energy transfer (FRET) is an electrodynamic phenomenon 
which occurs between a donor fluorophore (D) in the excited state and an acceptor 
fluorophore (A) in the ground state.  For FRET to occur the distance between both 
fluorophores should be less than 100 nm.  The most important factor for FRET is the 
requirement of the overlap between the emission of a donor and the absorption of an 
acceptor.  The less overlapping integral decreases the FRET efficiency.  FRET was first 
reported by Theodor Förster in 1946.2  FRET is now widely used in various biological 
application such as medical diagnostics, DNA analysis, and cell imaging.  The energy 
transfer (ET) which takes place between the donor and the acceptor separated by a 
distance r, is given by the following equation: 
 
kT(r) =
QD!
2
"Dr
6
9000(ln 10)
128#5Nn4
!
0
! FD($)%A($)$4d$ (i)
 
 
where QD is quantum yield of the donor in the absence of the acceptor, and κ2 is 
orientation factor (range from 0 to 4, usually assumed to be 0.67 for dynamic random 
averaging).  When the transition dipole moments of the donor and the acceptor are 
perfectly parallel, then κ2 is 4.  If the dipole moments of both fluorophores are 
orthogonal, κ2 is given by 0.  N is Avogadro’s number (6.02 x 1023), n is the refractive 
index of the medium, τD is the lifetime of the donor in the absence of acceptor.  FD(λ) is 
the integral of the corrected fluorescence intensity of the donor and εA(λ) is the 
extinction coefficient of the acceptor at wavelength λ.  The rate of ET is inversely 
proportional to the sixth power of the distance r, between the donor and the acceptor.  
The overlap integral J(λ) is given as: 
 
J(!) =
!
0
! FD(!)"A(!)!4d! (ii)
 
 
 3 
The Förster radius, R0, is the distance r, at which the rate of ET is equal to the rate of 
decay of the donor (1/τD) in the absence of the acceptor.  Therefore it is also the distance 
at which FRET is 50 % efficient.  At r = Ro, kT = (1/τD) and equation (i) can be written 
as: 
R0
6 =
9000(ln 10)QD!
2
128"5Nn4
!
0
! FD(#)$A(#)#4d# (iii)
 
 
R0 is typically in the range of 20 to 60 Å for organic fluorophores.  The ET rate can be 
calculated by: 
kT(r) =
1
!D r
R0
6
(iv)
 
 
The efficiency of ET, E, is the fractions of photons absorbed by the donor that are 
transferred to the acceptor.  E is given by: 
 
E =
kT(r)
!D
–1 + kT(r)
(v)
 
 
which is the ratio of the energy transfer rate to the total decay rate of the donor.  Hence 
the ET efficiency can be easily calculated from the fluorescence emission intensity of the 
donor in the absence and in the presence of the acceptor or from the fluorescence 
lifetime of the excited donor in the presence and absence of the donor (equation vi).1 
 
E =
!D
!D – !DA
(vi)
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1.3 Through-bond Energy Transfer (TBET) 
The idea of through-bond energy transfer was reported by Lindsey and co-workers in 
1994.3  They used a boron-dipyrromethene (BODIPY) as a donor and zinc-coordinated 
porphyrin as an acceptor.  The concept of TBET cassettes is that when donor and 
acceptor systems are connected via conjugated linkers that do not allow them to become 
planar, then rapid energy transfer from the donor to the acceptor may occur in through 
bonds (Figure 1.2).  Through-bond energy transfer is mechanistically different to FRET 
(Figure 1.3), and there is no known requirement of overlapping of the emission of the 
donor fragment with the absorption of the acceptor part.  Therefore, appropriately 
designed through-bond energy transfer cassettes could absorb photons via a donor part, 
or parts, at a convenient wavelength (eg 488 nm: excitation from an argon-laser), 
transfer the energy rapidly through the conjugated linker to the acceptor fragment that 
emits at a far longer wavelength.  There is no constraint on the difference between the 
donor absorption and the acceptor emission wavelengths in this system.  Consequently it 
is possible to design dyes that absorb strongly at a short wavelength and emit brightly 
with very similar intensities at several wavelengths (governed by the chemical nature of 
the acceptor) that are many wavenumbers apart, ie with excellent resolution.  Coupling 
more than one donor in a conjugated system with an acceptor facilitates absorption of 
more light thereby increasing the intensity of the emission.  In summary, through bond 
energy transfer cassettes have the potential to increase both the resolution and 
fluorescence intensities obtained from several probes excited by a laser source operating 
at a single wavelength. 
 
n
hv
donor acceptor
hv'
through-bond energy transfer
! electron conjugated linkage  
Figure 1.2.  The concept of through-bond energy transfer cassette. 
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hv
donor acceptor
hv'
through-space energy transfer
non-conjugated linkage  
Figure 1.3.  Through-space energy transfer (concept for FRET). 
 
 
1.4 Multiplexing in Cellular Imaging 
Cellular imaging has become essential to obtain information about protein 
expression and molecular dynamics of protein in cells.  Various techniques for 
fluorescence imaging of cells have been reported.4  Multiplexing is useful for gaining 
information simultaneously from the different parts of the cell.  Multiplexed observation 
of fluorescently tagged biochemical components is simplest when all the tags are excited 
using the same laser source; the equipment required is less complex and all the labels 
receive the same input power.  However, fluorescent dyes that emit close to the 
excitation source tend to absorb light most efficiently since they have the greatest 
absorption at that wavelength, while those dyes that emit further into the red have red-
shifted absorption spectra and harvest less photons at the excitation wavelength.  
Combinations of dyes arranged to maximize FRET only partially alleviate this 
problem5,6 because poor overlap of donor emission with acceptor dye absorption gives 
inefficient energy transfer. 
The use of TBET cassettes will probably facilitate multiplexing study in the cells 
because only single excitation wavelength is required to obtain multiple fluorescent 
colors.  Figure 1.4 demonstrates the plausible multiplexing for protein interaction in the 
cell.  Each TBET cassettes are conjugated with different proteins and those dye-protein 
conjugates will be imported to corresponding places of the cell (eg: nucleus, golgi, 
mitochondria, lysosome...) with carrier protein.  The excitation at single wavelength will 
hypothetically give multiple colors at the same time from the places to which cassette-
 6 
protein conjugates were imported.  It is possible to obtain simultaneous fluorescent 
signals from the cells, and therefore it is very time efficient.  Thus TBET-cassettes can 
be used to obtain information about protein-protein interaction in vitro and ex vivo.  The 
number of false positives can also be reduced to a greater extend by using TBET-
cassettes instead of FRET based systems. 
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Figure 1.4.  Plausible multiplexing imaging of the cell. 
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1.5 Specific Labeling of Proteins 
Fluorescent labeling of proteins has become an essential tool in biological assays. 
Amino acids containing reactive functional groups such as thiol (cysteine) and primary 
amine (lysine), are usually reacted with succinimidyl esters or maleimides of dyes to 
label proteins.  However these labeling methods are non-specific.  The site-specific 
labeling of tetra-cysteines was reported by Tsien and co-workers.7  Recombinant 
proteins containing tetra-cysteines was successfully tagged by bisarsenical fluorophore 
(FlAsH tag) and this small tag is membrane permeable and binds with high affinity.  The 
small peptide containing tetra-cysteines were also selectively tagged by Cy3 based 
bisarsenical dyes.8  Di-cysteine of recombinant protein was labeled by dimaleimide 
fluorogens, but the distance between two cysteines must be ca. 10 Å which is almost 
similar to two maleimide groups.9  In recent years, the specific labeling of recombinant 
proteins which contains an unnatural amino acid have been reported by some groups.  
Tirrell et al reported the specific dye-labeling between a terminal alkyne on protein and 
an azide on coumarin via 2+3 cycloaddition reaction.10  The C-terminus of green 
fluorescent protein (GFP) was modified with aniline derivative and this aromatic amine 
was specifically reacted with rhodamine analogue via oxidative coupling and this work 
was done by Francis’ group.11  More recently, Schultz, Deniz et al reported the synthesis 
of recombinant T4 lysozyme (T4L*) containing one cysteine residue and one ketone 
functionality which is formed by the incorporation of unnatural amino acid, p-
acetylphenylalanine.  The dual-labeling of cysteine (thiol-group) and ketone were 
performed with Alexa594-maleimide and Alexa488-ONH2, respectively.  The resulting 
dyes-T4L* conjugate had a desired FRET efficiency.12  There are many reports about  
site-specific labeling of recombinant biomolecules as shown above.  The application of 
such techniques to native proteins could be possible via the slight modification of natural 
biomolecules. 
 8 
CHAPTER II 
 
SYNTHESIS OF WATER-SOLUBLE FLUORESCENT PROBES 
 
2.1 Introduction 
Water-soluble fluorescent probes are essential tools in intracellular imaging.  These 
dyes must have significant water solubilities and high quantum yields at physiological 
pH.  The most widely used fluorescent probes are the Alexa Fluor series (developed by 
Molecular Probes, Inc. Figure 2.1).13  The core structures of these dyes are based on 
coumarin and rhodamine, and each dye has one or two sulfonic acids to enhance water 
solubility and carboxylic acids to conjugate with biomolecules.  All Alexa Fluor dyes 
tend to be more fluorescent and photostable than other commonly used dyes, e.g. 
fluorescein, rhodamine 6G, and Texas Red.  Alexa Fluor dyes are pH insensitive in the 
range of 4 to 10, and they have high quantum yields in aqueous media.  Their dye-
protein conjugates also tend to have relatively high quantum yields.  Moreover, 
absorption and emission wavelengths of Alexa Fluor series cover from UV-vis to NIR 
regions, but the structures of NIR Alexa dyes have not been published. 
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Figure 2.1.  Structure of Alexa Fluor series.  The numbers in the Alexa names 
correspond to the approximate λabs max of each dyes. 
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All the Alexa Fluor dyes are sulfonated; this helps in improving water-solubility and 
preventing aggregation with good photophysical properties.  Purification of water-
soluble fluorescent dyes are usually difficult due to the high polarities of dyes.  Some 
cases require a reverse phase preparative HPLC and this is unsuitable for large scale 
syntheses.  In those cases, a better synthetic approach is required and purification 
procedures have to be modified.  Therefore, the specific aims for synthesizing 
fluorescent probes are as follows: 
 
(i) design of molecules which absorb and fluoresce in the desired wavelengths; 
(ii) convenient synthesis and easy purification of fluorophores; and, 
(iii) high quantum yields and water-solubilities at physiological pH. 
 
We will describe three fluorescent dyes: carboxyfluorescein, water-soluble BODIPY 
dye, and water-soluble Nile Blue derivatives.  Syntheses of these dyes and their 
photophysical properties will be discussed and some biological applications of BODIPY 
and Nile Blue dyes will also be shown. 
 
 
2.2 Fluorescein Derivatives 
Fluorescein is a highly fluorescent molecule that absorbs at 492 nm and emits at 517 
nm in water, with a quantum yield of 0.92 at pH > 8.  The synthesis of fluorescein via 
condensation reaction of resorcinol with phthalic anhydride catalyzed by zinc chloride 
was first reported in 1871 by von Baeyer.14  Despite their widespread use in biological 
studies, fluorescein has some remarkable deficiencies.  First and foremost, fluorescein-
based dyes cause irreversible photobleaching, which results in a rapid decrease of 
fluorescent signal.  Second, in aqueous media, it can exist as cationic, neutral, anionic 
and dianionic forms, making its absorption and fluorescence properties highly pH 
dependent (Figure 2.2).15  Third, the dye-protein conjugates usually tend to show a 
fluorescence quenching relative to that of the free fluorophore.  This leads to the protein-
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dye conjugates exhibiting less fluorescence even with increasing number of dye 
molecules conjugated to protein,16,17 reducing the sensitivity that is possible for assays 
using fluorescein conjugates. 
 
 
O OH2O
CO2H
O OHO
CO2H
O OHO
CO2
–
O O–O
CO2
–
O OHHO
O
O
O OH–O
O
O
cationic
neutral
! 0.29
anionic
! 0.36
dianionic
! 0.93
lactone
anionic
lactone
pKa 2.08
pKa 4.31
pKa 6.43
 
Figure 2.2.  Different ionic forms of fluorescein in various pH’s. 
 
 
2’,7’-Halogenated fluorescein derivatives have been synthesized and used in 
biological studies by many researchers (Figure 2.3).  These halogen atoms dramatically 
change the electron density of xanthene part of fluorescein because of highly 
electronegative nature and small van der Waals radius.  These features make the dyes 
exist as anionic forms at lower pH, resulting in higher quantum yield and photostability 
in acidic media.  A chlorine substituted fluorescein, 4’,5-alkylated-2’,7’-
dichlorofluorescein derivative was used as a cell-permeable fluorescent probe for zinc 
sensor by Lippard.18,19  The functionalized 2’,7’-dichlorofluorescein derivatives were 
well studied as metal (palladium20 and mercury21) and specific RNA22-24 sensors by 
Koide. 
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Figure 2.3.  Structures of fluorescein and halogenated-fluorescein derivative. 
 
 
The synthesis and photophysical properties of 2’,7’-difluorofluorescein (also called 
Oregon Green, with pKa of 4.8) were first described in 1997 by Sun and co-workers.15  
This probe has a similar quantum yield (Φ 0.97, pH 9.0) to fluorescein, but with superior 
photostability.  In 2005, Nagano and co-workers reported a novel series of fluorescein 
derivatives where benzene moiety was functionalized by methyl or methoxy group 
(called Tokyo Greens).25  Tokyo Green showed almost the same fluorescent properties 
as fluorescein and has less pH dependence than that of fluorescein.  Moreover, the 
synthesis of Tokyo Green was carried out via Grignard coupling of substituted 
bromobenzenes and xanthone and this reaction yielded a single isomer in high yield of 
96 %.  More recently, Peterson and co-workers reported a novel fluorophore (called 
Pennsylvania Green) which has similar pH-insensitivity and photostability as compared 
to Oregon Green and hydrophobicity similar to Tokyo Green.26  At pH 9.0, 5-carboxy-
Pennsylvania Green and 5-carboxy-Tokyo Green have similar quantum yields of 0.91 
and 0.93, respectively.  However, at pH 5.0, more acidic media, 5-carboxy-Pennsylvania 
Green was substantially brighter with a quantum yield of 0.68 compared with 0.39 for 
the 5-carboxy-Tokyo Green.  Further, Pennsylvania Green is more photostable than 
Tokyo Green, which makes it a very useful fluorophore in biological assays. 
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One of the most interesting applications of Pennsylvania Green is as a SNAP-Tag27 
based biological assays.  Fluorescent probes 1 and 2 derived from O6-benzylguanine 
were described by Peterson (Figure 2.4a).28  O6-Benzylguanine derivatives (SNAP-Tag 
substrates) are useful molecular probes for cellular study because they selectively 
alkylate the DNA repair protein O6-alkylguanine DNA alkyltransferase (AGT), and it 
produces the covalent labeling of AGT fusion proteins (SNAP-Tag fusion protein).  
AGT is an important protein because the lack of AGT causes apoptosis and mutagenesis 
of cell. 
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Figure 2.4.  a; Structures of O6-benzylguanine-Pennsylvania and Oregon green, 
b; reaction mechanism of SNAP-tag assay. 
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The reaction mechanism of SNAP-Tag involves the nuclephilic attack of cysteine 
residue-145 of AGT on alkylguanine and the fluorescent labeled fusion protein is formed 
by releasing a guanine molecule (Figure 2.4b).  Next, to compare the cellular 
permeability of 1 and 2, Chinese hamster ovary-K1 (CHO) cells were used for this 
biological assay.  For the imaging of cellular plasma membrane, AGT was fused to a C-
terminal CAAX peptide sequence from a human Ras protein and treated with probes 1 or 
2.  On the other hand, AGT was fused to the C-terminus of the human histone 2B (H2B) 
protein and treated with fluorescent probes 1 or 2 to image the localization inside of cell 
nucleus.  For molecular probe 1, the clear labeling of cellular plasma membrane was 
observed, but only punctate fluorescence was detected in the cytoplasm of the subset of 
transfected cells for probe 2.  A strong fluorescence output was observed in the cell 
nucleus for probe 1, however, only weak nuclear fluorescence signal was detected for 
probe 2. 
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Figure 2.5.  Structures of 5- and 6-carboxyfluorescein. 
 
 
Although fluorescein has some deficiencies like pH sensitivity and poor 
photostability as shown in previous chapter, the derivatives of fluorescein, 5- and 6-
carboxyfluorescein 3 (also called FAM) are still widely used in biological imaging 
studies (Figure 2.5).  Many researchers use these compounds in biochemistry and 
medicinal chemistry and many papers have been published.  In 2006, Onoue and co-
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wokers reported the synthesis of C-terminally coupled 5-carboxyfluorescein TP5 (TP5-
FAM) as a fluorescent probe for thymopoietin receptor via solid-phase synthesis 
(Scheme 2.1).29  TP5 (thymopentin) is a synthetic pentapeptide fragment which has a 
specific amino acid sequence (Arg-Lys-Asp-Val-Tyr).  This sequence corresponds to the 
32-36 fragment of thymic polypeptide thymopoietin.  The fluorescent cellular imaging 
shows a specific binding of TP5-FAM to the thymopoietin receptor in MOLT-4 (human 
acute lymphoblastic leukemia cell line) with a dissociation constant (Kd) of 33.3 µM. 
 
 
Scheme 2.1.  Synthesis of TP5-FAM. 
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In 2008, Dubertret, Doris and co-workers reported the synthesis of new nanohybrids 
that consists of quantum dots (QDs) and CrAsH which is a FlAsH analogue.30  FlAsH 
(Fluorescein Arsenical Helix binder) is known as a fluorescein tag that specifically bind 
to tetra-cysteine of protein.7,31  The synthesis of CrAsH is shown in Scheme 2.2; 
mercuration of 6-carboxyfluorescein followed by transmetalation with AsCl3 and ligand 
exchange with ethanedithiol gave CrAsH (overall yield: 30 %).  Next, QD based on 
CdSe/CdZnS was encapusulated with poly(ethylene glycol) phospholipids to give 
hydrophilic and biocompartible QD micelles and this QD was further reacted with 
CrAsH via EDC-coupling to form CrAsH-QD nanohybrids (Figure 2.6). 
 
Scheme 2.2.  Synthesis of CrAsH. 
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Figure 2.6.  Formation of CrAsH-QD nanohybrids. 
 
The affinity of this CrAsH-QD nanohybrids was then tested for the tetra-cysteine 
tagged proteins.  This nanohybrid was treated with a viral lysate containing target 
cysteines and the increase of fluorescence intensity was observed when the concentration 
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of lysate was increased.  On the other hand, this nanohybrid was also treated with a viral 
lysate without target tetra-cysteine as a control experimental, and it resulted in a weak 
fluorescent signal.  These data shows that CrAsH-QD specifically binds to tetra-cysteine 
residues of protein. 
 
2.2.1 Results and Discussion (Preparation of 5- and 6-Carboxyfluorescein) 
Despite the widespread applications of 5- and 6-carboxyfluorescein32 as molecular 
probes,33-35 it is surprisingly difficult to obtain these compounds as pure regioisomers.  
These mixtures can be usually separated via preparative HPLC and such separation is 
not suitable for the large scale synthesis.  The commercial samples of these isomers are  
very expensive.  Therefore procedure for large-scale preparation of these fluorescein 
derivatives would definitely be preferred.  We have reported a fractional crystallization 
procedure for the preparation of pure 5- and 6-carboxyfluorescein isomers in mult-gram 
amounts. (Scheme 2.3).36 
 
Scheme 2.3.  Synthesis of 5- and 6-carboxyfluorescein 3. 
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The approach of purification via fractional crystallization is used for halogenated 
fluoresceins,15,37,38 and also for 5- and 6-carboxyfluorescein via a procedure that 
involves intermediates 5 (Figure 2.7).39  However, the latter procedure is not easily 
reproducible,34 and resorted to reduction of the 5- or 6-carboxylic acid functionality and 
separation of the regioisomers of this material instead.   
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Figure 2.7.  Structures of intermediate 5 and cyclic lactone form 6a. 
 
 
The key observation that led to the our procedure is that the compound formed from 
condensation of 4-carboxyphthalic anhydride with resorcinol in the presence of 
methanesulfonic acid was different to that formed when other acids were used (Scheme 
2.3).  Figure 2.8a shows the aromatic region of the 1H NMR spectrum of the product 4a 
formed from the condensation reaction, then purified via fractional crystallization.  
Treatment of this 4a with sodium hydroxide, then protonation with HCl affords a 
different material (Figure 2.8b): this compound is assumed to be cyclic lactone 6a.  
Conversely, product 4a was regenerated when 6a was treated with excess 
methanesulfonic acid.  Characterization of structures 4a and 4b to the products of the 
initial reaction was certified by data from elemental analyses. 
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Figure 2.8.  Aromatic 1H NMR (CD3OD) regions of: a, compound 4a; and, b, 
compound 6a formed from treatment of 4a with NaOH then HCl. 
 
 
The reaction shown in Scheme 2.3 affords compounds 4a and 4b in approximately a 
1:1 ratio.  Recrystallization of 20 g of that mixture from methanol/hexanes (3:1, 800 mL 
total) at –18 ºC gave a crude sample of compound 4b.  A second recrystallization gave 
1.0 g of this material in over 98 % regioisomeric purity by HPLC analysis.  Combination 
of the mother liquors, removal of the solvent, then two recrystallizations from a similar 
solvent system, ethanol/hexanes (3:1, 800 mL total), gave 3.2 g of the 5-carboxy isomer 
4a in over 98 % purity (anal. HPLC).  The mother liquors were again combined, the 
solvents were removed, and two recrystallizations of the residues from 
methanol/hexanes system afforded another 3.0 g of the 6-isomer 4b.  As a result, the 5- 
and 6-isomers were isolated in 3.2 and 4.0 g amounts corresponding to 32 and 40 % 
yields, respectively.  The methanesulfonic acid adducts 4a and 4b were easily converted 
to the 5- and 6-carboxyfluorescein 3a and 3b by treatment with sodium hydroxide 
solution then neutralizing with aq. HCl in quantitative yields. 
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2.2.2 Conclusion 
We synthesized 5- and 6-carboxyfluorescein 3 in multi-gram scale and high purity (> 
98 % by anal. HPLC) via a fractional crystallization with methanol/hexanes or 
ethanol/hexanes systems.  The procedures are reproducible and extremely convenient 
syntheses to produce pure 5- and 6-isomers.  In recent years, halogenated fluorescein 
derivatives such as Oregon, Tokyo, and Pennsylvania Greens have often used because of 
their excellent photostability.  However, 5- and 6-carboxyfluorescein are still powerful 
tools as fluorescent probes in biological application, and actually our fractional 
crystallization method has been often used by many other groups. 
 
2.3 Water-soluble BODIPY™ Dyes 
4,4-Difluoro-4-bora-3a,4a-diaza-s-indacene (BODIPY™) dyes are the widely used 
fluorescent probes in biological assays such as labeling of proteins40-44 or DNA.45  In 
spite of their small core structure, they tend to be strongly UV-absorbing and emit sharp 
fluorescence peaks with high quantum yields in the range of 500–700 nm.  These dyes 
are relatively photostable, and insensitive to the polarity and pH of their environment.  
Moreover, BODIPYs are reasonably stable to physiological conditions.  The 
modification of BODIPY core (i.e. extended conjugation) and functionalization of the 
benzene moiety have been described by many researchers46-49 and our group has also 
reported syntheses of functionalized BODIPY dye including water-soluble fluorophore 
in recent years.50-53 
Dehaen et al reported the useful selective functionalization of 3-chloro or 3,5-
dichloro BODIPY 7 by replacing chlorine with various nucleophiles via SNAr 
reaction54,55 or aromatic substituents via Pd-catalyzed cross-coupling reactions (Figure 
2.9a).56  The member in our group reported the synthesis of BODIPY 8 and 9, and 
studied the reactivity of SNAr reaction (Figure 2.9b).57  SNAr reaction of dye 9 smoothly 
worked because of the enhancement of reactivity by the trifluoro-group and the member 
in our group even succeeded the direct attachment of this dye 9 to protein (avidin was 
used), but the quantum yield of dye-protein conjugate was not reported.  The water-
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soluble derivatives of dye 9 were also made, compounds 10, 11 and 12, and their 
quantum yields in pH 7.4 buffer were quite high (Figure 2.10).57  Therefore, the 
modification of BODIPY 9 by different water-solubilizing groups can produce a variety 
of useful fluorescent probes for biological studies.  In this section, the synthesis of new 
water-soluble BODIPY derivative based on dye 9 and its photophysical properties will 
be covered.  The quantum yield of this new dye conjugated with protein in aqueous 
medium will also be discussed. 
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Figure 2.9.  a: Dehaen’s nucleophilic and Pd-catalyzed reaction systems, 
b: nucleophilic reaction systems studied in our group. 
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Figure 2.10.  Water-soluble BODIPY derivatives 10, 11, and 12. 
 
 
The water-soluble fluorescent dyes are definitely preferred for bioimaging studies 
and the use of oligoethylene glycol is one of the best strategies for synthesizing this class 
of dyes.  There are many advantages for using oligoethylene glycol, (i) increases water-
solubility, (ii) prevents aggregation because of its random orientation, (iii) serves dual 
purpose of increasing quantum yield in aqueous media and acting as a surfactant Triton 
X-100, and (iv) easy to work-up compared to other water-solubilizing groups (eg: 
sulfonic acid or phosphoric acid).  A few methods for preparing oligoethylene glycol 
units have been reported so far, however, even the best method requires a long reaction 
time and several chromatographic separations.58  In fact, the routes that feature iterative 
SN2 ether-bond-forming steps are vulnerable to formation of vinyl ether side-products 
via competing elimination reactions.  In 2006, the member in our group reported an 
iterative route to functionalized ethylene glycol units using copper-catalyzed [2+3] 
cycloaddition of azides to alkynes (also called “click” chemistry).59  This new 
methodology provided the triazole-decorated oligoethylene glycol with several end 
groups, and only one chromatographic separation in the closing stage gave the pure 
product 13 in moderate yield (overall 39 % yield, Scheme 2.4).   
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Scheme 2.4.  An iterative route to functionalized ethylene glycol. 
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2.3.1 Results and Discussion (Synthesis of Water-soluble BODIPY Derivative) 
We chose the above strategy to synthesize the new water-soluble oligoethylene 
glycol linker 14 (Figure 2.11).  Two hexaethylene glycol units are connected with 
triazole ring, and one end of ethylene glycol has a carboxylic acid for conjugation with 
biomolecules and the other end, an azido-group which will be used to form a triazole 
ring with alkyne on BODIPY dye via click chemistry. 
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Figure 2.11.  Structure of target functionalized ethylene glycol 14. 
 
To synthesize our target molecule 14, we needed two ethylene glycol units.  For the 
first unit, mono-tosylation58 of a hexaethylene glycol followed by the replacement with 
azido-group gave the mono-azido hexaethylene glycol 16.  This 16 was tosylated60 to 
afford an azido-hexaethylene glycol tosylate 17 (Scheme 2.5). 
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Scheme 2.5.  Synthesis of first ethylene glycol unit 17. 
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The synthesis of second unit involves the two steps.  Hexaethylene glycol was mono-
propargylated with propargyl bromide to give 18.  Compound 18 was then reacted with 
tert-butylbromo acetate to afford propargylated-ethylene glycol tert-butyl ester 19 
(Scheme 2.6). 
 
 
Scheme 2.6. Synthesis of second ethylene glycol unit 19. 
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The azido-ethylene glycol tosylate 17 and propargylated ethylene glycol ester 19 
were then reacted via a copper-catalyzed [2+3] cycloaddition to give triazole 20.  The 
tosyl group of 20 was replaced with azide to afford ester 21 in 95 % yield without 
chromatographic separation (Scheme 2.7). 
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Scheme 2.7.  Cu-catalyzed cycloaddition reaction of tosylate 17 and ester 19. 
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Ester 21 was then deprotected under mild reaction conditions (TFA/CH2Cl2, 25 ºC, 2 
h).  Trifluoroacetic acid and CH2Cl2 were removed and virtually pure target molecule 14 
was obtained in 99 % yield (Scheme 2.8). 
 
 
Scheme 2.8.  Synthesis of water-soluble ethylene glycol 14. 
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The nucleophilic reaction of propargylamine to dichloro-BODIPY 957 which was 
synthesized by Mrs. Lingling Li in our group, selectively gave the desired mono-
propargylated BODIPY 22 in 99 % yield at room temperature (Scheme 2.9).  Similar 
nucleophilic reaction at higher temperature (acetonitrile, reflux) gave di-substituted 
BODIPY derivative and this was done by Dehaen et al.55 
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Scheme 2.9.  Propargylation of BODIPY 9. 
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Building on the above results, a copper-catalyzed [2+3] cycloaddition of BODIPY 
22 with ethylene glycol linker 14 gave the target water-soluble BODIPY 23 in 76 % 
yield (Scheme 2.10).  Photophysical properties of dye 23 will be shown in the next 
section. 
 
Scheme 2.10.  Click reaction of BODIPY 22 and ethylene glycol 14. 
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Figure 2.12 represents the structure of BODIPY 12 and 23.  Dye 12 was synthesized 
by Mrs. Lingling Li and used as a control compound against dye 23 to compare their 
photophysical properties.  Figure 2.13 shows the UV absorption and fluorescence 
emission spectra for dye 12 and 23 in MeOH and pH 7.4 buffer.  Almost similar UV 
absorption and emission maxima were obtained for both dyes in MeOH.  UV absorption 
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of 23 resulted in a slight red-shift compared to that of 12 in pH 7.4 phosphate buffer.  
This is due to the enhanced water-solubility of dye 23; however, the fluorescence 
emission maxima of dye 12 and 23 were quite similar.  More details concerning the 
photophysical properties for these dyes are presented in the table on page 30. 
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Figure 2.12.  Structures of BODIPY 12 and 23. 
 
 
 
Figure 2.13.  Normalized UV absorption and fluorescence emission spectra of dyes 12 
and 23 in MeOH and pH 7.4 phosphate buffer. 
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Figure 2.13.  Continued.   
 
 
 
We next studied the effects of linker length on the photophysical properties of dye-
protein conjugates 12 and 23.  To perform this study, we first made dye-protein 
conjugates 12-BSA and 23-BSA (Scheme 2.11).  The carboxylic acid of dye 12 or 23 
were activated using NHS and DIC in DMF at 25 ºC.  The subsequent coupling reaction 
of activated dye 12 and 23 with BSA in pH 8.3 buffer followed by size exclusion column 
chromatography and lyophilization of the solvents afforded the dye-protein conjugates 
12-BSA and 23-BSA as a light yellow powder.  The dye:protein ratio for 12-BSA and 
23-BSA were calculated61 to be 2.5 and 1.3, respectively.  Figure 2.14 shows the 
normalized UV absorption and fluorescence spectra for dye-protein conjugates in pH 7.4 
buffer. 
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Scheme 2.11.  Syntheses of dye-protein conjugates 12-BSA and 23-BSA. 
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Figure 2.14.  Normalized UV absorption and fluorescence emission spectra of 12-BSA 
and 23-BSA in pH 7.4 phosphate buffer. 
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Steady-state fluorescence spectroscopic studies were performed on a Cary Eclipse 
fluorometer for the determination of quantum yields.  The slit width was 5 nm for both 
excitation and emission.  The relative quantum yield of the samples were obtained by 
comparing the area under the corrected emission spectrum of the test sample with that of 
a solution of fluorescein in 0.1 N NaOH, which has a quantum yield of 0.92 according to 
the literature.62  The quantum efficiencies of fluorescence were obtained from multiple 
measurements (N = 3) with the following equation: 
 
Φx = Φst (Ix/Ist) (Ast/Ax) (ηx2/ηst2) 
 
 Where Φst is the reported quantum yield of the standard, I is the area under the 
emission spectra, A is the absorbance at the excitation wavelength and η  is the refractive 
index of the solvent used, measured on a pocket refractometer from ATAGO.  X 
subscript denotes unknown, and st denotes standard.63  
 Table 2.1 shows the photophysical properties for free dyes, hexanoic acid BODIPY 
12 and oligoethylene glycol BODIPY 23, and dye-protein conjugates 12-BSA and 23-
BSA.  In MeOH, UV absorption and fluorescence maximum for 12 and 23 were almost 
the same (12: λabs 490 nm, λemiss 537 nm, 23: λabs 494 nm, λemiss 541 nm).  The quantum 
yield of dye 12 in MeOH (Φ 0.70) is slightly higher than that of 23 (Φ 0.65).  Similar 
photophysical properties were obtained when the UV and fluorescence were measured in 
pH 7.4 except for extinction coefficient.  The extinction coefficient of dye 23 in MeOH 
and pH 7.4 were decreased by about one-third and by half of those of dye 12, in 
respective solvents.  The quantum yield of dye 23 was increased by 0.1 in pH 7.4 
compared to MeOH.  This is due to the increasing water-solubility of fluorophore; 
actually dye 23 is highly water-soluble in aqueous media.  The quantum yields of 12-
BSA and 23-BSA in pH 7.4 were decreased by 30 and 41 % from those of free dyes, 
respectively.   
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Table 2.1.  Photophysical properties of free dyes and dye-protein conjugates. 
dye solvent λmax abs 
(nm) 
ε 
(M–1cm–1) 
λmax emiss 
(nm) 
fwhm 
(nm) 
Φc 
 
       
12 MeOH 490 34300 537 56 0.70 
12 pH 7.4a 468 24900 541 61 0.74 
12-BSA pH 7.4 488 – 538 56 0.52 
       
23 MeOH 494 11700 541 54 0.65 
23 pH 7.4 482 14000 545 56 0.74 
23-BSA pH 7.4 489 – 544 59 0.44 
                 a sodium phosphate buffer; b fluorescein was used as a standard (Φ 0.92 in 
           0.1 N NaOH). 
 
2.3.2 Conclusion 
We synthesized two water-soluble BODIPY derivatives with short (12) and long 
chains (23).  The absorption and fluorescence maxima of dye 12 were similar to those of 
dye 23.  Dye 12 had good photophysical properties in MeOH and pH 7.4 phosphate 
buffer with quantum yields of 0.70 and 0.74, respectively.  The BODIPY with the PEG 
chain (23) had a quantum yield of 0.65 in MeOH, and in aqueous medium the quantum 
yield improved by a factor of 0.1 to 0.74.  This phenomenon is due to the enhancement 
of water-solubility of dye 23.  Moreover, dye-protein conjugates of 12 and 23 were 
synthesized and their photophysical properties were studied in aqueous medium.  The 
quantum yields of dye-protein conjugates 12 and 23 were decreased only by 30 and 41 
% from those of free dyes, respectively.  The quantum yield of dye-protein conjugates 
dramatically decreases compare to those of free dyes in most cases.  Thus the quantum 
yields of 0.52 for 12-BSA and 0.44 for 23-BSA are highly desirable data at 
physiological pH. 
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2.4 Water-soluble Nile Blue Derivatives 
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Figure 2.15.  Series of benzophenoxazine-based dye. 
 
Benzophenoxazine-based dyes like Meldola’s Blue, Nile Red64, and Nile Blue64 have 
some desirable attributes as fluorescent probes (Figure 2.15).65  Nile Red and Nile Blue 
have reasonably high quantum yields in apolar organic solvents and they fluoresce at 
relatively long wavelengths.  However, none of these dyes are significantly soluble in 
aqueous media and their quantum yields are dramatically reduced.  One of the big 
challenges in the production of fluorescent dyes is to produce water-soluble probes that 
fluoresce strongly in aqueous media, particularly above 600 nm or at even longer 
wavelengths. 
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Figure 2.16.  Water-soluble Nile Red derivatives. 
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The first synthesis of water-soluble Nile Red derivative 24 was described by Briggs 
and co-workers, but  the data for photophysical properties were shown only in methanol 
(λabs 547 nm, λemiss 632 nm).66,67  Our group has reported functionalized water-soluble 
Nile Red derivatives 25 and 26, and their photophysical properties were shown in 
aqueous media (pH 7.4 and pH 9.0).68,69  Dyes 25 and 26 have excellent water-
solubilities and reasonable quantum yields in aqueous media (>0.3).  Moreover, they 
emit fluorescence around 650 nm and have reasonably sharp peaks (Figure 2.16). 
Nile Blue 27 is a fluorescent probe that has been known for over 110 years (Figure 
2.17).64,69  In polar media, its absorption and emission maxima shift to the red, which is 
indicative of stabilized charge separation in the excited state; consequently, this dye has 
been used to monitor events that depend upon solvent polarity.70-72  It has also been used 
for FRET studies.73,74  Nile Blue tends to have a higher affinity for cancerous cells than 
healthy ones75 and it is a photosensitizer for oxygen;76,77 these two properties together 
can be useful in photodynamic therapy.78  However, two properties of Nile Blue in 
aqueous media are limiting for many applications, specifically (i) low solubility and (ii) 
low quantum yield. 
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Figure 2.17.  Photophysical properties of Nile Blue 27 in various solvents. 
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Some work has been reported on Nile Blue derivatives with improved water 
solubilities.79-82  The aggregation of inherently flat, lipophilic aromatic dyes is 
disfavored when they are functionalized with water-solubilizing substituents and their 
quantum yields can improve as a result.  Consequently, Nile Blue derivatives with 
hydrophilic groups can have improved solubilities and fluorescence outputs.  Derivatives 
28 and 29 are the most interesting probes to arise from these studies (Figure 2.18).79  
Their quantum efficiencies are improved by as much as a factor of ten, however, they 
have no carboxylic acid handle for attachment to biomolecules, and the sharpness of 
their emissions broadens as the solvent is changed from methanol to water, which is 
perhaps indicative of aggregation. 
 
N O
N
NH2
ClO4
–
HO3S
N O
N
NH2
ClO4
–
SO3H
28
H2O, ! 0.10
"max abs 633 nm
"max emiss 675 nm
29
H2O, ! 0.03
"max abs 637 nm
"max emiss 677 nm
SO3H
N O
N
NHR
OH
HO3S
SO3H
O
OH
Cl–
30
a b
R =
N O
N
NHR
OH
CO2H
Cl–
HO2C
31
2
2 2
 
Figure 2.18.  Water-soluble Nile Blue derivatives in literature (28 and 29) and from our 
group (30 and 31). 
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2.4.1 Results and Discussion (Synthesis of Water-soluble Nile Blue Derivatives) 
In this section, we discuss the synthesis of 2-hydroxy Nile Blue derivatives 30 and 
3183 and compares their fluorescence properties with those of 28 and 29.  For both 
probes, a 2-hydroxy substituent was incorporated to enhance water solubility and other 
hydrophilic groups are situated on both ends of the molecule to reduce the potential for 
aggregation.  Not all possible applications of these dyes require functional groups for 
attachment to biomolecules, but many do, and compounds 31a and 31b were designed 
for that purpose. 
The western part of targets 30 and 31 were formed from functionalized 
nitrosophenols; these were prepared as outlined in Scheme 2.12.  Nitroso compound 36 
was formed via nitrosylation of phenol 35, a starting material previously used in our 
laboratories for syntheses of Nile Red derivatives.68  The 3-(N-ethylamino)phenol 32 and 
derivative 33 have been previously described in a patent that gives the experimental 
procedures.84  Nitrosylation of phenol 33 gave the nitroso compound 34. 
 
Scheme 2.12.  Syntheses of functionalized aminophenol 34 and 36. 
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Both the aminonaphthol components 37 required for the eastern half of these 
molecules were made via alkylation reactions.  Compound 37a was obtained via 
alkylation with propane sultone (Scheme 2.13a).  The triethylene glycol derivative 39 
was conveniently made via TBDMS-protection and tosylation of the parent diol, then 
this was used to N-alkylate 5-amino-2-naphthol to give compound 40.  Aminonaphthol 
40 was then deprotected to afford compound 37b as shown (Scheme 2.13b).60,85,86 
 
Scheme 2.13.  Syntheses of aminonaphthol components 37. 
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Previous syntheses of Nile Blue derivatives required relatively high temperatures 
and/or strong acids.  Compounds 30 and 31 were made via condensation at a relatively 
low temperature (90 °C) without addition of any additional acids.  The blue products 
were isolated by using medium-pressure liquid chromatography (MPLC) on a reverse 
phase C18 column (Scheme 2.14). 
 
 
Scheme 2.14.  Syntheses of water-soluble Nile Blue derivatives. 
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The electronic spectra (Figure 2.19) of the dyes were recorded in methanol (as a 
representative polar organic solvent), in 0.1 M phosphate buffer at pH 7.4 (PB, Table 
2.2), in the same buffer but with 3 % Triton X-100 (TX), and in 0.1 M pH 9.0 borate 
buffer (BB).  Only 30a and 31a were soluble in MeOH; data for 30b and 31b could not 
be obtained in this medium.  The effects of adding Triton X-100 to the medium are 
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ambiguous; this reagent changes the solvent polarity, but might also prevent aggregation 
effects.71,87,88  In borate buffer at pH 9.0, the phenolic hydroxyl of the dyes will be 
predominately in the anionic form. 
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Figure 2.19.  Absorption (dashed lines) and fluorescence (solid lines) of a: 30a and 31a 
in methanol and 30a,b and 31a,b in b: phosphate buffer (pH 7.4), c: phosphate buffer 
(pH 7.4) with 3% Triton X-100, and d: borate buffer (pH 9.0).  All dyes (2 x 10–6 M) 
were excited at their corresponding λmax. 
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Table 2.2.  Spectroscopic properties of the Nile Blue and its derivatives under different 
conditions. 
dye λabs 
(nm) 
ε 
(M-1cm-1) 
λem. 
(nm) 
fwhm 
(nm) 
Φa solvent 
       
30a 628 14400 662 47 0.56 MeOH 
30a 630 42400 671 52 0.14 PBb 
30a 631 51200 669 49 0.24 TXc 
30a 630 28400 670 56 0.02 BBd 
31a 629 58800 666 50 0.32 MeOH 
31a 630 30300 670 58 0.10 PBb 
31a 629 64100 669 56 0.11 TXc 
31a 631 34500 670 73 0.02 BBd 
30b 629 33600 671 55 0.14 PBb 
30b 628 44400 670 47 0.23 TXc 
30b 630 21800 672 51 0.13 BBd 
31b 632 38100 673 56 0.13 PBb 
31b 631 14700 672 54 0.26 TXc 
31b 630 38000 670 54 0.08 BBd 
27e 635 4000 675 115 0.01 water 
28e 633 36000 675 86 0.10 water 
29e 637 11000 677 93 0.03 water 
a standard used for quantum yield measurement: Nile Blue in MeOH (Φ : 0.27), quantum 
yield measurements were repeated three times and extinction coefficients were measured 
at 10-6 M; b pH 7.4 phosphate buffer; c 3 % Triton X-100 in pH 7.4 phosphate buffer; d 
pH 9.0 borate buffer; e values obtained from ref. [79]. 
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All the dyes under any of the conditions described above, had absorption maxima 
between 628 – 632 nm; consequently, there is little variation of this parameter with 
solvent polarity.  Extinction coefficients for the molecules, however, were in the range 
14,400 – 64,100.  For 30a, 31a, and 30b, the maximum values corresponded to the 
media that includes Triton X-100; such enhancement effects have been observed for 
fluorescent dyes,87,88 including Nile Blue.71  Fluorescent emission maxima for the dyes 
varied between 662 – 673 nm.  The fact that compounds 30a and 31a had fluorescence 
emission maxima in MeOH that were within 9 nm of the values obtained in aqueous 
buffers means that the solvatochromic effects for these two materials are much less than 
for Nile Red.  Further, the lack of significant variations between the emission 
wavelengths in the various buffers indicates that changing the pH away from 
physiological levels and adding lipophilic co-solvents have little effect on these dyes.  
The sharpness of the fluorescent emissions are expressed in terms of full width at half 
maximum peak heights (fwhm; where smaller is sharper).  All the dyes 30 and 31 
emitted with sharper fluorescence peaks than Nile Blue or the more water-soluble forms 
28 and 29 (data shown in Table 2.2 for these dyes is taken from the literature reference).  
Further, in aqueous media the quantum yields for these emissions were in all cases better 
for 30 and 31 relative to Nile Blue and its derivatives 28 and 29.79 
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Figure 2.20 outlines experiments performed to explore aggregation of the dyes in 
aqueous media.  Plots of the normalized UV absorbance versus concentration reveal that 
the λmax abs for compound 30a at 4 µM occurs at 671 nm, with an inflection on the blue 
side of the peak at approximately 600 nm (Figure 2.20a).  This inflection point grows as 
the concentration of the dye was increased; at 16 µM there are two distinct absorption 
maxima, and at higher concentrations, the shorter wavelength absorption becomes 
dominant.  Figure 2.20b shows that at concentrations of up to 4.0 µM the absorbance of 
30a varies in a near linear way with concentration.  Above that concentration, the 
absorbance deviated markedly from linear concentration dependence.  Overall, these 
data may be interpreted to mean that the dye is aggregating at concentrations above ca 
4.0 µM.  Similar analyses using UV absorption indicate that dye 30a deviates from Beer-
Lambert behavior above this concentration.  Probably the dyes are forming fluorescent J-
aggregates at concentrations above ca 4.0 µM, rather than the non-fluorescent H-forms.  
Analyses for dyes 30b, 31a, and 31b (Figures 2.20c – h) indicate very similar behavior.  
Concentration versus absorbance studies indicate that these materials tend to aggregate 
above 4.0 µM. 
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Figure 2.20.  Aggregation studies.  Normalized absorption for various concentrations of 
30a (a), 30b (c), 31a (e), and 31b (g) in phosphate buffer at pH 7.4, and plots of 
absorbance intensity vs. concentration of 30a (b), 30b (d), 31a (f), and 31b (h). 
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Finally the Nile Blue derivative, 31a was used to label ovalbumin by activation of 
the dye-dicarboxylic acids (N-hydroxysuccinimide and N,N’-diisopropylcarbodiimide in 
DMF) followed by addition of this activated probe to protein in 0.1M NaHCO3 solution 
(pH 8.3).  The dye:protein ratio was calculated61 to be 1.1 when 5 eq. of dye was used; 
this corresponds to 22 % labeling efficiency.  This sample was used to obtain the 
spectral data shown in Figure 2.21a.  The wavelengths for the absorption and 
fluorescence maxima for the free dye 31a and the 31a-ovalbumin conjugate were 
observed to be almost identical, but the fluorescence intensity was much less. 
 
 
 
Figure 2.21.  Absorption and fluorescence spectra of covalently and non-covalently 
bonded dye-protein conjugates.  a: Absorbance (blue) and fluorescence (red) spectra of 
31a-ovalbumin in 0.1 M phosphate buffer (pH 7.4).  b: Fluorescence spectra of 31a (5 x 
10–7 M) and blue: 0, green: 3.0, orange: 6.0, and red: 12.0 µM ovalbumin in phosphate 
buffer (pH 6.8), λex = 630 nm.  Inset: Variation in the fluorescence intensity of 31a vs. 
ovalbumin concentration. 
 
 
One application of Nile blue derivatives is to measure protein concentrations; this is 
possible because the fluorescence intensities of Nile blue derivatives tend to increase 
with protein concentration.70  However, one limitation of this method is that the 
solubility of Nile Blue derivatives can be problematic.  Herein, the Nile Blue derivative 
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31a was mixed with increasing concentrations of ovalbumin in pH 6.8 phopsphate 
buffer.  The fluorescence data for this set of experiments are shown in Figure 2.21b.  The 
measurements were performed at different pH values because in one case a covalent 
interaction was formed by using a protocol at pH 8.3, whereas the other was a simple 
addition at a more standard pH.  The fluorescence intensity of 31a was increased when 
the protein was added.  These increases were small, but the concentrations of ovalbumin 
were only varied between 3 – 12 µM, ie also small changes in protein concentration that 
are hard to detect.  Furthermore, unlike in some previous works with lipophilic Nile Blue 
derivatives, use of the water-soluble form 31a circumvented the need for any detergent 
additives. 
 
2.4.2 Conclusion 
The Nile Blue derivatives 30 and 31 have sharper fluorescence emissions (fwhm 30 
nm less), and improved quantum yields in pH 7.4 phosphate buffer relative to the known 
water-soluble Nile Blue derivatives 28 and 29.  They are formed via condensation 
reactions that do not require additional acids or very harsh reaction conditions (DMF, 90 
°C); this is in marked contrast to the syntheses of most other Nile Blue derivatives.  
Preparative HPLC purification of the products was not necessary: they were isolated by 
using reverse phase MPLC with acetonitrile/water as the eluent.  The phenolic OH 
functionalities of dyes 30 and 31 almost certainly increase the water solubilities of these 
compounds.  Alternatively, the phenolic group provides a potential avenue for further 
derivatization of the dyes (eg via triflation and organometallic couplings, or for 
attachment of a handle to enable dyes 30 to be conjugated to proteins).   Three other 
groups that promote water solubilities were included in these studies: a sulfonic acid, 
dicarboxylic acids, and a triethylene glycol fragment.  Despite this, the fluorescence 
properties of the dyes, and presumably their aggregation states at elevated 
concentrations, did not vary significantly.  All the dyes showed little tendency to 
aggregate below 1 – 4 µM; this characteristic would tend to make them useful for 
biochemical studies when used in relatively dilute solutions, but would exclude 
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applications where quantitation is required at higher concentrations.  Probably the most 
useful spectroscopic parameter of the dyes is their fluorescence at relatively long 
wavelengths, 670-680 nm, in aqueous media.  Probes that emit above 650 nm are 
relatively few, yet they tend to be the most useful ones for tissue and intracellular 
imaging applications.89,90 
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CHAPTER III 
 
THROUGH-BOND ENERGY TRANSFER CASSETTES 
FOR MULTIPLEXING  
 
3.1 Introduction 
Through-bond energy transfer (TBET) cassettes consist of donor and acceptor dyes 
connected by π-electron conjugated linkers (e.g. alkene, alkyne, or benzene moiety).  As 
described in Chapter I, a set of TBET cassettes based on one donor and different 
acceptors, simultaneously provides multiple fluorescence by the single excitation of 
donor part and this makes it possible to perform multiplexing. 
Fluorophores which have absorption maxima in the range of 450–530 nm can be 
used as donors.  Coumarin, fluorescein, and BODIPY dyes are some examples of dyes 
that can be used as donors.  However most coumarins tend to have short wavelength 
absorption maxima and thus high energy is required to excite them, and this leads to cell 
damage in biological studies.  Fluorescein and BODIPY dyes are superior because they 
can be excited at 488 nm and emit strong fluorescence.  In fact, we have been focusing 
on these fluorophores as donors for synthesizing TBET cassettes in our laboratory for 
several years.53,91-93 
Acceptor dyes for cassettes, must fluoresce above 600 nm with relatively high 
quantum yields.  The commonly used BODIPY dyes emit around 520 nm, however, 
these dyes with extended conjugation fluoresce above 600 nm, some even in near IR 
region and these were reported by Ziessel as bisisoindolomethene dyes48, Suzuki as 
furan-fused BODIPYs (also called Keio Fluors)49, and Burgess and O’Shea as B,O-
chelated aza-BODIPYs94 (Figure 3.1).  Rosamine dyes are photostable and tend to have 
high quantum yields, but purification of these dyes are usually difficult and gives low 
product yields.  Previous group members attempted the microwave-assisted syntheses of 
5-bromo rosamine derivatives and this approach improved the yields of rosamine dye 
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syntheses compared to syntheses under thermal conditions.95  However, the emission 
maxima of rosamine dyes cannot be easily extended beyond 650 nm. 
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Figure 3.1.  NIR fluorescent probes based on BODIPY dyes. 
 
We are interested in TBET cassettes which fluoresce near IR region.  Cyanine dyes 
fluoresce in the range of 600 to 800 nm with distinct emission maxima and there are no 
reports of TBET cassettes based on these dyes in literature.  Therefore, the specific aims 
for synthesizing TBET cassettes for multiplexing studies are as follows: 
 
(i) study the photophysical properties of cyanine dyes; 
(ii) design and synthesis of a series of TBET cassettes which can be excited at 
single wavelength and fluoresce at multiple wavelengths; and, 
(iii) enhancement of water-solubility and photostability by the encapsulation of 
cassettes with silica or calcium phosphate nanoparticles. 
 
We will discuss the synthesis of BODIPY derivatives as a donor in section 3.2, the 
structural and photophysical properties of cyanine dyes in section 3.3 and the syntheses 
of three TBET cassettes based on BODIPY and cyanine dyes in section 3.4.  The general 
synthetic approaches of encapsulating TBET cassettes in hydrophilic silica or calcium 
phosphate nanoparticles will also be described as applications in section 3.5. 
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3.1.1 Preliminary Through-bond Energy Transfer (TBET) Cassettes  
As a proof of concept, previous group members reported the syntheses and 
photophysical properties of four TBET cassettes 41-44 in 2003 (Figure 3.2).91  These 
cassettes 41-44 were synthesized via Sonogashira coupling between one 5-ethynyl 
fluorescein derivative as a donor and four different 5-bromo rosamine dyes 45-48 as 
acceptors.  Each cassettes fluoresce at different emission wavelengths (538, 582, 603, 
and 616 nm, respectively), when excited at fluorescein donor.  Their emissions are 
dispersed over a 78 nm wavelength range (Figure 3.3), and their fluorescence signals are 
easily differentiated.  When the donor fluorescein of each cassettes was excited at 488 
nm, these four cassettes 41-44 produce four different colors because of their different 
emission wavelengths, thus this property possibly serves for multiplexing study in DNA 
sequencing and cell imaging. 
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Figure 3.2.  TBET cassettes 41-44 and acceptor synthons 45-48 of those cassettes. 
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Figure 3.3. Fluorescence of equimolar EtOH solutions of 41-48 excited at 488 nm. 
 
These four TBET cassettes 41-44 were not water soluble and water-soluble cassettes 
are preferred in biological studies.  To address this issue, previous group members 
attached four carboxylic groups to rosamine component of cassette 41 and synthesized 
water-soluble TBET cassette 49 for intracellular imaging (Figure 3.4).92,96  Cassette 49 
was prepared via Sonogashira coupling between 5-ethynyl fluorescein derivative and 5-
bromo rosamine tetracarboxylic acids derivative. 
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Figure 3.4. Structure of cassette 49 (left) and fluorescence spectra of 49, donor 
fluorescein and acceptor rosamine (right). 
 
 
Cassette 49 shows approximately 80 % energy transfer in pH 8 phosphate buffer 
when cassette is excited at 488 nm which corresponds to the excitation wavelength of 
donor fluorescein (red line, Figure 3.4).  For cellular imaging studies, cassette 49 was 
attached to ACBP (mouse acyl-coenzyme A binding protein) and this dye-protein 
conjugate was imported into COS-7 cells with Chariot which is a cell-penetrating 
peptide.  Chariot is unique insofar as it binds nonselectively and noncovalently to 
extracellular proteins and mediates their transfer into cells.  Cellular imaging of ACBP-
49 conjugate in COS-7 cells showed colocalization around the nuclei.  When the cells 
were excited at 488 nm (excitation of donor fluorescein), the fluorescence signals from 
the acceptor (a filter at 598 nm) were observed and this signal was brighter than that of 
acceptor when it was excited at 520 nm (excitation of acceptor).  According to these 
data, ACBP-49 conjugate in the cell is more visible when the cassette 49 is irradiated at 
the donor excitation; hence, the function of the energy-transfer cassette is demonstrated 
ex vivo. 
 
49
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3.2 Donor Fragments (BODIPY Dyes) 
As described in Chapter II, most BODIPY dyes have excellent photophysical 
properties in organic and aqueous media.  Therefore, BODIPY dyes were chosen as 
donor parts for synthesizing TBET cassettes.   
 
3.2.1 Results and Discussion (4-Halogenated and Ethynyl-BODIPY Derivatives) 
Syntheses of BODIPY dyes involve condensation of two equivalents of pyrrole with 
one equivalent of an aliphatic or aromatic aldehyde, and their syntheses and 
photophysical properties were reviewed by Burgess50 and Ziessel.97  These dyes can be 
easily derivatized to their corresponding halogenated and ethynylated form.  As a 
starting material for BODIPY synthesis, 2-hydroxy-4-iodobenzoic acid was alkylated 
with iodomethane followed by DIBAL reduction to afford primary alcohol 51.  This 
alcohol 51 was oxidized back to iodobenzaldehyde 52 with pyridinium chlorochromate 
in 91 % yield (Scheme 3.1). 
 
 
Scheme 3.1.  Synthesis of 4-iodo-2-methoxybenzaldehyde 52. 
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 51 
4-Iodo-2-methoxybenzaldehyde 52 was condensed with 2.2 eq. of 2,4-
dimethylpyrrole followed by oxidation and BF2-chelation to afford BODIPY 53 in 
moderate yield.  This was coupled with trimethylsilyl acetylene via Sonogashira 
coupling to give TMS-protected BODIPY dye 54 and the TMS-group of this dye was 
deprotected with tetrabutylammonium fluoride to afford 4-ethynyl-BODIPY 55 in 92 % 
yield (Scheme 3.2).  Uses of BODIPY 55 to TBET cassette syntheses will be shown in 
section 3.4. 
 
 
Scheme 3.2.  Synthesis of 4-ethynyl tetramethyl-BODIPY 55. 
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4-Iodo tetramethyl BODIPY with carboxylic acid (58) was next synthesized.  4-
Iodobenzaldehyde 56 (provided by Mr. Liangxing Wu) was condensed with 2,4-
dimethylpyrrole (2.2 eq.) followed by oxidation and BF2-chelation to afford BODIPY 
57.  Methyl ester of this dye was deprotected under mild condition (K2CO3, 
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MeOH/THF/H2O, 25 ºC) and an aqueous work-up gave pure  BODIPY 58 (99 % yield) 
as a control compound for TBET cassette syntheses (Scheme 3.3). 
 
 
Scheme 3.3.  Synthesis of 4-iodo tetramethyl-BODIPY 58. 
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Finally, 5-ethynyl tetramethyl BODIPY with carboxylic acid (63) was synthesized.  
5-Iodobenzaldehyde 59 (provided by Mr. Liangxing Wu) was condensed with 2.2 eq. of 
2,4-dimethylpyrrole followed by oxidation and BF2-chelation to afford BODIPY 60.  
BODIPY 60 was coupled with trimethylsilyl acetylene via Sonogashira coupling to give 
TMS-protected BODIPY dye 61 and TMS-group of this dye was deprotected with 
tetrabutylammonium fluoride to afford 5-ethynyl-BODIPY 62.  Finally the deprotection 
of methyl ester with K2CO3 gave final product 63 (Scheme 3.4).  BODIPY 63 was used 
for the protein mono-labeling (Chapter IV). 
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Scheme 3.4.  Synthesis of 5-ethynyl tetramethyl-BODIPY 63. 
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3.2.2 Conclusion on Donor Synthesis 
In conclusion, we synthesized two useful 4-ethynyl-BODIPY derivatives 55 and 63.  
We also obtained three 4-halogenated derivatives 53, 58 and 60 as an intermediate for 
ethynyl-derivative, and these dyes can be used as donors for TBET cassettes syntheses.  
Similar BODIPY dyes were used to prepare cassettes in our group. 
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3.3 Acceptor Fragments (Cyanine Dyes) 
Cyanine dyes as acceptor fragments for TBET cassettes are promising because they 
have near IR emissions (typically 650-800 nm).  This section outlines structures, 
syntheses, and photophysical properties of general cyanine dyes in literature.  On the 
basis of this knowledge, we attempted to synthesize three iodinated-cyanine dyes.  The 
photophysical properties of these cyanine dyes will also be evaluated. 
 
3.3.1 Cyanine Dyes 
Cyanine dyes have been known for more than 150 years (first synthesized by C. H. 
G. Williams in 1856).98  These dyes tend to have long absorption and emission 
wavelengths (>550 nm) because of its unique structure.  Only few fluorescent probes 
emitting in the near-IR (NIR) region with high quantum yields are reported so far.89,94,99  
Such probes are valuable for intracellular imaging because auto-fluorescence in cells 
tends to obscure the fluorescence emission at wavelengths below ca. 550 nm, but this 
phenomenon becomes less at longer wavelengths.  Fluorescent probes that emit in the 
700–900 nm region are, therefore, relatively easy to visualize in vivo,90 and cyanine dye 
is the most widely used NIR fluorescent probes.  Futher, cyanine dyes are the least 
cyctotoxic dyes known till date,90 thus the use of cyanines is highly suitable for the 
biological assays. 
Cyanine dyes are categorized into three major groups: streptocyanines (or open 
cyanines), hemicyanines and closed cyanines (Figure 3.5).  Each two nitrogens are 
joined by polymethine chain (n = 0, 1, 2).  The heteroaromatic parts for hemicyanines 
and closed cyanines can be replaced with a variety of heterocyclic components. 
 
N N
n
N N
n
N N
n
streptocyanines or
open chain cyanines
hemicyanines closed chain cyanines
n = 0, 1, 2  
Figure 3.5.  Structures of cyanine series. 
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Figure 3.6 demonstrates the general structures and photophysical properties of 
cyanine dyes.  The numbers Cy3, Cy5 and Cy7 correspond to the number of carbons in 
polymethine chain.  The extended structures of aromatic parts are known as Cy3.5 and 
Cy5.5 where the benzene ring is replaced with naphthalene.  As shown in Figure 3.6, all 
cyanine dyes have extremely well separated UV absorption and fluorescence emission 
maxima.  The brightness of cyanine dyes increases with increasing conjugation, and 
dyes tend to have high extinction coefficient with moderate quantum yields.  
Remarkably, Cy3, Cy5 and Cy7 have ca. 100 nm difference in their absorption and 
emission;  this is a useful attribute in multiplexing studies for cellular imaging. 
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Figure 3.6.  General structures of cyanine dye. 
 
Cyanines suffer from low photostabilities and their synthetic manipulations are 
limited due to reactive alkene chain, modification of which may result in loss of 
extended conjugation.  However, there are few frequently used NIR fluorescent probes 
based on cyanine dye in biological assays.  Figure 3.7 shows the structure of those 
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compounds.  Indocyanine green (ICG) is most widely used in biological application 
because it does not have aggregation problem.90  Moreover ICG is one of the least toxic 
fluorescent probes ever administered to humans, with the only known undesirable 
reaction being rare anaphylaxis.  In recent years, some modification of indocyanine 
series have been attempted and the improved fluorophore IRDye78 was synthesized and 
commercialized as its N-hydroxysuccinimide ester to conjugate with biomolecules.  This 
dye has tetra-sulfonic acids and these groups increase water-solubility and also quantum 
yield in aqueous media. 
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Figure 3.7.  Most commonly used NIR dyes.  
 
Cyanine dyes can also act as pH sensitive fluorescent probes.  Cooper et al reported 
synthesis of water-soluble Cy5 pH probe and studied its fluorescent property in the range 
of pH 4.5-9.100  In this study, one of alkyl groups on nitrogen of heterocyclic ring is 
replaced with hydrogen.  In acidic media, this nitrogen is protonated and cyanine dye 
exists as fluorescent form.  On the other hand, this hydrogen is deprotonated in basic 
media and it showed almost no fluorescence above pH 8.  In fact, protonated form 
(cyanine dye) and deprotonated form (base form) resulted in different characteristic 
absorption maximum at 645 nm and 480 nm, respectively.  In basic media, the 
absorption maximum at 645 nm is greatly reduced as a new peak evolves at 480 nm.  
Recently similar pH probe based on cyanine dye was described by Hilderbrand’s group 
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and they studied ratiometric pH imaging in the cells and biological tissues.101  More 
recently, a new type of pH probe based on cyanine dye was reported by Achilefu et al 
and this probe was synthesized via barbituric acid mediated synthesis.102 
 
3.3.2 General Synthesis of Cyanine Dyes 
Both symmetric and unsymmetric cyanine dyes can be synthesized from heterocyclic 
compounds, and their syntheses and photophysical properties were reviewd by 
Behera.103  Scheme 3.5 shows a general synthesis of cyanine dyes.  This reaction is 
usually done by either one-pot or two steps reactions.  The advantages of cyanine dye 
synthesis are the relatively short reaction time and easy work-up procedure.  After the 
reaction, cyanine dyes are usually precipitated by addition of ether and most impurities 
can be removed with ether.104  At first, the indole 64 reacts with N,N’-
diphenylformamidine to form hemicyanine intermediate 65.  This intermediate can also 
be isolated.  Second, an another molecule of indole 66 reacts with intermediate 65 under 
mild condition (pyridine, 25 ºC) to afford a desired cyanine dye 67. 
 
 
Scheme 3.5.  General synthesis of cyanine dyes. 
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Solution phase syntheses of cyanine dyes sometimes require laborious 
chromatographic separation of intermediates or the final dye products.  To avoid this, 
solid-phase approaches to cyanine dyes were described by Balasubramanian (Scheme 
3.6).105,106  Hemicyanine 69 was synthesized from indole 68 and malonaldehyde 
bisphenylimine hydrochloride, then attached to a solid-support using sulfonyl chloride 
resin (PS-SO2Cl) to afford compound 70.  Nucleophilic attack of another benzthiazole 
71 to the sp2 carbon produces the desired product 72 in high purity (>95 %) by releasing 
the solid-support which acts as a leaving group; this concept is called “Catch-and-
Release”.  They reported preparation of more than ten different compounds where the 
heteroaromatic pairs are different, with high purities and moderate yields.  Syntheses of 
some water-soluble unsymmetric cyanines were also described using this method. 
 
 
Scheme 3.6.  Solid-phase “Catch-and-Release” synthesis. 
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3.3.3 Results and Discussion (Synthesis of Cyanine Dyes as Acceptors for TBET 
Cassettes) 
We designed three novel 5-iodo cyanine dyes 74a-c as acceptor precursors and three 
known cyanine dyes 73a-c as their control compounds (Figure 3.8).  Two different 
indolium salts were condensed with three polymethine chain with varying length to 
synthesize dyes 73 and 74.  Finally, dyes 74 were coupled with 4-ethynyl BODIPY 55 as 
a donor fragment via Sonogashira coupling to afford TBET cassettes 75 (Scheme 3.7). 
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Figure 3.8.   Structures of cyanine dyes 73 and 74 used in this research.  
I-Cy stands for iodo-cyanine. 
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Scheme 3.7.  Synthesis of TBET cassette 75 via Sonogashira coupling. 
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Two indolium salts were synthesized as starting materials for the synthesis of 
cyanine dyes (Scheme 3.8).  The alkylation of 2,3,3-trimethylindolenine by iodomethane 
or 6-bromohexanoic acid at 80 ºC afforded iodide salt 68107 and bromide salt 76108, 
respectively, using previously reported procedures. 
 
Scheme 3.8.  Alkylation of 2,3,3-trimethylindolenine. 
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Convenient one-pot syntheses of Cy3 and Cy5 derivatives on a multi-gram scale 
were described by Shmanai, Korshun, et al108 and their method was used for the cyanine 
dye syntheses in our group.  A solution of bromide salt 76 and N,N’-
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diphenylformamidine in acetic anhydride was heated at 120 ºC for 30 min to generate 
hemicyanine 77 in situ.  This hemicyanine intermediate 77 was used for making two 
cyanine dyes 73a and 74a (Scheme 3.9).  After the addition of iodide salt 68 with 
pyridine, the reaction was completed in 1 h and ether was added to the reaction mixture 
to precipitate the crude product.  The addition of ether also helps to wash away acetic 
anhydride and pyridine.  After the chromatographic separation of crude materials, pure 
Cy3 73a was obtained and this will be using as a control compound.  On the other hand, 
the reaction with iodo-indolium salt 78 afforded iodo-Cy3 74a and the same work-up 
procedure was used, but it took a longer reaction time.  This is because of the poor 
solubility of salt 78 in pyridine.  Cy5 73b and iodo-Cy5 74b were synthesized by Mr. 
Jiney Jose using similar reaction conditions and obtained in 74 and 65 % yields, 
respectively. 
 
Scheme 3.9.  Syntheses of Cy3 73a and iodo-Cy3 74a. 
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Cy7 73c and iodo-Cy7 74c were synthesized in two steps because the attempted one-
pot synthesis for Cy7 resulted in a messy reaction and low yields.  Therefore, we decided 
to isolate hemicyanine intermediates.  The condensation of iodide salt 68 and 
glutaconaldehydedianil hydrochloride afforded pure hemicyanine intermediate 79 in 90 
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% yield after the chromatographic separation and, this intermediate was quite isolable 
and stable.  The second condensation of hemicyanine 79 with bromide salt 76 at 50 ºC 
gave pure Cy7 73c in 78 % yield (Scheme 3.10).  This 73c was used as a control 
compound. 
 
 
Scheme 3.10.  Synthesis of Cy7 73c via two steps condensation reaction. 
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The hemicyanine intermediate 80 was synthesized in 81 % yield via the 
condensation of iodo-indolium salt 78 and glutaconaldehydedianil hydrochloride.  The 
second condensation of intermediate 80 with boromide salt 76 at 50 ºC afforded pure 
iodo-Cy7 74c in 72 % yield (Scheme 3.11).  This iodo-Cy7 74c was used for the 
synthesis of TBET cassette, as described in the next section. 
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Scheme 3.11.  Synthesis of iodo-Cy7 74c via two steps condensation. 
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The UV absorption and fluorescence emission spectra of Cy3 73a, Cy5 73b, and Cy7 
73c were recorded in EtOH with the concentration of 10–7 and 10–8 M, respectively 
(Figure 3.9).  These three cyanine dyes have well-separated UV absorption and 
fluorescence emissions. 
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Figure 3.9.  Absorption and fluorescence spectra of cyanine dyes 73 in EtOH.  
Fluorescence spectra: excited at corresponding excitation wavelengths. 
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Table 3.1 summarizes the photophysical properties of Cy3 73a, Cy5 73b, and Cy7 
73c.  Remarkably, the extinction coefficients (ε) of those dyes were extremely high.  
Surprisingly, the insertion of another methine chain into cyanine dye led to 
approximately twice the ε value because of its extended conjugation.  This kind of 
phenomenon has not been seen for any other fluorescent dyes.  Cy3 73c had a quantum 
yield (Φ) of 0.085 in EtOH, and this 73c was slightly soluble in water and the 
measurement of Φ in pH 7.4 phosphate buffer gave 0.039.  Quantum yields of Cy5 73b 
and Cy7 73c in EtOH were also measured and these resulted in Φ of 0.31 and 0.13, 
respectively.  Quantum yields of those dyes in pH 7.4 were not measured because of 
their poor solubilities in aqueous media. 
 
 
Table 3.1.  Photophysical properties of cyanine dyes 73a-c. 
dye solvent λmax abs 
(nm) 
ε 
(M–1cm–1) 
λmax emiss 
(nm) 
fwhm 
(nm) 
Φ 
 
       
Cy3 73a EtOH 549 92100 565 35 0.085b 
Cy3 73a pH 7.4a 542 – – – 0.039 
       
Cy5 73b EtOH 644 164500 665 38 0.31c 
       
Cy7 73c EtOH 747 292000 774 48 0.13d 
a sodium phosphate buffer; b Rhodamine 101 was used as a standard (Φ 1.0 in EtOH);  
c Nile Blue (Φ 0.27 in EtOH); d Cardiogreen (Φ 0.04 in MeOH). 
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3.4 Synthesis of TBET Cassettes 
We next synthesized three novel TBET cassettes 75a-c consisting of BODIPY 
donors and cyanine acceptors.  Scheme 3.12 represents the synthesis of TBET cassette 
75a which is based on Cy3.  Palladium (0)-catalyzed Sonogashira coupling109 of 
BODIPY derivative 55 and iodo-Cy3 74a was completed in 45 min.  The use of PdII 
catalyst resulted in a messy reaction and the reaction was not completed.  After the 
reaction, ether was added into the reaction mixture to wash away Et3N and DMF.  The 
obtained crude product was purified with flash chromatography to afford TBET cassette 
75a in 45 % yield.  TBET cassette 75b based on Cy5 was synthesized by Mr. Jiney Jose 
using similar reaction conditions and obtained in 26 % yield. 
 
Scheme 3.12.  Synthesis of TBET cassette 75a. 
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Similar reaction conditions were used for synthesizing TBET cassette 75c based on 
Cy7.  In this process, Cy7 74c and BODIPY 55 were reacted via Sonogashira coupling 
to afford TBET cassette 75c in 33 % yield (Scheme 3.13).  The reaction was not clean 
for Cy5 and Cy7 based cassettes, and we expect this is due to the side-reaction of 
reactive polymethine chain with palladium catalyst.  Palladium could be coordinated to 
polymethine chain and it results in decomposition of this chain.  The reactions between 
cyanine dyes with longer methine chains (Cy5 and Cy7) and palladium catalyst are more 
prone to this type of decomposition.  In fact, the purification was harder for cassettes 
75b and 75c compared to cassette 75a, and we obtained some other fractions containing 
unknown compounds. 
 
Scheme 3.13.  Synthesis of TBET cassette 75c. 
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The UV absorption and fluorescence emission spectra of cassettes 75a-c were 
recorded in EtOH with the concentration of 10–6 and 10–7 M, respectively (Figure 3.10).  
For cassette 75c based on Cy3, some spectral overlap of UV absorption between 
BODIPY donor and Cy3 was observed because their excitation wavelengths are near to 
each other and their absorption intensities are almost the same.  As we expected, the 
higher UV absorption intensities from Cy5 and Cy7 compared to those of BODIPY 
donor were observed for cassettes 75b and 75c, and this is reasonable because of their 
high extinction coefficients.  In the fluorescence spectra, TBET cassettes 75a-c had 
emission wavelengths that are extremely well-separated from the cyanine parts.  
According to UV and fluorescence measurements of cassettes, we observed ca. 100 nm 
difference in their absorptions and emissions for the acceptor fragments. 
 
 
 
Figure 3.10.  Absorption and fluorescence spectra of cassettes 75a-c.  Fluorescence 
spectra: excited at 504 nm which corresponds to excitation wavelength of BODIPY. 
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Figure 3.10.  Continued. 
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The summary of photophysical properties for the cassettes are shown in Table 3.2.  
The UV absorption maxima from BODIPY parts were seen at 504 nm.  As described 
above, the fluorescence emission from cyanine part of cassettes 75a-c showed 
approximately 100 nm difference i.e. 590, 687, and 794 nm, respectively.  Energy 
transfer efficiency (ETE) was calculated by the equation below.  For this, the quantum 
yields of a donor and an acceptor fragments are first needed and finally ETE of cassette 
75a (Cy3) and 75b (Cy5) were calculated to be 90 and 88 %, respectively.  A quantum 
yield for cassette 75c was not measured due to lack of a proper standard.  The correction 
curve for our fluorescence spectrometer covers only the 200–800 nm range, but the 
fluorescence of 75c is broadly centered on 794 nm, extending beyond 800 nm as shown 
in Figure 3.10.  This feature causes a huge error in quantum yield calculations in this 
region. 
 
 
Table 3.2.  Photophysical properties of TBET cassettes 75a-c. 
cassette solvent λmax abs 
(nm) 
λmax emiss 
(nm) 
Φa 
ex. at donor 
Φb 
ex. at acceptor 
ETE 
(%) 
       
75a (Cy3) EtOH 504, 569 590 0.20 0.22 90 
       
75b (Cy5) EtOH 504, 662 687 0.35 0.40 88 
       
75c (Cy7) EtOH 504, 763 794 – – – 
a Rhodaime 6G was used as a standard (Φ 0.92 in EtOH); b  Rhodamine 101 for Cy3 (Φ 
1.0 in EtOH); Nile Blue for Cy5 (Φ 0.27 in EtOH).  
 
energy transfer
efficiency (ETE) (%)
!excited at donor
!excited at acceptor
x 100=
 
 
 
3.4.1 Conclusions for Cyanine Dyes and Their TBET Cassettes  
In conclusion, we synthesized three cyanine dyes 73a-c as control compounds, three 
novel iodo-cyanine dyes 74a-c, and three novel through-bond-energy-transfer cassettes 
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75a-c consist of BODIPY as a donor and cyanine dyes as acceptors.  Synthesis of 
cyanine dye series were carried out using the reported one-pot reaction or two steps.  
Cassettes 75a-c were prepared via Sonogashira couplings; they were obtained in 
moderate yields.  The control compound 73a was slightly water soluble, however, other 
materials including cassettes 75a-c had poor water-solubility, thus photophysical 
properties of those dyes were not measured in aqueous media.  Each control compounds 
73a-c had about 100 nm difference in their absorption and emission spectra in EtOH and 
gave reasonable quantum yields.  Energy transfer efficiencies of cassettes 75a (based on 
Cy3) and 75b (based on Cy5) were found to be 90 and 88 %, respectively.  Moreover the 
well-separated fluorescence spectra were observed for all cassettes 75a-c.  This is one of 
the most important factors in multiplexing studies and these cassettes will be possible 
candidates for the same.  Further modification of these cassettes, e.g. coating by silica or 
calcium phosphate, can produce water-soluble materials and higher photostabilities.  
Water-soluble fluorescent probes with good photophysical properties are more preferred 
when biological studies are performed.  Therefore silica- or calcium-coated cassettes 
may possibly be useful for multiplexing studies.  The syntheses of nanoparticles will be 
described in the next section and this research is currently in progress in our laboratory. 
 
 
3.5 Dye-doped Nanoparticles for Bioimaging in Cells 
One of the requirements for bioimaging is that the fluorescent probe should be 
sufficiently water soluble because imaging is preferred to be done at physiological pH.  
Moreover cells are not stable in organic solvents.  Many water soluble fluorescent 
probes are described in the literature68,83,90,110,111 but their brightnesses in aqueous media 
tend to be much less than in organic media.  This effect can be attributed to 
aggregation112,113 of dyes in aqueous media, and this cannot be prevented completely 
even if water solubilizing groups are present on the dyes.  Further, most organic dyes 
have low photostabilities,114 therefore fluorescent signal cannot be observed for longer 
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duration.  The dye-protein conjugates always tend to be less brighter than the parent dye 
itself which again causes problem in signal detection. 
In the past decade, quantum dots (QDs) have been widely investigated in 
nanotechnology for cell imaging study because of their excellent properties such as 
tunable emission wavelengths from UV-Vis to near IR region, photostable, and highly 
fluorescent.115-117  However, the core shell of QDs consists of toxic atoms such as 
cadmium, selenium, and lead.114  The toxicity of QDs have not well-proven yet and this 
may cause a cell damage when QDs are imported into cells. 
Several research groups have encapsulated fluorescent probes into nanoparticles to 
improve their photophysical properties.  These improvements are due to suppressing 
interactions between the fluorescent probe and the outside environment.  Two prominent 
ways to achieve this are to coat the fluorescent probe with silica118-120 or calcium 
phosphate.121-123  Syntheses of such nanoparticles are well documented in the literature.  
Photostabilities of such nanoparticles are higher than the dye by itself.  Surface 
modifications of these nanoparticles are possible124-126 and therefore this too is 
advantageous for cellular imaging.  One of the most important criteria while dealing 
with nanoparticles is their cytoxicity.  Silica nanoparticles are biocompartible when used 
at or below concentration of 0.1 mg/mL.114  There is no known cytoxicity for calcium 
nanoparticles and they are bioresorbable.121  Thus these nanoparticles are less harmful to 
cells compared to QDs. 
Syntheses of such nanoparticles were achieved by forming a dye core and then 
covering it with an outside shell.  The shell thickness usually ranges between 10–30 nm 
which gives sufficient protection to the dye core from the outside environment.  
Microemulsion is widely used for formation of nanoparticles, but the dye may leach out 
after a week or two.  To overcome this issue, covalent attachment of the dye core to the 
shell has been developed.  Both water soluble and insoluble dyes can be encapsulated 
inside nanoparticles.127  These nanoparticles are well dispersed in aqueous media and 
therefore can be used for biological studies. 
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3.5.1 Syntheses of Dye-doped Silica and Calcium Phosphate Nanoparticles 
Scheme 3.14 illustrates a general synthetic scheme for formation of fluorescent dye-
doped silica nanoparticles as in a reported procedure.128  The carboxylic acid of 
fluorescent dye reacts with aminopropyl silicate via EDCI-coupling to give triethyl-
silicate 81.  Compound 81 is then hydrolyzed under basic conditions to afford silicate 
82, and finally this 82 is treated with tetraethyl-silicate to form silica nanoparticle 83. 
  
Scheme 3.14.  General synthetic scheme for silica nanoparticle formation. 
CO2H
 EDC, pyridine, 25 oC, 3 h
(EtO)3Si NH2
O
HN Si(OEt)3
3
(i) NH3 in EtOH (0.2 M)
(ii) H2O (0.855 M)
EtOH, 25 oC, 12 h
O
HN Si(OH)3
3
Si(OEt)4 (0.155 M)
EtOH, 25 oC, 12 h
fluorescent
dye
5.0 mg, 0.02 mmol
1.7 x 10–5 M
81
82 83
silica-coated
 
 
 
A general synthesis of calcium phosphate nanoparticle is shown in Figure 3.11.123  
Two microemulsion A and B are separately formed with a cyclohexane/Igepal CO-
520/water system.  Typically, 650 µL of 1 x 10–2 M CaCl2 in CO2-free deionized water 
is added to 14 mL of a 29 vol % solution of Igepal CO-520 in cyclohexane to form 
microemulsion A.  Similarly, 650 µL of 6 x 10–3 M disodium phosphate with 8 x 10–4 M 
disodium silicate in CO2-free deionized water (pH 7.4) is added to 14 mL of a 29 vol % 
solution of Igepal CO-520 in cyclohexane to form microemulsion B.  Disodium silicate 
is present to act as a nucleation agent for the calcium phosphate.  The addition of the 
aqueous solution to the cyclohexane/Igepal CO-520 solution forms a self-assembled, 
reverse micelle suspension.  Dyes which are insoluble in water can be added in ethanol 
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or ethanol/water solution after the microemulsion is formed.  A dispersant is then added 
to microemulsion C.  For carboxy-functionalized particles, 225 µL of 1 x 10–3 M sodium 
citrate is added and allowed to react for 15 min. 
 
14.0 ml 29 % Igepal CO-520
in cyclohexane
650.0 µL10–2 M CaCl2 (ii) 650.0 µL 6 x 10
–3 M Na2HPO4
(iii) 65.0 µL 8 x 10–3 M Na2SiO3
14.0 ml 29 % Igepal CO-520
in cyclohexane
microimulsion A microimulsion B
(i) 1.0 mL of 10–3 M dye solution
microimulsion C ( 25 oC, 5 min.)
 25 oC, 5 min.
225.0 µL sodium citrate 
25 oC, 15 min
purified by silica column chromatography
(silica 15 µm diameter,60 Å pores)  
Figure 3.11.  General synthesis of calcium phosphate nanoparticle. 
 
3.5.2 Cyanine 73a-c and TBET cassettes 75a,b doped Silica Nanoparticles 
The encapsulations of cyanine dyes 73a-c and TBET cassettes 75a-c with silica were 
performed by Mr. Jiney Jose in our group using the procedure128 described in Scheme 
3.14.  Figure 3.12 shows UV absorption and emission spectra of cyanine dyes 73a-c 
doped silica nanoparticles in pH 7.4 phosphate buffer.  The absorption and emission 
maxima for dye-doped nanoparticles were quite similar to those of free cyanine dyes 
73a-c in ethanol. 
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Figure 3.12.  Absorption and fluorescence of cyanine acceptors 73a-c doped silica 
nanoparticles in 0.1 M phosphate buffer (pH 7.4). 
73a (silica)
73b (silica)
73c (silica)
73a (silica)
73b (silica)
73c (silica)
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The absorption and emission spectra of TBET cassettes 75a,b doped silica 
nanoparticles were also similar to those of free cassettes 75a and 75b (Figure 3.13) (see 
Figure 3.10 for free cassettes 75a and 75b in ethanol).  The attempted encapsulation of 
cassette 75c with silica resulted in the decomposition of cassette, therefore no 
photophysical properties were obtained. 
 
 
 
 
Figure 3.13.  Absorption and fluorescence of TBET cassette 75a,b doped silica 
nanoparticles in 0.1 M phosphate buffer (pH 7.4). 
Cy3 cassette 75a (silica)
Cy5 cassette 75b (silica)
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Figure 3.13.  Continued. 
 
 
 
The photophysical properties of cyanine 73a-c doped silica nanoparticles in pH 7.4 
phosphate buffer are shown in Table 3.3.  Quantum yields of cyanine 73a,73b, and 73c 
in silica nanoparticles were calculated to be 0.30, 0.15, and 0.09, respectively.  For 
cyanine 73a in pH 7.4 buffer, Φ of silica-coated 73a was increased by ca. 7-fold 
compared to that of free dye 73a (Φ 0.039 in pH 7.4, see Table 3.1).  This improvement 
was because of the less interactions between the dyes inside the silica particle and the 
outside environment.  Table 3.4 summarizes the photophysical properties of silica-
coated TBET cassettes 75a and 75b in pH 7.4 buffer.  Energy transfer efficiencies (ETE 
%) were calculated by the equation showed in Table 3.2.  Both silica-coated cassettes 
75a and 75b gave good ETE of 91 and 81 %, respectively, but quantum yields were 
quite low. 
Cy3 cassette 75a (silica)
Cy5 cassette 75b (silica)
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Table 3.3.  Photophysical properties of cyanine 73a-c doped silica nanoparticles in 0.1 
M phosphate buffer (pH 7.4).   
dye λmax abs 
(nm) 
λmax emiss 
(nm) 
Φ 
 
    
Cy3 73a in silica 550 566 0.30a 
    
Cy5 73b in silica 646 666 0.15b 
    
Cy7 73c in silica 751 776 0.09c 
a Rhodamine 101 was used as a standard (Φ 1.0 in EtOH); b Nile Blue (Φ 0.27 in EtOH); 
c Cardiogreen (Φ 0.04 in MeOH). 
 
Table 3.4.  Photophysical properties of TBET cassettes 75a,b doped silica nanoparticles 
in 0.1 M phosphate buffer (pH 7.4). 
cassette λmax abs 
(nm) 
λmax emiss 
(nm) 
Φa 
ex. at donor 
Φb 
ex. at acceptor 
ETE (%) 
      
75a in silica 504, 568 592 0.04 0.044 91 
      
75b in silica 504, 659 687 0.021 0.026 81 
aRhodamine 6G was used as a standard (Φ 0.92 in EtOH); bRhodamine 101 for Cy3 (Φ 
1.0 in EtOH); bNile Blue for Cy5 (Φ 0.27 in EtOH). 
 
 
The transmission electron microscope (TEM) images for silica-nanoparticles were 
also measured and this was performed by Dr. Hansoo Kim (TAMU, MIC lab).  As 
shown in Figure 3.14, all the silica-nanoparticles were spherical in shape, and the 
average particle size for each compounds were in the range of 22 to 25 nm. 
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Figure 3.14.  TEM images of silica nanoparticles. a, Cy3 73a; b, Cy5 73b; c, Cy7 73c; 
d, Cy3 cassette 75a; and e, Cy5 cassette 75b; average particle size: 22, 25, 22, 24, and 
24 nm, respectively. 
 
a 
b 
d 
e 
c 
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3.5.3 Cyanine 73a-c and TBET cassettes 75a-c doped Calcium Phosphate 
Nanoparticles 
Calcium phosphate (CP) nanoparticles of cyanine dyes 73a-c and TBET cassettes 
75a-c were synthesized by Mr. Jiney Jose using the procedure123 described in Figure 
3.11.  Figure 3.15 shows UV absorption and emission spectra of cyanine dyes 73a-c 
doped calcium phosphate nanoparticles in pH 7.4 phosphate buffer.  Each dye doped 
CPs had well distinguished absorption and emission maxima separated by approximately 
100 nm. 
 
 
 
 
 
Figure 3.15.  Absorption and fluorescence of cyanine 73a-c doped calcium phosphate 
(CP) nanoparticles in 0.1 M phosphate buffer (pH 7.4). 
Cy3 73a (CP)
Cy5 73b (CP)
Cy7 73c (CP)
 81 
 
 
Figure 3.15.  Continued. 
Cy3 73a (CP)
Cy5 73b (CP)
Cy7 73c (CP)
 82 
 
 
 
Figure 3.16.  Absorption and fluorescence of cassettes 75a-c doped calcium phosphate 
nanoparticles in 0.1 M phosphate buffer (pH 7.4). 
 
Cy3 cassette 75a (CP)
Cy5 cassette 75b (CP)
Cy7 cassette 75c (CP)
Cy3 cassette 75a (CP)
Cy5 cassette 75b (CP)
Cy7 cassette 75c (CP)
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Figure 3.16 shows absorption and emission spectra of cassettes 75a-c doped CP 
nanoparticles.  We did not observe decomposition of Cy7 cassette 75c under the reaction 
conditions for the formation of CP nanoparticles. 
The photophysical properties of cyanine 73a-c doped CP nanoparticles in pH 7.4 
phosphate buffer are shown in Table 3.5.  Both absorption and emission maxima of CP 
particles were again quite similar to those of free cyanine dyes in ethanol.  Quantum 
yields of cyanine dyes 73a, 73b, and 73c in CP nanoparticles were calculated to be 0.07, 
0.21, and 0.14, respectively.  The quantum yields of Cy5 73b and Cy7 73c coated by CP 
were slightly higher than those of 73b and 73c coated by silica (Φ 0.15 and 0.09, see 
Table 3.3).  However we obtained Φ of 0.07 for Cy3 CP particle 73a, and this was ca. 
one forth of silica-coated 73a (Φ 0.30).   
 
 
Table 3.5.  Photophysical properties of cyanine 73a-c doped CP nanoparticles in 0.1 M 
phosphate buffer (pH 7.4). 
dye  λmax abs 
(nm) 
λmax emiss 
(nm) 
Φ 
 
    
Cy3 73a in CP 543 564 0.07a 
    
Cy5 73b in CP 643 663 0.21b 
    
Cy7 73c in CP 748 774 0.14c 
aRhodamine 101 was used as a standard (Φ 1.0 in EtOH); bNile Blue (Φ 0.27 in EtOH); 
cCardiogreen (Φ 0.04 in MeOH); CP stands for calcium phosphate. 
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Table 3.6.  Photophysical properties of cassettes 75a-c doped CP nanoparticles in 0.1 M 
phosphate buffer (pH 7.4). 
cassette λmax abs 
(nm) 
λmax emiss 
(nm) 
Φa 
ex. at donor 
Φb 
ex. at acceptor 
ETE 
(%) 
      
Cy3 75a in CP 504, 569 590 0.037 0.041 90 
      
Cy5 75b in CP 504, 659 687 0.051 0.057 90 
      
Cy7 75c in CP 504, 764 793 0.039 – – 
aRhodaime 6G was used as a standard (Φ 0.92 in EtOH); bRhodamine 101 for Cy3 (Φ 
1.0 in EtOH); bNile Blue for Cy5 (Φ 0.27 in EtOH).  CP stands for calcium phosphate. 
 
 
 
Figure 3.17 shows atomic force microscopy (AFM) images for cyanine dyes 73a-c 
and TBET cassettes 75a-c doped calcium phosphate nanoparticles.  As shown in figure, 
all the CP nanoparticles were spherical in shape, and the average particle size were 14–
29 nm.  TEM images could not be obtained because CP particles were not stable to 
electron beam. 
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Figure 3.17.  AFM images of calcium phosphate nanoparticles. a, Cy3 73a; b, Cy5 73b; 
c, Cy7 73c; d, Cy3 cassette 75a; e, Cy5 cassette 75b; and f, Cy7 cassette 75c; average 
particle size: 14-29 nm; scale: 100 nm. 
 
a 
b 
c f 
e 
d 
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3.5.2 Conclusion on Silica and Calcium Phosphate Nanoparticles 
Cyanine dyes 73a-c as control compounds and TBET cassettes 75a,b were 
covalently coated by silica to form corresponding nanoparticles and their photophysical 
properties were studied in aqueous media.  These silica nanoparticles were well 
dispersed in phosphate buffer (pH 7.4) and silica-coated cassette 75a,b showed moderate 
energy transfer efficiencies (ETE) with low quantum yields, but we expect these values 
to be better than those of free dyes in water.  Cyanine 73a-c and cassettes 75a-c were 
also non-covalently coated by calcium phosphate, and their photophysical properties 
were studied at pH 7.4 phosphate buffer.  These nanoparticles were highly water-soluble 
and the ETE of cassettes 75a,b doped CP nanoparticles were about 90 %.  Again both 
silica and CP nanoparticles had well-resolved absorption and emission maxima 
separated by ca. 100 nm.  Further the formation of silica and calcium phosphate 
nanoparticles were confirmed by measuring TEM and AFM images, respectively, and 
both particles were spherical in shape.  The photo-stabilities of silica nanoparticles 73a-c 
(cyanine) and 75a,b (cassette) are currently being measured by Dr. Son’s group 
(TAMU) and will be compared to those of the free cassettes and cyanine dyes.  As a 
future work, we will study multiplexing of TBET cassettes 75a-c doped calcium 
phosphate nanoparticles in intracellular imaging. 
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CHAPTER IV 
 
DEVELOPMENT OF METHODS FOR PROTEIN MONO-LABELING 
 
4.1 Introduction 
Single molecule imaging has become an important tool in the cell studies.  It 
provides information about molecular dynamics, distribution, and protein-protein 
interactions.  The most widely used technique is a total internal reflection fluorescence 
microscopy (TIRFM) which makes possible to visualize individual interactions in vivo 
and in vitro.129,130  On the other hand, the uses of single-fluorescent-labeled 
biomolecules could also be powerful tools for such studies.  It is valuable if a protein of 
interest can be selectively mono-labeled with only one fluorescent dye, then this leads to 
the quantification of protein and makes possible to perform single molecule studies in 
cell imaging. 
Lysine residues are commonly used to label natural proteins because most proteins 
have several number of lysines and primary amines are quite reactive with succinimidyl 
ester of fluorophores, but this is not specific.  The mono-labeling of lysine residues in 
natural proteins is extremely difficult.  To overcome this drawback, we propose a new 
method for mono-fluorescent labeling of protein using a solid-phase approach and a 
photo-cleavable system.  The specific aims for mono-labeling of natural protein are as 
follows: 
 
(i) design and synthesis of cleavable linkers and fluorescent dyes; 
(ii) focus on the nature of resin (the number of reactive sites on the resin and 
the particle sizes); and, 
(iii) label one lysine residue in natural protein with one fluorescent dye on 
solid-support. 
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4.1.1 Background: Selective Labeling of Protein 
Specific labeling of protein with fluorescent tags requires the modification of protein 
under study either chemically or genetically incorporating an unnatural amino acid.10,12  
The later method is most widely used because any functional groups can be introduced 
into the protein which can then selectively react with the fluorescent tags.  Site-specific 
labeling of cysteine residues in recombinant proteins7,9,12 is a well known method for 
mono-labeling as shown in Chapter I. 
There are very few reports on the selective modification of natural proteins.  Francis’ 
group reported a selective labeling of tyrosine residues in natural protein via a Pd-
catalyzed alkylation (Figure 4.1).131  The key features in this work are the uses of 
reactive π-allyl species and the tyrosine residues for the conjugation.  The π-allyl Pd-
complex B was formed from rhodamine-allylic acetate A in aqueous buffer, this B was 
readily available to conjugate with protein (Chymotrypsinogen A was used for this 
study).  Excess A was converted to diene C, and this was easily removed using gel-
filtration or extraction.  Two tyrosine residues are available for reactions; tyrosine (Y)-
171 and -146.  The Y171 is more accessible for conjugation than Y146.  The single-dye-
labeled protein D and double-labeled protein were observed from ESI analyses, 
indicating that this Pd-catalyzed reaction is effective for bioconjugations. 
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Figure 4.1.  Francis’ selective labeling of tyrosine.  a; Pd-catalyzed alkylation, and b; 
structure of Chymotrypsinogen A.131 
 
 
The selective modification of tryptophan in the natural protein was reported by the 
same group.132  A similar approach was attempted for this study.  The tryptophan 
residues in myoglobin (two tryptophan residues are available for the conjugation) were 
alkylated with rhodium carbenoids and this afforded mono- and di-alkylated protein by 
ESI-MS.  However quantification of dye-protein conjugate cannot be determined by 
mass spectrometry analyses alone.  Even though mono- and di-alkylated proteins were 
obtained via a Pd-catalyzed alkylation or an alkylation with rhodium carbenoids, these 
methods need further modification to achieve site-specific mono-labeling. 
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4.1.2 Our Approach: The Process of Protein Mono-labeling 
Other members in our group have reported work involving photocleavable 
linkers,133-135 a similar strategy was chosen for this project.  The essential components 
are the solid-support, photolabile linker, fluorescent dye, and carboxylic acid for the 
attachment of biomolecules (Figure 4.2).  The photolabile linker is attached on solid-
support.  The fluorescent dye and carboxylic acid are connected to this photolinker with 
or without another spacer.  There are two ways to synthesize the target molecule; (i) the 
traditional solid-phase synthesis, and (ii) the solution phase synthesis of the photolabile 
linker with fluorescent dye and attachment of this functionalized dye to solid-support in 
the final step.  In the solution-phase synthesis, the characterization of each compounds is 
easier than in the traditional solid-phase synthesis. 
 
 
 handle for
biomolecule
solid-
support
photolinker
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fluorescent
dye
N
H
O
O
OMe
NO2
O
CO2H
photolabile
bond  
 
Figure 4.2.  Design of molecule in this work. 
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Figure 4.3 shows the overall scheme for protein mono-labeling process and some key 
features.  a) the state of functionalized solid-support and proteins: Solid-support is 
modified with the cleavable linker and fluorescent dye, and all carboxylic acids on the 
support are activated with succinimidyl esters.  The attachment of protein is carried out 
in diluted conditions to prevent further reactions (protein di- or tri-labeling).  b) dye-
protein conjugates on solid-support: The mono-labeling of protein could be achieved 
because other active (reactive) sites on resin are far apart from protein.  c) cleavage of 
dye-protein conjugate: The cleavable linker is cleaved to release a mono-fluorescent dye 
labeled protein and unreacted fluorescent dyes; these are separated by size-exclusion 
column and analyzed by CE, MALDI, and LCMS. 
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Figure 4.3. Overall scheme for protein mono-labeling process. 
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Based on this idea, four different strategies for this project were attempted: 
 
section 4.2: photolinker based on o-nitrobenzyl alcohol derivative, PEGA resin, CPG,   
and Nile Red as a fluorescent tag (System A); 
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section 4.3: an activated photolinker based on a modification of o-nitrobenzyl alcohol 
derivative, CPG, Nile Red and BODIPY as fluorescent tags (System B); 
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section 4.4: an activated photolinker with BSA-coated CPG, and BODIPY as a 
fluorescent probe (System C); 
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section 4.5: chemically cleavable linker, azobenzene (System D). 
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Unfortunately, the above strategies on protein mono-labeling did not work.  We will 
describe problems which we observed and how we tried to overcome these.  This project 
is a collaboration between Prof. Burgess (synthesis of fluorescent dye and production of 
mono-labeled protein), Prof. Vigh (analysis of dye-protein sample using capillary 
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electrophoresis; CE), and Dr. Shane Tichy (analysis of dye-protein sample using 
MALDI and LCMS). 
Prof. Vigh’s group uses capillary electrophoresis (CE) for single molecule detection 
and purification of proteins.  They are currently studying specific mono-labeling of 
natural protein using this technique.  Overall concept is similar to our approach; use of 
reactive sites on solid-support for the protein conjugation (see Figure 4.3 for our 
approach).  They attach fluorescent-tags and cleavable linkers inside of a capillary tube; 
this acts as a solid-support.  The reactive sites on the support are far apart from each 
other, thus mono-labeling of protein could occur inside of capillary.  Then the cleavage 
of linkers affords mono-labeled protein molecule and this can be directly analyzed by 
CE.  If proteins are labeled with one or two fluorescent tags, these dye-protein 
conjugates can be separated by CE and quantified. 
In theory for detection purposes, if a protein is labeled with large number of 
fluorescent tags, this leads to more signal intensity, however, this may cause quenching 
of signals because of the close proximity of fluorescent tags on protein surface.  
Therefore labeling of protein with a single dye molecule is more advantageous.  Before 
the results and discussion, we will describe short background about cleavable linkers 
(section 4.1.3) and some key reports involving our research (section 4.1.4). 
 
4.1.3 Cleavable Linkers 
Linker syntheses and the cleavage of linkers are the most important factors in solid-
phase organic synthesis (SPOS).  The linkers should not only be stable to perform SPOS, 
but also must be easy to cleave.  Moreover, cleaner reaction conditions for cleavage are 
preferred, because chromatographic purifications are usually not attempted after the 
cleavage of linkers.  There are many strategies for the cleavage of linkers from the solid-
support.136  Merrifield resin, Wang linker, and Trityl linker are widely used in solid-
phase peptide synthesis (SPPS).  These linkers are quite stable under basic conditions 
and are usually cleaved with TFA in CH2Cl2 at room temperature to release the product.  
Another useful method for cleavage is the palladium-catalyzed cleavage of allylic 
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linkers.  The main drawback for solid-phase synthesis is that the use of metals are 
invasive and it is difficult to remove.  Therefore, these methods are more preferred in 
solution-phase synthesis, in fact, this method was previously used in our group for the 
cleavage of nucleotides in solution-phase.135  However, the use of acid even weak acid 
like TFA or any other chemicals for the cleavages, are not suitable when proteins are 
used for some studies, because it may cause damage to the biomolecules and also 
denature the proteins.  Bogyo and co-workers reported a mild chemically cleavable 
linker for which the cleavage conditions are compatible with biochemical systems 
(Figure 4.4).137  This linker is based on an azobenzene derivative and the azo bond can 
be cleaved under mild reaction condition by sodium dithionite.  The activity-based probe 
SV1 is the analogue of a general papain-family-probe DCG04. 
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Figure 4.4.  Cleavage of azobenzene linker with Na2S2O4. 
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Photolysis produces a mild and orthogonal method of cleavage that takes place under 
neutral conditions, and tends to be suitable for biomolecules.  Photolabile protecting 
groups were reviewed by Bochet in 2002.138  The most widely used photocleavable 
linkers are o-nitrobenzyl alcohol derivatives.  Photochemically-induced 
photoisomerisation of this compound produces its cleaved product, o-
nitrosobenzaldehyde.  The mechanism of photolysis is based on Norrish-type II reaction 
(Figure 4.5).  The excitation of o-nitrobenzyl alcohol derivative 84 can generate a highly 
reactive diradical species 85.  The radical on oxygen in nitro-group abstracts γ-hydrogen 
to form another diradical species 86a.  The resonance structure of 86a, non-radical form 
86b, cyclizes to form five-membered ring 87 and the ring opening leads to o-
nitrosobenzaldehyde 88 as a cleaved product.  Amide, ester, carbamate and ether can be 
used for this photolysis system. 
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Figure 4.5.  Mechanism of photocleavage reaction. 
 
 
 
 97 
4.1.4 Key Reports Involving Our Research 
One of the most important features in this project is the choice of solid-support.  
Bradley and co-workers studied enzyme accessibility to some solid-supports like 
TentaGel, PEGA, and CPG (control pore glass).139  These solid-supports were loaded 
with peptide 4-CBA-Gly-Pro-Leu-Gly-Leu-Phe-Ala-Arg-OH (4-CBA: 4-cyanobenzoic 
acid) and incubated with five different enzymes with a range of molecular weights (22–
90 kDa).  The absence or presence of CN signal (2230 cm–1) was recorded by Raman 
spectroscopy.  When TentaGel and PEGA were treated with most enzymes, a CN signal 
was clearly seen at 2230 cm–1.  This indicated that the peptide sequence was not cleaved 
by the enzyme.  On the other hand, the CN signal was not detected when CPG was 
incubated with all enzymes, the peptide was cleaved by the enzymes and this result 
proved that the accessibility of the enzyme to CPG was the best in these solid-supports. 
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Figure 4.6.  MacBeath’s work based on BSA-coated glass slide. 
 
MacBeath and Schreiber reported an innovative biological study for protein-protein 
interaction by modifying the surface of glass slide (Figure 4.6).140  They uniformly 
coated the surface of glass slide with BSA and used those coated slides for biological 
assays such as screening for protein-protein interactions, and identifying the substrates 
of protein kinases or the protein targets of small molecules.  Their work produced that 
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the BSA-coated glass slide made possible to do the direct protein-protein interactions on 
solid-support, indicating the increases of bioaccessibilities to solid-support. 
 
4.2 System A: Nile Red Based Photolabile System 
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Figure 4.7.  o-Nitrobenzyl alcohol linker based solid-support (System A). 
 
Our first system was designed with an o-nitrobenzyl alcohol derivative photolabile 
linker and Nile Red as a fluorescent dye (Figure 4.7).  4-Bromomethyl-3-nitrobenzoic 
acid was first protected with tBuOH, DIC and DMAP to afford the tert-butyl ester 89.  
Ester 89 was reacted with 3-hydroxybenzyl alcohol and brominated (CBr4, PPh3) to give 
the photolabile-protected benzyl bromide 91 (Scheme 4.1). 
 
Scheme 4.1.  Synthesis of photolabile-protected benzylbromide 91. 
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Nucleophilic attack of 2-hydroxy Nile Red dimethyl ester 92 (provided by Mr. Jiney 
Jose) to benzylbromide 91 afforded compound 93.  Deprotection of the tBu-group under 
normal reaction condition (TFA, CH2Cl2, 25 ºC) resulted in the decomposition of 
molecule.  Fortunately, compound 94 could be obtained in 77% yield using conditions 
(TMSOTf, 2,6-lutidine, CH2Cl2, 25 ºC) which had previously been reported for the 
deprotection of Boc-protected amino acid on TFA-sensitive resins by our group (Scheme 
4.2).141 
 
Scheme 4.2.  Synthesis of photolabile-protected Nile Red derivative 94. 
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The PEGA (polyethylene glycol polyacrylamide copolymers) resin142 was the first 
solid-support used to synthesize the target molecule.  Although Bradley reported that the 
accessibilities of enzymes to PEGA resins are lesser,139 swelling of PEGA resins is 
excellent in solvents of various polarities ranging from dichloromethane to water143 and 
this is widely used in peptide synthesis.144,145  The photolabile-protected Nile Red 94 
was reacted with PEGA resin for 24 h, and the ninhydrin test was positive (purple beads) 
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after the reaction.  This resin was then capped using normal capping conditions for 
primary amines (Ac2O, pyridine, CH2Cl2) and the ninhydrin test was negative (brown 
beads).  The dimethyl ester 95-PEGA was deprotected under the mild reaction 
conditions (K2CO3, MeOH/H2O, 40 ºC, 24 h) to afford diacid 96-PEGA as purple beads 
(Scheme 4.3). Nile Red dimethyl ester 92 was previously deprotected under these 
conditions to afford the corresponding diacid in solution phase, thus we assume that 96-
PEGA was formed. 
 
Scheme 4.3.  Attachment of compound 94 on PEGA resin or aminopropyl-CPG. 
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We made 96-PEGA and thought this could help coupling reaction between 96-
PEGA and biomolecules in aqueous medium because PEGA has excellent swelling in 
water.  However, there are two problematic issues: (i) the sticky nature of PEGA resin 
makes it difficult to handle, and (ii) the loading of PEGA resin is too high (0.59 
mmol/g).  It was difficult to continue the synthesis using this material (96-PEGA) 
because of above issues, therefore, we decided to use CPG as a solid support.   
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Following the synthetic approach outlined in Scheme 4.3, we tried to prepare 96-
CPG from aminopropyl-CPG (control pore glass, 0.162 mmol/g).  CPG-supported 
dimethyl ester 95-CPG was obtained as dark purple beads and K2CO3 was used for the 
deprotection of dimethyl ester (Scheme 4.3).  However, we obtained very light pink 
beads after the deprotection, indicating the loss of some Nile Red.  We were supposed to 
get purple beads because Nile Red has a reddish purple color.  When TMSOK was used 
for the deprotection of the methyl ester,146 brown beads were obtained.  Decomposition 
of 95-CPG or 96-CPG might have occurred under those conditions and we were not 
sure how.  However, at least if some of 96-CPG were formed, then we could try some 
studies using this material. 
It is important to confirm if photolysis of compounds work when photolabile linkers 
are synthesized.  To do this, there are some possible analytical methods, eg anal. HPLC, 
mass spectrometry, and UV and fluorescence spectrometry.  A control study was 
performed to confirm the photolysis of compound 96-CPG using anal. HPLC.  The aim 
was that we tried to compare the retention time between the product 102 obtained from 
the photolysis of 96-CPG and compound 102 synthesized via solution phase.  If the 
retention time of those peaks match, then this is strong evidence that the photolysis of 
96-CPG worked. 
O
N
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For the synthesis of control compound 102, 3-hydroxybenzaldehyde was protected 
with TBDPS-group followed by sodium borohydride reduction to give alcohol 98.  This 
alcohol 98 was then brominated to afford compound 99 in overall 73 % yield (Scheme 
4.4).  Compound 99 was reacted with 2-hydroxy Nile Red dimethylester 92 via 
nucleophilic attack to form protected-Nile Red 100.  The deprotection of TBDPS-group 
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with TBAF and dimethyl ester with K2CO3 afforded a control compound 102 in 77 % 
yield (Scheme 4.5). 
 
Scheme 4.4.  Synthesis of TBDPS-protected benzylbromide 99. 
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Scheme 4.5.  Synthesis of Nile Red derivative 102 as a control compound. 
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The photocleavage reactions of compound 96-CPG obtained from K2CO3 and 
TMSOK deprotections were performed using our previously reported method (Scheme 
4.6).135  Ethanolamine was necessary for the photolysis since without it the deprotection 
was only partial,102 and compound 103 is the cleaved solid-support part.  Both samples 
from photolysis and control compound 102 (made by solution-phase synthesis, Scheme 
4.5), were analyzed by anal. HPLC.  However, the samples from photolysis showed 
several peaks and the retention time of those peaks did not match with the retention time 
of the control compound 102.  Thus it was difficult to analyze those samples and this 
control experement did not work. 
 
 
Scheme 4.6.  Photocleavage reaction of compound 96-CPG. 
aminopropyl
CPG
N
H
O
NO2
O
O
N
O
O
N
CO2H
CO2H
  h! (360 nm)
ethanolamine
  MeOH, 3 h
O
N
O ON
HO2C
CO2H
OH
N
H
O
NO HN
O
+
96-CPG
102103  
 
 
In summary, PEGA resin was difficult to handle because of its sticky nature and the 
accessibility of biomolecules to PEGA was presumably not good (Bradley’s work).139  
For the CPG-supported compound, deprotection of the dimethyl esters lead to 
decomposition upon treatment with TMSOK and substantial loss of the dye from the 
CPG upon treatment with K2CO3.  Furthermore, due to their lesser reactivities, o-
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nitrobenzyl alcohol based photolinker required longer reaction time and harsh conditions 
for the photolysis making the substrate more prone to decomposition.  In the next 
section, the synthesis and the uses of an activated photolinker will be described. 
 
4.3 System B: Activated Photolabile-protecting Group 
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Figure 4.8.  Activated photolinker based solid-support (System B). 
 
Activation of photolinkers by introduction of a methoxy-group is often used in 
organic synthesis and in biological applications.135,136,138,147,148  This methoxy group is 
incorporated onto the benzene ring (p-position with respect to nitro-group) and can serve 
to enhance the photocleavage rate, ie methoxy group increases quantum yields of 
photolinkers.  This results in cleaner and faster reaction than the less-activated o-
nitrobenzyl linker, however, several steps are required to synthesize this type of 
photolinkers.  
The synthesis of activated photolinkers from vanillin was described by Klinman and 
co-worker.149  Protection of vanillin with benzyl bromide, followed by nitration gave O-
benzyl-6-nitrovanillin 105 and deprotection of O-benzyl-group with HBr/AcOH 
afforded 3-methoxy-6-nitrovanillin 106.  Aldehyde 106 was then reduced to the 
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corresponding alcohol 107 using sodium borohydride.135  This primary alcohol was 
reacted with tert-butylbromoacetate to afford the photolinker 108 in 96 % yield (Scheme 
4.7).  In fact, the photolinker 107 is a very useful compound because many modifications 
of phenol and primary alcohol functionality are possible.  Photolinker 108 was reacted 
with propiolic acid or 4-pentynoic acid using DIC-coupling to insert alkyne 
functionality.  Compound 109a and 109b were then deprotected with TFA to afford 
carboxylic acid 110a and 110b in quantitative yields (Scheme 4.8). 
 
Scheme 4.7.  Synthesis of activated photolabile-protecting group 108.  
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Scheme 4.8.  Insertion of alkyne functionality. 
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First, we examined whether this new photolinker 109 was cleavable.  For a solution-
phase control, alkyne 109a was cyclized with benzyl azide 111150 to afford triazole 112.  
This triazole 112 was then irradiated under UV (strip UV light designed to emit at 360 
nm; Southern New England Ultraviolet Company); the reaction was complete in 1 h 
(TLC, >95 % conversion, Scheme 4.9).  Samples from the photolyses were analyzed by 
mass spectrometry and triazole 112 and the photo-cleaved product 114 were detected.  
Compound 113 was not detected presumably because of its instability. 
 
 
Scheme 4.9.  Control experimental for photochemical reaction. 
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For the control photolysis study on solid-phase, alkyne 110a was first attached onto 
glass beads (GB) using DIC and DMAP to give 115 (Scheme 4.10).  The ninhydrin test 
of compound 115 resulted in negative (brown beads), indicating no primary amine 
functionality were left on the solid support. 
 
 
Scheme 4.10.  Attachment of photolinker 110a onto glass beads. 
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Next, alkyne 115 was clicked with 4-azido-BODIPY 116 (provided by Mrs. Lingling 
Li) to form triazole 117 (Scheme 4.11).  This triazole 117 was then photo-cleaved in a 
quartz cuvette under UV (360 nm).  The fluorescence intensity in the solution above the 
beads was measured every 5 min over a period of time of 80 min.  As shown in Figure 
4.9, the fluorescence intensity increased from 0 to 80 min, indicating that the 
photocleavage reaction of compound 117 occurred.  Some fluorescence was detected at 
0 min, probably due to the small amounts of photolysis of compound 117. 
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Scheme 4.11.  Synthesis of control compound 117 and its photochemical reaction. 
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Figure 4.9.  Fluorescence emission spectra from the photochemical reaction of 117 upon 
excitation at 498 nm. 
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In conclusion, we proved that photolysis of the new photolinker 109 works well in a 
short reaction time with good conversion (>95 %); (mass spectrometry analysis; 
solution-phase).  We also observed the increase of fluorescence intensity of BODIPY 
dye 119 at around 515 nm from a solid-phase synthesis.  Unfortunately, glass beads 
(loading: 0.162 mmol/g) were no longer available from Sigma at this time.  Therefore, 
we purchased another CPG (controlled pore glass) from 3-Prime and used it. 
Photolinker 110a was reacted with CPG (pore size: 1000 Å, loading: 0.082 mmol/g) 
to give solid-support 120.  This alkyne 120 was cyclized with lysine-derivative 121 
(provided by Ms. Eunhwa Ko) via click reaction to afford triazole 122.  Deprotection of 
the Boc-group with TFA gave the primary amine 123 and positive ninhydrin test for 
these beads indicated that the amino-functionalities were on the surface of the CPG 
(Scheme 4.12). 
 
 
Scheme 4.12.  Synthesis of CPG-support triazole 123. 
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Nile Red derivative 124 (provided by Mr. Jiney Jose) was activated with NHS (N-
hydroxysuccinimide) and DIC (diisopropylcarbodiimide), and used without purification 
for the coupling reaction with solid-support 123, and the carboxylic acid was activated 
with NHS to afford product 126 (Scheme 4.13).  Compound 126 had a red fluorescence 
in organic solvents (DMF, MeOH, and CH2Cl2). 
 
 
Scheme 4.13.  Attachment of Nile Red to solid-support. 
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With the supported dye 126 in hand, we could investigate mono-labeling of proteins.  
Two important factors concerning the protein were: (i) the number of lysine residues; 
and (ii) the protein molecular weight (MW).  The smaller molecular weight is preferred, 
because the distinction of one or two dyes on the protein by MALDI is more difficult 
when a protein of big molecular weight is used since the molecular weight of the dye is 
comparatively small (~550 MW).  Therefore, ubiquitin was chosen for mono-labeling 
with molecule 126.  Ubiquitin has seven lysines and all of them are surface exposed and 
available to conjugate with other molecules.  The molecular weight of ubiquitin is 8565 
Da, and can be analyzed by MALDI. 
Compound 126 was coupled with ubiquitin under basic conditions (pH 8.3 buffer).  
Excess ubiquitin was washed away after the reaction and photolysis of dye-protein 
conjugate on solid-support 127 was performed (Scheme 4.14).  However, when the dye-
protein conjugate 129 was purified using size-exclusion column, we did not see any 
purple band.  UV absorption spectra for each fraction were taken and we observed only a 
small peak at 268 nm instead of 280 nm, a characteristic peak for protein.  Furthermore, 
only a small absorption band characteristic of Nile Red at around 548 nm was observed.  
Similarly, a weak fluorescence emission at 648 nm was observed for each fraction.  
MALDI analysis for 129 did not show any dye-protein conjugates.  According to these 
observations, no dye-protein conjugate or at least no detectable functional, non- 
denatured, unfolded protein was obtained.  It is also important to mention that it was 
difficult to measure UV absorption and fluorescence emission spectra of lipophilic Nile 
Red in water because of its poor photophysical properties in aqueous media.  Therefore 
we decided to study a similar system using BODIPY dye which has good photophysical 
properties even in aqueous media. 
 
 112 
Scheme 4.14.  Photolysis of dye-protein conjugates on solid-support 127. 
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4.4 System C: Photolabiling System Based on BSA-coated CPG 
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Figure 4.10.  Activated photolinker based BSA-coated CPG (System C). 
 
 
MacBeath and Schreiber described interesting biological studies as shown in section 
4.1.4,140 and we could use their method to our research to enhance the accessibility of 
biomolecules against CPG.  Using their method, we prepared BSA-coated glass beads.  
The CPG was activated with N,N’-disuccinimidyl carbonate to afford NHS-CPG 130, 
and this was then coupled with an excess amount of BSA in pH 7.4 buffer at 25 ºC.  
Ninhydrin test for BSA-coated CPG 131 showed positive result (purple beads).  Next the 
photolinker 110b was attached on BSA-coated CPG 131 under the mild conditions (DIC, 
DMAP, DMF, 25 ºC) to form alkyne 132.  Ninhydrin test for these beads gave a 
negative (brown beads).  Finally, aspartic acid and glutamic acid residues on BSA were 
capped by activation of acids with NHS followed by coupling with ethanolamine to 
afford product 133 (Scheme 4.15). 
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Scheme 4.15.  Synthesis of photolinker on BSA-coated CPG. 
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The Boc-protected azido lysine 121 was deprotected with TFA to give lysine 
derivative 134 in quantitative yield (Scheme 4.16a).  Next, BODIPY dye 135 (provided 
by Mr. Cliferson Thivierge) was activated using NHS followed by coupling reaction with 
compound 134 to afford BODIPY derivative 137 (Scheme 4.16b). 
 
 
Scheme 4.16.  Synthesis of BODIPY derivative 137. 
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The BSA-coated CPG 133 and BODIPY 137 were then cyclized to form triazole 138 
via a 2+3 cycloaddition.  After the reaction, the beads were washed with several organic 
solvents and the resulting light orange beads showed a yellow-green fluorescence in 
organic solvents (Scheme 4.17).  The carboxylic acid of triazole 138 was then activated 
with NHS and DIC in DMF at 25 ºC.  After washing off excess chemicals, this activated 
material was coupled with ubiquitin in pH 8.3 buffer at 25 ºC.  The ubiquitin-conjugated 
beads 139 had a quite strong yellow-green fluorescence in water (Scheme 4.18). 
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Scheme 4.17.  Click reaction of solid-support 133 and BODIPY 137. 
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Scheme 4.18.  Coupling reaction with ubiquitin. 
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Photolysis of dye-protein conjugate on solid-support 139 was attempted, and as we 
expected a strong yellow-green fluorescent solution was obtained after the reaction 
(Scheme 4.19).  The sample of compound 141 was directly analyzed by CE (capillary 
electrophoresis using UV and fluorescence detectors, Dr. Vigh’s group), MALDI and 
LCMS (Dr. Tichy).  The results of MALDI and LCMS analyses will be shown on page 
121. 
 
 
Scheme 4.19.  Photochemical reaction of compound 139. 
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Figure 4.11 shows the electropherogram from CE analyses with UV detection 
(uncoated capillary was used for these studies).  DMSO was used as a mobility marker; 
effective mobility (µeff) of the sample was calculated by comparing retention time 
between sample and marker.  At first, native ubiquitin (a solution of 5 mg/mL in H2O, E 
= 18 kV) was injected as a control study and it showed a single peak of µeff = 14 (Figure 
4.11a).  A single peak was also detected when the sample 141 (a solution of 1 mg/mL in 
background electrolyte: 10 mM acetic acid/10 mM β-alanine at pH 4.11) obtained from 
the photocleavage reaction of compound 139 was injected (µeff = 8.5, Figure 4.11b).  
Figure 4.11c shows an electropherogram spiked with native ubiquitin and sample 141, 
and two different peaks with a mobility of 7.8 and 6.9, respectively, were observed.  
However, the effective mobility of spiked peaks did not match with any control 
experimental data (µeff = 14 for native ubiquitin or 8.5 for sample 141).  This sample 141 
was also analyzed by CE with fluorescence detection, but several peaks were observed 
and characterization was therefore very difficult.  Effective mobilities were obtained by 
the equations given below. 
 
µeff = µobs – µEOF
µobs or µEOF =
LT x LD
T x V
µEOF = effect of flow (marker: DMSO)
µobs = observed (sample)
µeff = effective mobility
LT = total length of capillary
LD = length of detection
T = time (min)
V = volt (kV)  
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Figure 4.11.  CE results a: ubiquitin, b: sample 141, and 
c: spiked of ubiquitin and 141. 
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Electro-osmotic flow in a capillary varies with the pH of background electrolyte.  
We used ethanolamine as a trapping agent in our photolysis system and this probably 
changes the mobility of the injected sample.  A control experiment was performed to 
confirm this hypothesis.  Two samples were injected, one native ubiquitin and the other 
native ubiquitin with ethanolamine (10 µL).  We tried to compare the µeff of ubiquitin 
and DMSO (marker), however those were obviously different between two samples, i.e. 
the difference of retention time between Ubq and DMSO with ethanolamine was closer 
compared to that of Ubq and DMSO without ethanolamine (Figure 4.12).  To solve this 
problem, the sample from the photolysis (141) was purified using size-exclusion column 
to remove excess ethanolamine, however, most of the dye-protein sample was lost in the 
column because of small amount of sample. 
 
 
Figure 4.12.  CE results, ubiquitin and ubiquitin with ethanolamine. 
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The compound 141 (predicted mono-dye labeled protein) was also analyzed by 
MALDI and LCMS (by Dr. Tichy).  A solution of this sample in H2O had a slightly 
yellow color and a strong yellow-green fluorescence under UV irradiation.  According to 
our hypothesis, if one dye (MW: 555.27) was conjugated with ubiquitin (MW: ~8565 
Da), then the molecular weight of dye-ubiquitin conjugate (total MW: ~9120.27 Da) 
should be detected by LCMS and MALDI.  A maximum of seven dyes can be possibly 
conjugated with ubiquitin which will correspond to a dye-protein conjugate with a MW 
of ca. 12400 Da (Figure 4.13).  Data from both LCMS and MALDI showed a single 
peak at 8570 Da.  As a control experimental, LCMS and MALDI analyses of native 
ubiquitin gave a single peak at 8570 Da.  Therefore, we could conclude that the 
photolysis product of 139 contained only ubiquitin and free BODIPY dyes, no dye-
protein conjugates were observed in these experiments. 
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Figure 4.13.  Structure of BODIPY-ubiquitin conjugate 141. 
 
 
 
 
 122 
Interestingly, a yellow-green fluorescent solution was obtained during the activation 
and coupling steps between 138 and ubiquitin.  This indicates that some BODIPY dyes 
were being cleaved from the solid-support under those conditions.  A possible reason for 
this decomposition is the stability of the ester bond between the photolinker and the 
triazole under basic condition (Figure 4.14a).  If the hydrolysis of the ester occurred with 
bases, BODIPY dye can be released from the resin and this leads to a strong yellow-
green fluorescence.  To prevent this possible side reaction and improve the overall 
stability of our system, we designed a new system with an ether based spacer (Figure 
4.14b). 
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Figure 4.14.  a; Ester system (138), and b; ether (148) system. 
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Resorcinol was chosen as a spacer and mono-propargylic resorcinol 143151 was first 
synthesized via the mono-alkylation of resorcinol with propargyl tosylate 142152 
(Scheme 4.20a).  Next, photolinker 108 was tosylated to give tosylate 144 in 99 % yield 
without chromatographic purification.  This tosylate 144 was then alkylated with 
compound 143 to form the ether 145.  The tert-butyl-group was deprotected with 
TFA/CH2Cl2 conditions to afford the desired product 146 in 99 % yield (Scheme 4.20b). 
 
 
Scheme 4.20.  Synthesis of ether based photolinker 146. 
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Photolinker 146 was attached on the solid-support (CPG; 0.097 mmol/g) via DIC 
coupling.  After the reaction, ninhydrin test of compound 147 gave a positive result 
(purple beads).  Those beads were then capped using normal conditions (Ac2O, pyridine, 
CH2Cl2) and the ninhydrin test gave a negative result (brown beads).  The alkyne 147 
was then cyclized with BODIPY 137 via click reaction to afford compound 148 as 
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orange beads (Scheme 4.21).  These beads showed a strong yellow-green fluorescence in 
organic solvents (DMF, THF, MeOH and CH2Cl2) and aqueous solution. 
 
 
Scheme 4.21.  Synthesis of solid-support photolinker with BODIPY 148. 
NH2
CPG
0.097 mmol/g
(i) 146, DIC, DMAP, DMF
25 ºC, 24 h, dark
(ii) Ac2O, pyridine
CH2Cl2, 25 ºC, 2 h, dark
N
H
O
O
OMe
O
NO2
O
137, cat. CuSO4
sodium ascorbate
THF/H2O, 25 ºC
24 h, dark
N
CO2H
HN
O
N B
F2
N
NN
OO
OMe
NO2
O
N
H
O
colorless beads
ninhydrin test: negative
(after capping)
orange beads
yellow-green fluorescence
in organic and aqueous solvents
147
148
 
 
Several different conditions (EDCI in pH 7.4, NHS with DIC in DMF, iso-
butylchloroformate with Et3N in CH2Cl2) for the activation of the carboxylic acid of 
ether system (148) were attempted to study its stability.  However, a strong yellow-green 
fluorescent solution was immediately observed in all cases after the addition of the 
reagents.  Washing the beads with several organic and aqueous solvents many times 
before the activation reaction also gave a fluorescent solution.  Therefore, the 
decomposition process does not involve the ester and ether bonds, and probably a more 
complicated mechanism is happening in the cleavage of the dye. 
Although we knew some BODIPY’s docomposed during the activation step, we tried 
to couple it with a small peptide (Figure 4.15) using EDCI activated molecule 148.  The 
molecular weight of the small peptide used was 1652 g/mol and this was easier to react 
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with the dyes on solid-support than the ubiquitin.  After the photocleavage reaction, the 
sample was analyzed by Dr. Tichy using LCMS and MALDI, however, both 
experiments showed only a peptide peak (MW: 1652).  No dye-peptide conjugates were 
observed in this study. 
 
Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro
small peptide: MW 1652  
Figure 4.15.  Amino acid sequence of small peptide used in this study. 
 
Another synthesis was also attempted via Sonogashira coupling (Scheme 4.22).  This 
idea is structurally more simple than the previous one.  The alkyne 147 was directly 
coupled with 4-iodo-BODIPY 58 (synthesis was described in Chapter 3.2.1) to form 
compound 149.  The obtained beads had a slightly yellow-green fluorescence in organic 
solvents.  The activation of the carboxylic acid in 149 (NHS with DIC in DMF, and 
N,N’-disuccinimidyl carbonate with 1-methylimidazole in CH2Cl2) led to similar results.  
As soon as we treated the beads with the chemicals, we obtained a strong yellow-green 
fluorescent solution. 
 
Scheme 4.22.  Synthesis of solid-support 149 via Sonogashira coupling. 
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4.5 System D: Chemically Cleavable Linker, Azobenzene 
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Figure 4.16.  Azobenzene linker based solid-support (System D). 
 
 
There are many chemically cleavable linkers, however, acids or bases are usually 
required for a cleavage and those systems are not suitable to biomolecules.  As shown in 
section 4.1.3, Bogyo’s azobenzene linker is cleaved under mild reaction conditions and 
this is biocompartible.137  Thus, we used the linker 152 (previously synthesized by Mr. 
Jiney Jose and used for other research) to design the new solid-supported compound 155 
(Figure 4.16) and studied its stability for the activation step.  A carboxylic acid was 
attached on solid-support and an azide was cyclized with an ethynylated BODIPY dye. 
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Scheme 4.23 illustrates the synthesis of BSA-coated CPG with a azobenzene linker 
(154).  The amine-functionality of CPG (pore size: 500 Å) was activated with N,N’-
disuccinimidyl carbonate followed by BSA coating to afford BSA-coated CPG 151.  The 
azobenzene compound 152 was then coupled with BSA-CPG 151 to give azide 153 as 
orange beads and the ninhydrin test of 153 gave negative (brown beads).  Aspartic acids 
and glutamic acids of BSA were capped via the activation of acids with NHS followed 
by coupling with ethanolamine to afford product 154. 
 
 
Scheme 4.23.  Synthesis of BSA-coated CPG with azolinker (154). 
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The compound 155 was synthesized from azide 154 and BODIPY derivative 63 
(synthesis was described in Chapter III, section 3.2.1) via a 2+3 cycloaddition reaction 
(Scheme 4.24).  These beads had a slightly yellow-green fluorescence in organic 
solvents (DMF, EtOH). 
 
Scheme 4.24.  Synthesis of BSA-coated azobenzene-linked BODIPY 155. 
N
H
N
H
O
BSA
N
H
O
N
N
N3
O NH
OH
N
B
F2
N
O CO2H+
N
H
N
H
O
BSA
N
H
O
N
N
N
O NH
OH
N N
N B
N
O
CO2H
F
F
cat. CuSO4
sodium ascorbate
THF/H2O, 25 ºC
24 h, dark
dark brown beads
less yellow-green fluorescence
in organic solvents
154
155
63
 
 
Next, two activation methods for the carboxylic acid of compound 155 were 
attempted.  However, both the methods (NHS, DIC, DMF, 25 ºC or EDCI, pH 7.4 PBS, 
25 ºC) led to the decomposition of the molecule again, because the starting colorless 
solution turned to a strong yellow-green fluorescent solution immediately after the 
addition of chemicals in both cases (Scheme 4.25).  The decomposition process is not 
clear since there are no clevable bonds under those activating conditions. 
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Scheme 4.25.  Activation of carboxylic acid for compound 155. 
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The non-BSA-coated CPG 157 was also synthesized to study how the reaction works 
without BSA (Scheme 4.26).  The CPG (pore size; 500 Å) were directly coupled with 
the azo compound 152 followed by click chemistry with BODIPY 63 to afford 
compound 157 as reddish brown beads.  Activation of the carboxylic acid using the same 
method as above (NHS, DIC or EDCI, pH 7.4) resulted in the decomposition of the 
molecule again (appearance of a strong yellow-green fluorescence in solution).  On the 
other hand, the cleavage reaction of the azobenzene linker (157) was tried using 100 mM 
sodium dithionite (25 ºC, 12 h) to confirm whether the reaction work or not.  However, 
the mass spectrometry analysis of the sample from this reaction did not detect compound 
159, but this could be because BODIPY 159 containing a free amine and a carboxylic 
acid is probably quite unstable.  Moreover the obtained beads (158) were still reddish 
brown color and the ninhydrin test of these beads gave a negative result (brown bead) 
indicating that the reaction was not completed even after 12 h. 
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Scheme 4.26.  Synthesis of solid-support azobenzene-linked BODIPY 157. 
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4.6 Summary for Each Approach and Reactions 
Table 4.1 shows the summary for each compounds and reactions which we have 
attempted in this project. 
 
Table 4.1.  Summary of this project. 
strategy cpd. solid- support dye 
cleavable-
linker protein
d  results 
1 96 PEGA Nile Red photo (ONBa) – 
difficult to handle, 
swelling too much 
2 96 CPG Nile Red ″ – decomposed during deprotection 
3 112 ″ BODIPY photo (MNBb) – 
photolysis was 
confirmed 
(solution-phase) 
4 117 ″ ″ ″ – 
photolysis was 
confirmed 
(solid-phase) 
5 127 ″ Nile Red ″ Ubq not detected by MALDI 
6 139 BSA-CPG BODIPY ″ Ubq 
not detected by CE, 
MALDI and LCMS 
7 148 CPG ″ ″ small peptide 
decomposition in 
activation step, 
not detected by 
MALDI and LCMS 
8 149 ″ ″ ″ – decomposition in activation step 
9 155 BSA-CPG ″ chemical
c – decomposition in activation step 
10 157 CPG ″ ″ – decomposition in activation step 
a; o-nitrobenzyl, b; 5-methoxy-2-nitrobenzyl, c; azobenzene, and d; Ubq = ubiquitin. 
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(MNB)
c: azobenzene
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Strategy 1: 
N
H
O
NO2
O
O
N
O
O
N
CO2H
CO2H
entry 1: 96-PEGA
entry 2: 96-CPG
PEGA or CPG
support
 
 
Molecule 96 based on o-nitrobenzyl linker, Nile Red, and PEGA-support was 
synthesized, but PEGA resin swelled too much in these solvents and was difficult to 
handle due to its sticky nature.  PEGA resin also has a limited accessibility for protein. 
 
Strategy 2: 
O
N
ON O
HO2C
CO2H
OH
102
control compound  
 
For compound 96 with CPG, decomposition occurred during the deprotection of the 
methyl ester with K2CO3 or TMSOK as indicated by the dramatic color change of the 
beads.  Photolysis of 96 was performed and analyzed by HPLC to compare to its 
cleaved-product (control compound 102 which was made via solution-phase synthesis), 
however, the retention time for both samples did not match. 
 
 
 
 
 133 
Strategy 3: 
O
NO2
O
O
NBn
NN
OMeO
tBuO
UV
h! (360 nm)
ethanolamine
CH3CN, 1 h
quartz cuvette
O
NO
OMeO
tBuO
HO2C
NBn
NN
HN
O
+
113 114112
detected in mass spec.
not detected in mass spec.
due to less stability  
 
Model study for photolysis was performed in solution-phase.  Compound 112 was 
irradiated under UV and the desired photo-cleaved product 114 was obtained and 
observed by mass spectrometry.  We confirmed that the photolysis works. 
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Model study for photolysis was performed in solid-phase.  Compound 117 was 
irradiated under UV, and UV absorption and fluorescence emission spectra were 
recorded and these λmax matched with those of parent BODIPY. 
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Strategy 5: 
O
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O
N
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N
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ethanolamine
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N
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ubiquitin
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not detected in MALDI  
 
Compound 127 was photo-cleaved and the dye-protein conjugate 129 was analyzed 
by measuring UV and fluorescence spectra.  However, we did not see a peak at 280 nm 
which is a characteristic peak of protein. 
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Strategy 6: 
+
N
H
N
H
O
BSA
N
H
O
O
OMe
NO
O NH
OH
HN
O
CPG
0.097 mmol/g
ubiquitin
N
H
N
H
O
BSA
N
H
O
O
OMe
NO2
O
O
O NH
OH
N
NN
HN
O
N B
F2
N
O
NH
ubiquitin
HO2C
N
NN
HN
O
N B
F2
N
O
NH
h! (360 nm)
10 eq. ethanolamine
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with stirring & air cooling
139
140 141
not detected from CE,
MALDI and LCMS  
 
Photolysis of dye-protein conjugate 139 was performed and the sample was analyzed 
by CE, MALDI, and LCMS.  Products from CE analysis could not be easily assigned 
because the presence of ethanolamine affected the mobility of the compounds.  For 
MALDI and LCMS analyses of compound 141, only a peak at 8570 Da (corresponding 
to the MW of native ubiquitin) was observed.  No dye-protein conjugates were detected 
from these analyses. 
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Strategy 7: 
N
CO2A
HN
O
N B
F2
N
NN
OO
OMe
NO2
O
N
H
O
148
A = EDCI
(i) coupling with
small peptide
(ii) photolysis
not detected from MALDI and LCMS  
 
Compound 148 was activated and coupled with a small peptide.  The sample from 
the photolysis was analyzed by MALDI and LCMS, however, we obtained only a small 
peptide with MW of 1652.  There was no dye-peptide conjugate in the sample. 
 
Strategy 8: 
OO
OMe
NO2
O
N
H
O N
BF2
N
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CO2H
149
NHS, DIC
or
N,N'-disuccinimidyl carbonate
1-methylimidazole
decomposed:
obtained fluorescent solution  
 
The activation of compound 149 led to the decomposition of the molecule: rapid 
appearance of a strong yellow-green fluorescence in solution after the addition of the 
reagents. 
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Strategy 9: 
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155
 
 
Chemically cleavable linker, azobenzene, was used for compound 155 (based on 
BSA-CPG).  Again a strong yellow-green fluorescent solution was obtained after the 
addition of the reagents. 
 
Strategy 10: 
NHS, DIC, DMF, 25 ºC
or
EDCI, pH 7.4, 25 ºC
both reaction:
obtained strong fluorescent
solution immediately
N
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Chemically cleavable linker, azobenzene, was used for compound 157 (based on 
CPG).  In the activation step of the carboxylic acid, a strong yellow-green fluorescent 
solution was immediately obtained after the addition of the chemicals.  The cleavage of 
azobenzene linker was also performed using sodium dithionite, but the cleaved product 
159 was not detected in mass spectrometry. 
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4.7 Conclusion 
There are two possible explanations for the decomposition process.  First, the 
photolinker may not be stable even when the reactions are carried out in dark.  
Chemically cleavable linkers can be used instead of photolabile linker, but cleavage 
conditions must be mild to prevent protein damage.  A chemically cleavable linker, 
azobenzene derivative, was used for this study because it is cleaved under mild reaction 
condition.  Nevertheless, we obtained a strong yellow-green fluorescent solution during 
the activation of carboxylic acid and also did not confirm the cleavage of azobenzene 
linker with 100 mM sodium dithionite (25 ºC, 12 h) by mass spectrometry.  Second, the 
dye must be carefully chosen.  It is very important that the dye used be stable under 
strong acid or basic conditions.  The BODIPY dye chosen in these studies might have 
been a poor choice as it is known that the BF2 group can fall off under strong basic 
conditions.  Furthermore, the high energy irradiation (360 nm) required to cleave off the 
photolinker, could also damage the protein or the dye.  Therefore, other chemically and 
photostable dyes such as halogenated-fluorescein or rhodamine derivatives may be a 
better choice for this project.  
For the dye-protein conjugation on solid-phase, the coupling reaction between large 
beads and biomolecules may not be efficient.  Thus further screening for different size of 
beads will be required, e.g. the use of smaller CPGs.  Second, we selected the amide-
coupling between carboxylic acid on bead (succinimidyl ester) and amine-group (from 
lysine) of protein to make dye-protein conjugates.  Succinimidyl esters are not stable in 
basic media, i.e. they do not survive for a long time.  In this solid-phase synthesis, the 
succinimidyl ester was on the bead and its stability might have been less than that of one 
in solution-phase synthesis.  If this succinimidyl ester was decomposed before coupling 
with protein, then no dye-protein conjugates will be formed.  In fact, this might occur in 
the coupling stage between the dye on solid-support and ubiquitin (Ubq) because only 
Ubq was observed after photolysis instead of any dye-protein conjugates, or dye-peptide 
conjugates from MALDI and LCMS analyses.  However, the reason why we obtained 
Ubq is not clear since excess Ubq was washed away in the previous stage (coupling 
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between Ubq and dye on resin).  A plausible reason for this is that Ubq was stuck on the 
beads without forming amide bond.  Instead of amide-coupling, click reaction might be a 
good idea, and this 2+3 cycloaddition is usually efficient in solution and solid-phase.  
The insertion of azido or alkyne functionality onto beads is easy, however, the problem 
is the functionalization of native protein surface.  There is literature for the insertion of 
alkyne-functionality into recombinant protein, and this was successfully cyclized with 
azido-coumarin.10  Therefore if the functionalization of protein surface is achieved, then 
this could produce more efficient strategy for coupling reaction in solid-phase synthesis.  
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CHAPTER V 
 
CONCLUSIONS AND OUTLOOK 
 
5.1 Water-soluble Fluorescent Probes 
We synthesized regioisomerically pure 5- and 6-carboxyfluorescein 3a and 3b via 
fractional crystallization (MeOH/hexanes or EtOH/hexanes system) on multi-gram scale 
(Figure 5.1).  This method is very convenient because no expensive chemicals are 
required and it produces both isomers in high purity (>98 %).  In fact, both commercial 
samples are expensive.  Dyes 3a and 3b cannot be directly used to synthesize TBET 
cassette but they are very useful to couple to proteins.  Their derivatives, 5- and 6-
bromofluorescein which were previously synthesized in our lab, are used for cassettes 
synthesis.38 
 
OO OH
CO2H
CO2H
OO OH
CO2H
HO2C
5
6
5-carboxyfluorescein 6-carboxyfluorescein
3a 3b
 
Figure 5.1.  5- and 6-Carboxyfluorescein 3. 
 
 
Water-soluble BODIPY derivative 23 and dye-protein conjugate 23-BSA were 
synthesized and their photophysical properties in aqueous medium were studied.  As 
shown in Figure 5.2, dye 23 and its dye-protein conjugate 23-BSA had quantum yields 
(0.74 and 0.44) in pH 7.4 phosphate buffer.  Further functionalization of chlorine on dye 
23 was tested via nucleophilic attack of taurine.  However the reaction was not 
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completed and resulted in difficult purification due to the high porality of dye 23.  
Fluorescent probe 23 has excellent photophysical properties at physiological pH. 
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# ---
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Figure 5.2.  Photophysical properties of water-soluble BODIPY derivative 23 and its 
dye-BSA conjugate 23-BSA. 
 
 
Water-soluble Nile Blues 30a,b and 31a,b were synthesized and their quantum 
yields were improved in aqueous medium compared to the reported Nile Blues 28 and 
29 (Figure 5.3).  Dyes 30 and 31 were synthesized via condensation reaction (DMF, 90 
ºC) that do not require additional acids or very harsh conditions.  Further 
functionalization of 30 and 31 is possible e.g. via triflation of the 2-hydroxy substituent 
and organometallic cross-coupling.  All the dyes showed little tendency to aggregate 
below 4 µM, this property is useful when biological studies are performed in dilute 
conditions.  Moreover, dyes 30 and 31 have relatively long emission wavelengths (670-
680 nm) and therefore these dyes are suitable probes for tissue and intracellular imaging. 
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Figure 5.3.  Water-soluble Nile Blue derivatives 30 and 31. 
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5.2 Through-bond Energy Transfer Cassettes 
Three novel iodo-cyanine dyes 74a-c were synthesized as acceptor fragments for 
synthesizing TBET cassettes.  Syntheses of these dyes are relatively straightforward via 
two steps condensation.  All cyanine dyes had well-distinguished absorption and 
emission maxima (ca. 100 nm).  We synthesized a series of TBET cassettes 75a-c (26-
45 % yields) from the corresponding iodo-cyanine dyes 74a-c and 4-Ethynyl BODIPY 
via Sonogashira coupling (Figure 5.4).  The fluorescence emission maxima of these 
cassettes were extremely well-separated in EtOH by approximately 100 nm and this is 
very useful for multiplexing study in cellular imaging.   
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4
N
I–
N
CO2H
4
I
n
n = 0; 74a, 1; 74b, 2; 74c
n
n = 0; 75a, 1; 75b, 2; 75c  
Figure 5.4.  Iodo-cyanine series 74a-c, and novel TBET cassettes 75a-c. 
 
We are particularly interested in incorporating these cassettes into silica or calcium 
phosphate (CP) nanoparticles to improve their photostabilities and solubilities in 
aqueous media.  These three cassettes were coated with silica via covalent bonding or 
calcium phosphate by non-covalent bonding, and the corresponding both nanoparticles 
were water soluble.  The cassettes doped nanoparticles had moderate ETE (about 85 %) 
with low quantum yields in aqueous media.  Further the formation of silica and CP 
nanoparticles were confirmed by TEM and AFM images, respectively.  Their 
photostabilities are being studied by Dr. Son’s group and we will also work multiplexing 
in intracellular imaging in future. 
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5.3 Solid-phase Approach Towards Protein Mono-labeling 
Different designs (surmmarized in Table 4.1 in Chapter IV) for protein mono-
labeling were prepared on various solid supports, but no dye-protein conjugates could be 
detected after photolysis by CE, MALDI, and LCMS.  There are some plausible reasons 
for this; (i) lower reactivity between large beads and biomolecules, (ii) stability of the 
photolabile linker, and (iii) stability of the succinimidyl ester on solid-support.  As 
described in Chapter IV, succinimidyl esters are not very stable under basic conditions, 
and different coupling strategies must be envisaged i.e. click reaction. 
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O
OMe
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O
CO2H
halogenated-fluorescein
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azide, alkyne, or cyanato
triazole or ether
azobenzene
linker
CPG
 
Figure 5.5.  Alternative design for this project. 
 
 
Figure 5.5 illustrates an alternative design for this project.  Each fragments will be 
replaced with other functional groups or compounds as shown in Figure 5.5.  The use of 
chemically cleavable linker instead of photolabile one is preferred to perform this 
research because irradiation at 360 nm may cause damage to protein and fluorophores.  
Azobenzene linker which can be cleaved under mild condition,137 was one of the first 
chemically cleavable linkers investigated by us in this project.  However, we did not 
detect the cleaved products when 100 mM sodium dithionite was used.  This reaction has 
only been done once, thus further exploration of reaction condition e.g. increasing 
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concentration of sodium dithionite and reaction time, will be necessary to optimize 
cleavage condition.  For the fluorescent dye part, halogenated-fluorescein or rhodamine 
dyes will be more suitable because they are much more photo- and chemically stable 
than BODIPY.  Finally, coupling to the biomolecules could be done via click chemistry.  
This could solve some of the problems we encountered during the activation step of 
carboxylic acid.  However, the handle for attachment of biomolecules would have to be 
replaced with an azide or alkyne and this might be difficult to do. 
Without modification of the protein surface, Tan and co-worker’s method may be an 
other good idea.153  They modified the surface of silica nanoparticles using cyanogen 
bromide (CNBr) to form a cyanato-group.  This was then coupled with antibody to 
afford antibody immobilized silica nanoparticle (Figure 5.6).  There are big advantages 
in this method; (i) it is not necessary to isolate a compound activated with cyanato-
group, (ii) short activating reaction time, and (iii) possibility to add biomolecules 
directly into the solution containing activated materials.  These issues make it more 
efficient bioconjugations and this could be an alternative method to our project. 
 
Si
Si
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OCN
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O
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Figure 5.6.  Antibody immobilization process onto the luminophore-doped 
silica nanoparticle’s surface. 
 145 
REFERENCES 
 
(1) Lakowicz, J. R. Principles of Fluorescence Spectroscopy; 3rd ed.; Springer: New 
York, 2006. 
(2) Förster, T. Naturwissenschaften 1946, 6, 166-175. 
(3) Wagner, R. W.; Lindsey, J. S. J. Am. Chem. Soc. 1994, 116, 9759-60. 
(4) Lang, P.; Yeow, K.; Nichols, A.; Scheer, A. Nat. Rev. Drug Discovery 2006, 5, 
343-356. 
(5) Ju, J.; Glazer, A. N.; Mathies, R. A. Nature Med. 1996, 2, 246-9. 
(6) Metzker, M. L.; Lu, J.; Gibbs, R. A. Science 1996, 271, 1420-2. 
(7) Griffin, B. A.; Adams, S. R.; Tsien, R. Y. Science 1998, 281, 269-272. 
(8) Cao, H.; Xiong, Y.; Wang, T.; Chen, B.; Squier, T. C.; Mayer, M. U. J. Am. 
Chem. Soc. 2007, 129, 8672-8673. 
(9) Girouard, S.; Houle, M.-H.; Grandbois, A.; Keillor, J. W.; Michnick, S. W. J. 
Am. Chem. Soc. 2005, 127, 559-566. 
(10) Beatty, K. E.; Xie, F.; Wang, Q.; Tirrell, D. A. J. Am. Chem. Soc. 2005, 127, 
14150-14151. 
(11) Hooker, J. M.; Esser-Kahn, A. P.; Francis, M. B. J. Am. Chem. Soc. 2006, 128, 
15558-15559. 
(12) Brustad, E. M.; Lemke, E. A.; Schultz, P. G.; Deniz, A. A. J. Am. Chem. Soc. 
2008, 130, 17664-17665. 
(13) Panchuk-Voloshina, N.; Haugland, R. P.; Bishop-Stewart, J.; Bhalgat, M. K.; 
Millard, P. J.; Mao, F.; Leung, W.-Y.; Haugland, R. P. J. Histochem. Cytochem. 
1999, 47, 1179-1188. 
(14) Baeyer, A. v. Chem. Ber. 1871, 5, 255. 
(15) Sun, W.-C.; Gee, K. R.; Klaubert, D. H.; Haugland, R. P. J. Org. Chem 1997, 62, 
6469-75. 
(16) Chapple, M. R.; Johnson, G. D.; Davidson, R. S. J Microsc 1990, 159, 245-53. 
(17) Chen, R. F.; Knutson, J. R. Anal Biochem 1988, 172, 61-77. 
 146 
(18) Walkup, G. K.; Burdette, S. C.; Lippard, S. J.; Tsien, R. Y. J. Am. Chem. Soc. 
2000, 122, 5644-5. 
(19) Tomat, E.; Nolan, E. M.; Jaworski, J.; Lippard, S. J. J. Am. Chem. Soc. 2008, 
130, 15776-15777. 
(20) Song, F.; Garner, A. L.; Koide, K. J. Am. Chem. Soc. 2007, 129, 12354-12355. 
(21) Song, F.; Watanabe, S.; Floreancig, P. E.; Koide, K. J. Am. Chem. Soc. 2008, 
130, 16460-16461. 
(22) Sparano, B. A.; Shahi, S. P.; Koide, K. Org. Lett. 2004, 6, 1947-1949. 
(23) Sparano, S.; Koide, K. J. Am. Chem Soc. 2005, 127, 14954-55. 
(24) Sparano, B. A.; Koide, K. J. Am. Chem. Soc. 2007, 129, 4785-4794. 
(25) Urano, Y.; Kamiya, M.; Kanda, K.; Ueno, T.; Hirose, K.; Nagano, T. J. Am. 
Chem. Soc. 2005, 127, 4888-4894. 
(26) Mottram, L. F.; Boonyarattanakalin, S.; Kovel, R. E.; Peterson, B. R. Org. Lett. 
2006, 8, 581-584. 
(27) Keppler, A.; Pick, H.; Arrivoli, C.; Vogel, H.; Johnsson, K. Proc. Nat. Acad. Sci. 
U.S.A. 2004, 101, 9955-9959. 
(28) Mottram, L. F.; Maddox, E.; Schwab, M.; Beaufils, F.; Peterson, B. R. Org. Lett. 
2007, 9, 3741-3744. 
(29) Onoue, S.; Liu, B.; Nemoto, Y.; Hirose, M.; Yajima, T. Anal. Sci. 2006, 22, 
1531-1535. 
(30) Genin, E.; Carion, O.; Mahler, B.; Dubertret, B.; Arhel, N.; Charneau, P.; Doris, 
E.; Mioskowski, C. J. Am. Chem. Soc. 2008, 130, 8596-8597. 
(31) Thorn, K. S.; Naber, N.; Matuska, M.; Vale, R. D.; Cooke, R. Protein Sci. 2000, 
9, 213-217. 
(32) Orndorff, W. R.; Hemmer, A. J. J. Am. Chem. Soc. 1927, 49, 1272-1280. 
(33) Adamczyk, M.; Fishpaugh, J. R.; Heuser, K. J. Bioconjugate Chem. 1997, 8, 253-
5. 
(34) Adamczyk, M.; Chan, C. M.; Fino, J. R.; Mattingly, P. G. J. Org. Chem. 2000, 
65, 596-601. 
 147 
(35) Fischer, R.; Mader, O.; Jung, G.; Brock, R. Bioconjugate Chem. 2003, 14, 653-
660. 
(36) Ueno, Y.; Jiao, G.-S.; Burgess, K. Synthesis 2004, 2591-2593. 
(37) Lyttle, M. H.; Carter, T. G.; Cook, R. M. Org. Process Res. Dev. 2001, 5, 45-9. 
(38) Jiao, G.-S.; Han, J. W.; Burgess, K. J. Org. Chem. 2003, 68, 8264-7. 
(39) Rossi, F. M.; Kao, J. P. Y. Bioconjugate Chem. 1997, 8, 495-7. 
(40) Karolin, J.; Johansson, L. B. A.; Strandberg, L.; Ny, T. J. Am. Chem. Soc. 1994, 
116, 7801-6. 
(41) Haugland, R. P. Handbook of Fluorescent Probes and Research Chemicals; 6th 
ed.; Molecular Probes: Eugene, OR, 1996. 
(42) Wagner, R. W.; Lindsey, J. S. Pure Appl. Chem. 1996, 68, 1373-80. 
(43) Tan, K.; Jaquinod, L.; Paolesse, R.; Nardis, S.; Di Natale, C.; Di Carlo, A.; Prodi, 
L.; Montalti, M.; Zaccheroni, N.; Smith, K. M. Tetrahedron 2004, 60, 1099-
1106. 
(44) Yee, M.-c.; Fas, S. C.; Stohlmeyer, M. M.; Wandless, T. J.; Cimprich, K. A. J. 
Biol. Chem. 2005, 280, 29053-29059. 
(45) Metzker, M. L. Substituted 4,4-Difluoro-4-bora-3a,4a-diaza-s-indacene 
Compounds for 8-Color DNA Sequencing. WO Patent 2003066812, August 14, 
2003. 
(46) McDonnell, S. O.; O'Shea, D. F. Org. Lett. 2006, 8, 3493-3496. 
(47) Ueno, T.; Urano, Y.; Kojima, H.; Nagano, T. J. Am. Chem. Soc. 2006, 128, 
10640-10641. 
(48) Ulrich, G.; Goeb, S.; De Nicola, A.; Retailleau, P.; Ziessel, R. Synlett 2007, 
1517-1520. 
(49) Umezawa, K.; Nakamura, Y.; Makino, H.; Citterio, D.; Suzuki, K. J. Am. Chem. 
Soc. 2008, 130, 1550-1551. 
(50) Loudet, A.; Burgess, K. Chem. Rev. 2007, 107, 4891-4932. 
(51) Wu, L.; Burgess, K. J. Am. Chem. Soc. 2008, 130, 4089-4096. 
(52) Li, L.; Han, J.; Nguyen, B.; Burgess, K. J. Org. Chem. 2008, 73, 1963-1970. 
 148 
(53) Han, J.; Gonzalez, O.; Aguilar-Aguilar, A.; Pena-Cabrera, E.; Burgess, K. Org. 
Biomol. Chem. 2009, 7, 34-36. 
(54) Baruah, M.; Qin, W.; Vallee, R. A. L.; Beljonne, D.; Rohand, T.; Dehaen, W.; 
Boens, N. Org. Lett. 2005, 7, 4377-4380. 
(55) Rohand, T.; Baruah, M.; Qin, W.; Boens, N.; Dehaen, W. Chem. Commun. 2006, 
266-8. 
(56) Rohand, T.; Qin, W.; Boens, N.; Dehaen, W. Eur. J. Org. Chem. 2006, 4658-
4663. 
(57) Li, L.; Nguyen, B.; Burgess, K. Bioorg. Med. Chem. Lett. 2008, 18, 3112-3116. 
(58) Loiseau, F. A.; Hii, K. K.; Hill, A. M. J. Org. Chem. 2004, 69, 639-647. 
(59) Lu, G.; Lam, S.; Burgess, K. Chem. Commun. 2006, 1652-54. 
(60) Yoshida, Y.; Sakakura, Y.; Aso, N.; Okada, S.; Tanabe, Y. Tetrahedron 1999, 
55, 2183-2192. 
(61) Molecular Probes; http://probes.invitrogen.com. Invitrogen Corporation: Eugene, 
OR, 2006. 
(62) Melhuish, W. H. J. Phys. Chem. 1960, 64, 762-4. 
(63) Williams, A. T. R.; Winfield, S. A.; Miller, J. N. Analyst 1983, 108, 1067-71. 
(64) Mohlau, R.; Uhlmann, K. Justus Liebigs Ann. Chem. 1896, 289, 94-128. 
(65) Wichmann, C. F.; Liesch, J. M.; Schwartz, R. E. J. Antibiot. 1989, 42, 168-73. 
(66) Briggs, M. S. J.; Bruce, I.; Miller, J. N.; Moody, C. J.; Simmonds, A. C.; Swann, 
E. J. Chem. Soc., Perkin Trans. 1 1997, 7, 1051-1058. 
(67) Simmonds, A.; Miller, J. N.; Moody, C. J.; Swann, E.; Briggs, M. S. J.; Bruce, I. 
E. Benzophenoxazine Dyes. WO Patent 9729154, August 14, 1997. 
(68) Jose, J.; Burgess, K. J. Org. Chem. 2006, 71, 7835-7839. 
(69) Jose, J.; Burgess, K. Tetrahedron 2006, 62, 11021-11037. 
(70) Lee, S. H.; Suh, J. K.; Li, M. Bull. Korean Chem. Soc. 2003, 24, 45-48. 
(71) Das, K.; Jain, B.; Patel, H. S. Spectrochim. Acta, Part A 2004, 60A, 2059-2064. 
(72) Krihak, M.; Murtagh, M. T.; Shahriari, M. R. J. Sol-Gel Sci. Technol. 1997, 10, 
153-163. 
 149 
(73) Maliwal, B. P.; Kusba, J.; Lakowicz, J. R. Biopolymers 1995, 35, 245-255. 
(74) Lakowicz, J. R.; Piszczek, G.; Kang, J. S. Anal. Biochem. 2001, 288, 62-75. 
(75) Nikas, D. C.; Foley, J. W.; Black, P. M. Lasers Surg. Med. 2001, 29, 11-7. 
(76) Lin, C. W.; Shulok, J. R.; Wong, Y. K.; Schanbacher, C. F.; Cincotta, L.; Foley, 
J. W. Cancer Research 1991, 51, 1109-16. 
(77) Lin, C.-W.; Shulok, J. R. Photochem. Photobiol. 1994, 60, 143-6. 
(78) Juzeniene, A.; Peng, Q.; Moan, J. Photochem. Photobiol. Sci. 2007, 6, 1234-
1245. 
(79) Ho, N.-h.; Weissleder, R.; Tung, C.-H. Tetrahedron 2006, 62, 578-585. 
(80) Frade, V. H. J.; Coutinho, P. J. G.; Moura, J. C. V. P.; Goncalves, M. S. T. 
Tetrahedron 2007, 63, 1654-1663. 
(81) Lopez-Calle, E.; Fries, J. R.; Mueller, A.; Winkler, D. Innovation and  
Perspectives in Solid Phase Synthesis & Combinatorial Libraries: Peptides, 
Proteins and Nucleic Acids--Small Molecule Organic Chemistry Diversity, 
Collected Papers, International Symposium, 7th, Southampton, UK, MD, Sep. 
18-22, 2001; pp 129-136. 
(82) Yan, X.; Yuan, P. M. Sulfonated [8,9]Benzophenoxazine Dyes and The Use of 
Their Labelled Conjugates. US Patent 7238789, November 8, 2001. 
(83) Jose, J.; Ueno, Y.; Burgess, K. Chem. Eur. J. 2009, 15, 418-423. 
(84) Kina, K.; Horiguchi, D. Novel Water-soluble Nitrosophenolic Compound and Its 
Application. JP Patent 57091969, August 6, 1982. 
(85) Hansen, T. M.; Engler, M. M.; Forsyth, C. J. Bioorg. Med. Chem. Lett. 2003, 13, 
2127-30. 
(86) Burns, C. J.; Field, L. D.; Petteys, B. J.; Ridley, D. D. Aust. J. Chem. 2005, 58, 
738-748. 
(87) Mishra, V. N.; Datt, N. Indian J. Chem., Sect. A: Inorg., Phys., Theor. Anal. 
Chem. 1985, 24A, 597-600. 
(88) Mathur, A. K.; Agarwal, C.; Pangtey, B. S.; Singh, A.; Gupta, B. N. Int. J. Cos. 
Sci. 1988, 10, 213-18. 
 150 
(89) Sun, C.; Yang, J.; Li, L.; Wu, X.; Liu, Y.; Liu, S. J. Chromatogr. B 2004, 803, 
173-190. 
(90) Frangioni, J. V. Curr. Opin. Chem. Biol. 2003, 7, 626-634. 
(91) Jiao, G.-S.; Thoresen Lars, H.; Burgess, K. J. Am. Chem. Soc. 2003, 125, 14668-
9. 
(92) Bandichhor, R.; Petrescu, A. D.; Vespa, A.; Kier, A. B.; Schroeder, F.; Burgess, 
K. J. Am. Chem. Soc. 2006, 128, 10688-10689. 
(93) Han, J. W.; Castro, J. C.; Burgess, K. Tetrahedron Lett. 2003, 44, 9359-62. 
(94) Loudet, A.; Bandichhor, R.; Burgess, K.; Palma, A.; McDonnell, S. O.; Hall, M. 
J.; O'Shea, D. F. Org. Lett. 2008, 10, 4771-4774. 
(95) Jiao, G.-S.; Castro, J. C.; Thoresen, L. H.; Burgess, K. Org. Lett. 2003, 5, 3675-
7. 
(96) Bandichhor, R.; Petrescu, A. D.; Vespa, A.; Kier, A. B.; Schroeder, F.; Burgess, 
K. Bioconjugate Chem. 2006, 17, 1219-1225. 
(97) Ulrich, G.; Ziessel, R.; Harriman, A. Angew. Chem., Int. Ed. 2008, 47, 1184-
1201. 
(98) Williams, C. H. G. Trans. R. Soc. Edinburg 1856, 21, 377. 
(99) Kiyose, K.; Kojima, H.; Nagano, T. Chem.--Asian J. 2008, 3, 506-515. 
(100) Briggs, M. S.; Burns, D. D.; Cooper, M. E.; Gregory, S. J. Chem. Commun. 2000, 
2323-4. 
(101) Hilderbrand, S. A.; Kelly, K. A.; Niedre, M.; Weissleder, R. Bioconjugate Chem. 
2008, 19, 1635-1639. 
(102) Lee, H.; Berezin, M. Y.; Guo, K.; Kao, J.; Achilefu, S. Org. Lett. 2009, 11, 29-
32. 
(103) Mishra, A.; Behera, R. K.; Behera, P. K.; Mishra, B. K.; Behera, G. B. Chem. 
Rev. 2000, 100, 1973-2011. 
(104) Lindsey, J. S.; Brown, P. A.; Siesel, D. A. Tetrahedron 1989, 45, 4845-66. 
(105) Mason, S. J.; Balasubramanian, S. Org. Lett. 2002, 4, 4261-4264. 
 151 
(106) Mason, S. J.; Hake, J. L.; Nairne, J.; Cummins, W. J.; Balasubramanian, S. J. 
Org. Chem. 2005, 70, 2939-2949. 
(107) Tomasulo, M.; Sortino, S.; Raymo, F. M. J. Org. Chem. 2008, 73, 118-126. 
(108) Kvach, M. V.; Ustinov, A. V.; Stepanova, I. A.; Malakhov, A. D.; Skorobogatyi, 
M. V.; Shmanai, V. V.; Korshun, V. A. Eur. J. Org. Chem. 2008, 2107-2117. 
(109) Sonogashira, K.; Tohda, Y.; Hagihara, N. Tetrahedron Lett. 1975, 16, 4467-70. 
(110) Thivierge, C.; Bandichhor, R.; Burgess, K. Org. Lett. 2007, 9, 2135-2138. 
(111) Atilgan, S.; Ozdemir, T.; Akkaya, E. U. Org. Lett. 2008, 10, 4065-4067. 
(112) Vickerstaff, T.; Lemin, D. R. Nature 1946, 157, 373. 
(113) Wang, J. C. Adv. Color. Sci. Technol. 2000, 3, 20-31. 
(114) Choi, J.; Burns, A. A.; Williams, R. M.; Zhou, Z.; Flesken-Nikitin, A.; Zipfel, W. 
R.; Wiesner, U.; Nikitin, A. Y. J. Biomed. Optics 2007, 12, 064007. 
(115) Chan, W., CW.; Maxwell, D. J.; Gao, X.; Bailey, R. E.; Han, M.; Nie, S. Curr 
Opin Biotechnol 2002, 13, 40-6. 
(116) Bailey, R. E.; Smith, A. M.; Nie, S. Physica E 2004, 25, 1-12. 
(117) Medintz, I. L.; Uyeda, H. T.; Goldman, E. R.; Mattoussi, H. Nat. Mater. 2005, 4, 
435-446. 
(118) Burns, A.; Ow, H.; Wiesner, U. Chem. Soc. Rev. 2006, 35, 1028-1042. 
(119) Burns, A.; Sengupta, P.; Zedayko, T.; Baird, B.; Wiesner, U. Small 2006, 2, 723-
726. 
(120) Kim, S. H.; Jeyakumar, M.; Katzenellenbogen, J. A. J. Am. Chem. Soc. 2007, 
129, 13254-13264. 
(121) Altinoglu, E. I.; Russin, T. J.; Kaiser, J. M.; Barth, B. M.; Eklund, P. C.; Kester, 
M.; Adair, J. H. ACS Nano 2008, 2, 2075-2084. 
(122) Kester, M.; Heakal, Y.; Fox, T.; Sharma, A.; Robertson, G. P.; Morgan, T. T.; 
Altinoglu, E. I.; Tabakovic, A.; Parette, M. R.; Rouse, S.; Ruiz-Velasco, V.; 
Adair, J. H. Nano Lett. 2008, 8, 4116-4121. 
 152 
(123) Morgan, T. T.; Muddana, H. S.; Altinoglu, E. I.; Rouse, S. M.; Tabakovic, A.; 
Tabouillot, T.; Russin, T. J.; Shanmugavelandy, S. S.; Butler, P. J.; Eklund, P. C.; 
Yun, J. K.; Kester, M.; Adair, J. H. Nano Lett. 2008, 8, 4108-4115. 
(124) Santra, S.; Bagwe, R. P.; Dutta, D.; Stanley, J. T.; Walter, G. A.; Tan, W.; 
Moudgil, B. M.; Mericle, R. A. Adv. Mater. 2005, 17, 2165-2169. 
(125) Wu, C.; Hong, J.; Guo, X.; Huang, C.; Lai, J.; Zheng, J.; Chen, J.; Mu, X.; Zhao, 
Y. Chem. Commun. 2008, 750-752. 
(126) Sokolov, I.; Naik, S. Small 2008, 4, 934-939. 
(127) Ow, H.; Larson, D. R.; Srivastava, M.; Baird, B. A.; Webb, W. W.; Wiesner, U. 
Nano Lett. 2005, 5, 113-117. 
(128) Larson, D. R.; Ow, H.; Vishwasrao, H. D.; Heikal, A. A.; Wiesner, U.; Webb, W. 
W. Chem. Mater. 2008, 20, 2677-2684. 
(129) Funatsu, T.; Harada, Y.; Tokunaga, M.; Saito, K.; Yanagida, T. Nature 1995, 
374, 555-9. 
(130) Weiss, S. Science 1999, 283, 1676-83. 
(131) Tilley, S. D.; Francis, M. B. J. Am. Chem. Soc. 2006, 128, 1080-1081. 
(132) Antos, J. M.; Francis, M. B. J. Am. Chem. Soc. 2004, 126, 10256-10257. 
(133) Burgess, K.; Jacutin, S. E.; Lim, D.; Shitangkoon, A. J. Org. Chem. 1997, 62, 
5165-8. 
(134) Burgess, K.; Martinez, C. I.; Russell, D. H.; Shin, H.; Zhang, A. J. J. Org. Chem. 
1997, 62, 5662-3. 
(135) Lu, G.; Burgess, K. Bioorg. Med. Chem. Lett. 2006, 16, 3902-3905. 
(136) Guillier, F.; Orain, D.; Bradley, M. Chem. Rev. 2000, 100, 2091-157. 
(137) Verhelst, S. H. L.; Fonovic, M.; Bogyo, M. Angew. Chem. Int. Ed. 2007, 46, 
1284-1286. 
(138) Bochet, C. G. J. Chem. Soc., Perkin Trans. 1 2002, 125-42. 
(139) Kress, J.; Zanaletti, R.; Amour, A.; Ladlow, M.; Frey, J. G.; Bradley, M. Chem. 
Eur. J. 2002, 8, 3769-72. 
(140) MacBeath, G.; Schreiber, S. L. Science 2000, 289, 1760-3. 
 153 
(141) Zhang, A. J.; Russell, D. H.; Zhu, J.; Burgess, K. Tetrahedron Lett. 1998, 39, 
7439-42. 
(142) Meldal, M. Tetrahedron Lett. 1992, 33, 3077-80. 
(143) Auzanneau, F.-I.; Meldal, M.; Bock, K. J. Pep. Sci. 1995, 1, 31-44. 
(144) Meldal, M.; Auzanneau, F.-I.; Hindsgaul, O.; Palcic, M. M. J. Chem. Soc., Chem. 
Commun. 1994, 1849-50. 
(145) Nielsen, T. E.; Le Quement, S.; Meldal, M. Org. Lett. 2005, 7, 3601-3604. 
(146) Laganis, E. D.; Chenard, B. L. Tetrahedron Lett. 1984, 25, 5831-4. 
(147) Holmes, C. P. J. Org. Chem. 1997, 62, 2370-2380. 
(148) Kostiainen, M. A.; Smith, D. K.; Ikkala, O. Angew. Chem. Int. Ed. 2007, 46, 
7600-7604. 
(149) Tsai, S.-C.; Klinman, J. P. Bioorg. Chem. 2003, 31, 172-190. 
(150) Alvarez, S. G.; Alvarez, M. T. Synthesis 1997, 413-414. 
(151) Srinivasan, M.; Sankararaman, S.; Hopf, H.; Dix, I.; Jones, P. G. J. Org. Chem. 
2001, 66, 4299-4303. 
(152) Srinivasan, R.; Uttamchandani, M.; Yao, S. Q. Org. Lett. 2006, 8, 713-716. 
(153) Santra, S.; Zhang, P.; Wang, K.; Tapec, R.; Tan, W. Anal. Chem. 2001, 73, 4988-
4993. 
(154) Maxam, A. M.; Gilbert, W. Proc. Natl. Acad. Sci. 1977, 74, 560-4. 
(155) Sanger, F.; Nicklen, S.; Coulson, A. R. Proc. Natl. Acad. Sci. 1977, 74, 5463-
5467. 
(156) Corey, E. J.; Hopkins, P. B. Tetrahedron Lett. 1982, 23, 1979-82. 
(157) Chu, C. K.; Bhadti, V. S.; Doboszewski, B.; Gu, Z. P.; Kosugi, Y.; Pullaiah, K. 
C.; Van Roey, P. J. Org. Chem. 1989, 54, 2217-25. 
(158) Saito, Y.; Zevaco, T. A.; Agrofoglio, L. A. Tetrahedron 2002, 58, 9593-9603. 
(159) McGuigan, C.; Pathirana, R. N.; Snoeck, R.; Andrei, G.; De Clercq, E.; 
Balzarini, J. J. Med. Chem. 2004, 47, 1847-1851. 
(160) Watanabe, K. A.; Fox, J. J. Angew. Chem. Inter. Ed. 1966, 5, 579-80. 
 154 
(161) Manchand, P. S.; Belica, P. S.; Holman, M. J.; Huang, T. N.; Maehr, H.; Tam, S. 
Y. K.; Yang, R. T. J. Org. Chem. 1992, 57, 3473-8. 
(162) Marcuccio, S. M.; Elmes, B. C.; Holan, G.; Middleton, E. J. Nucleosides & 
Nucleotides 1992, 11, 1695-701. 
(163) Clive, D. L. J.; Wickens, P. L.; Sgarbi, P. W. M. J. Org. Chem. 1996, 61, 7426-
7437. 
(164) Kovács, T.; Ötvös, L. Tetrahedron Lett. 1988, 29, 4525-8. 
(165) Ludwig, J.; Eckstein, F. J. Org. Chem. 1989, 54, 631-5. 
(166) Thoresen, L. H.; Jiao, G.-S.; Haaland, W. C.; Metzker, M. L.; Burgess, K. Chem. 
Eur. J. 2003, 9, 4603-4610. 
(167) Jiang, Z.-Y.; Wang, Y.-G. Tetrahedron Lett. 2003, 44, 3859-3861. 
(168) Jiao, G.-S.; Castro, J. C.; Thoresen, L. H.; Burgess, K. Org. Lett. 2003, 5, 3675-
3677. 
(169) Wang, Z.-Q.; Diwu, Z.; Francisco-Reyes, J.; Yi, G. G. Chem. Lett. 2005, 34, 404-
405. 
(170) Kalbag, S. M.; Roeske, R. W. J. Am. Chem. Soc. 1975, 97, 440-1. 
(171) Rai, D.; Johar, M.; Srivastav, N. C.; Manning, T.; Agrawal, B.; Kunimoto, D. Y.; 
Kumar, R. J. Med. Chem. 2007, 50, 4766-4774. 
(172) Lam, S. Q. M.S. Thesis, Texas A&M University, 2005. 
(173) Quiclet-Sire, B.; Zard, S. Z. Synthesis 2005, 3319-3326. 
 
 
 155 
APPENDIX A 
 
EXPERIMENTAL DATA FOR CHAPTER II 
 
General Experimental Procedures 
All reactions were carried out under an atmosphere of dry nitrogen.  Glasswares 
were oven-dried prior to use.  Unless otherwise indicated, common reagents or materials 
were obtained from commercial source and used without further purification.  All 
solvents were dried prior to use with appropriate drying agents.  Dry distilled DMF was 
obtained from Acros and used as such.  Flash column chromatography was performed 
using silica gel 60 (230-400 mesh).  Analytical thin layer chromatography (TLC) was 
carried out on Merck silica gel plates with QF-254 indicator and visualized by UV.  
Fluorescence spectra were obtained on a Varian Cary Eclipse fluorescence 
spectrophotometer at room temperature.  Absorbance spectra were obtained on a Varian 
100 Bio UV-Vis spectrophotometer at room temperature.  IR spectra were recorded on a 
Bruker Tensor 27 spectrometer. 
Nuclear Magnetic Resonance (NMR) spectra were recorded on a Varian 300 (1H at 
300 MHz; 13C at 75 MHz; 31P at 121 MHz), Mercury 300 (1H at 300 MHz; 13C at 75 
MHz) or Inova 500 (1H at 500 MHz; 13C at 125 MHz) spectrometer at room temperature.  
Chemical shifts were reported in ppm (parts per million) relative to the residual CDCl3 
(δ 7.26 ppm 1H; δ 77.0 ppm 13C), CD3OD (δ 3.31 ppm 1H; δ 49.0 ppm 13C), acetone-d6 
(δ 2.09 ppm 1H; δ 205.87 & 30.6 ppm 13C) or DMSO-d6 (δ 2.54 ppm 1H; δ 40.45 ppm 
13C).  Coupling constants (J) were reported in Hertz. 
Analytical HPLC were run on a Beckman System Gold 125 solvent module and 166 
UV-vis detector using a Vydac analytical (4.6 x 250 mm) C-18 column.  Gradient 
elution was used (A = water, B = CH3CN, both with 0.1 % v/v TFA) with a constant 
flow rate of 1.0 mL/min.  Preparative HPLC were run on a Beckman System Gold 125P 
solvent module and 166P UV-vis detector using a Vydac semi-preparative C-18 column 
(22 x 250 mm), the solvent system described above, and a flow rate of 10 mL/min. 
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5- and 6-Carboxyfluorescein (3a) and (3b), 
and their methanesulfonic acid adducts (4a) and (4b) 
 
OHO OH
MeSO3
CO2H
CO2H
OHO OH
MeSO3
CO2H
HO2C
OO OH
CO2H
CO2H
OO OH
CO2H
HO2C
5
6
5
6
5-carboxyfluorescein
methanesulfonic acid adduct
6-carboxyfluorescein
methanesulfonic acid adduct
5-carboxyfluorescein 6-carboxyfluorescein
3a 3b
4a 4b
 
 
1,2,4-Benzenetricarboxylic anhydride (also called 4-carboxyphthalic anhydride, 25.0 
g, 0.13 mol) was added to a solution of 1,3-dihydroxybenzene (also called resorcinol, 
28.6 g, 0.26 mol) in methanesulfonic acid (130 mL, 1 M against to 4-carboxyphthalic 
anhydride [0.13 mol]).  An air condenser was attached to the flask and the reaction was 
heated at 85 ºC in an open vessel for 24 h.  After cooling to room temperature, the 
reaction mixture was poured into 7 volumes of ice-H2O (900 mL).  An orange-yellow 
precipitate formed; this was collected by filtration and dried in an oven at 200 ºC for 10 
h to afford 67.2 g of mixture.  20 g of this material was recrystallized from MeOH-
hexanes (2 times: 1st recrystallization: 600 mL of MeOH and 200 mL of hexanes, 2nd 
recrystallization: 120 mL of MeOH and 40 mL of hexanes) at –18 ºC to give 6-
carboxyfluorescein methanesulfonic acid adduct 4b (1.0 g, >98 % purity by anal. 
HPLC).  The mother liquors from this procedure were collected, the solvent was 
removed in vacuo, and the residues were recrystallized from EtOH-hexanes (2 times: 1st 
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recrystallization: 600 mL of EtOH and 200 mL of hexanes, 2nd recrystallization: 120 mL 
of EtOH and 40 mL of hexanes) to give 5-carboxyfluorescein methanesulfonic acid 
adduct 4a (3.2 g, 32 %, >98 % purity by anal. HPLC).  Finally, the mother liquors from 
this experiment were combined, evaporated to dryness, and recrystallized from MeOH-
hexanes (2 times: 1st recrystallization: 600 mL of MeOH and 200 mL of hexanes, 2nd 
recrystallization: 120 mL of MeOH and 40 mL of hexanes) to give another 3.0 g of 6-
isomer 4b, making a total yiled of 4.0 g (40 %).  Careful dropwise addition of concd. aq. 
HCl to solutions of these methanesulfonic esters 4a and 4b in 4 M NaOH gave 5- and 6-
carboxyfluorescein 3a and 3b, respectively in near quantitative yield. 
 
Notes for recrystallization 
1: The ratio of solvents must be 3:1 (MeOH/hexanes or EtOH/hexanes). 
2: Small amount of methanesulfonic acid was added to solution dropwise when 
the material was not soluble in MeOH or EtOH.  The solution can also be heated 
to dissolve material in MeOH or EtOH completely. 
3: MeOH or EtOH and hexanes are immiscible at room temperature and this is 
important.  Because the yellow solids started precipitating from the solvent 
interphase between MeOH of EtOH and hexanes in freezer. 
 
3a:  mp 385-388 ºC; 1H NMR (300 MHz, NaOD-D2O) δ 8.26 (d, 1H, J = 1.9 Hz), 8.07 
(dd, 1H, J = 7.8, 1.7 Hz), 7.33 (d, 1H, J = 7.7 Hz), 7.20 (d, 2H, J = 9.1 Hz), 6.66 (dd, 
2H, J = 9.4, 2.2 Hz), 6.56 (d, 2H, J = 2.5 Hz); 13C NMR (75 MHz, NaOD-D2O) δ 176.4, 
174.57, 174.55, 158.5, 158.0, 139.7, 137.8, 133.9, 131.7, 130.1, 129.9, 128.8, 121.7, 
114.2, 103.4; MS (ESI) m/z 375 (M–H)–; Anal. Calcd for C21H12O7•1.5H2O: C, 62.53; 
H, 3.75. Found: C, 62.70; H, 3.49. 
 
3b:  mp 372-374 ºC; 1H NMR (300 MHz, NaOD-D2O) δ 8.09 (dd, 1H, J = 8.1, 1.5 Hz), 
7.89 (s, 1H), 7.86 (d, 1H, J = 1.1 Hz), 7.24 (d, 2H, J = 9.4 Hz), 6.68 (m, 4H); 13C NMR 
(75 MHz, NaOD-D2O) δ 175.3, 174.6, 174.3, 158.2, 157.9, 141.7, 137.5, 131.9, 131.1, 
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130.4, 130.2, 128.6, 121.3, 115.0, 103.3; MS (ESI) m/z 375 (M–H)–; Anal. Calcd for 
C21H12O7•1.5H2O: C, 62.53; H, 3.75. Found: C, 62.43; H, 3.36. 
 
4a:  mp 196-198 ºC; 1H NMR (300 MHz, NaOD-D2O) δ 8.23 (d, 1H, J = 1.2 Hz), 8.02 
(dd, 1H, J = 9.0, 1.8 Hz), 7.21 (d, 1H, J = 7.8 Hz), 7.13 (d, 2H, J = 9.3 Hz), 6.60 (dd, 
2H, J = 9.6, 2.4 Hz), 6.53 (d, 2H, J = 2.1 Hz), 2.80 (s, 3H); 13C NMR (75 MHz, NaOD-
D2O) δ 180.7, 174.9, 174.7, 158.8, 158.7, 139.8, 137.5, 134.2, 131.5, 130.2, 129.6, 
128.6, 123.1, 112.3, 103.8, 38.57; MS (ESI) m/z 471 (M–H)–; Anal. Calcd for 
C22H16O10S•H2O: C, 53.88; H, 3.70; S, 6.54. Found: C, 53.66; H, 3.86; S, 6.61. 
 
4b:  mp 318-321 ºC; 1H NMR (300 MHz, NaOD-D2O) δ 8.06 (dd, 1H, J = 9.0, 1.2 Hz), 
7.84 (d, 1H, J = 8.1 Hz ), 7.76 (s, 1H), 7.19 (d, 2H, J = 9.6 Hz), 6.61 (m, 4H), 2,79 (s, 
3H); 13C NMR (75 MHz, NaOD-D2O) δ 177.2, 174.8, 174.4, 158.3, 141.9, 137.5, 131.9, 
131.2, 130.5, 130.1, 128.5, 121.9, 114.2, 103.5, 38.58; MS (ESI) m/z 471 (M–H)–; Anal. 
Calcd for C22H16O10S•2H2O: C, 51.97; H, 3.96; S, 6.31. Found: C, 52.30; H, 4.02; S, 
6.23. 
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1H NMR (NaOD-D2O) 
 
 
 
13C NMR (NaOD-D2O) 
OO OH
CO2H
CO2H
5
5-carboxyfluorescein
3a
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1H NMR (NaOD-D2O) 
 
13C NMR (NaOD-D2O) 
OO OH
CO2H
HO2C 6
6-carboxyfluorescein
3b
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1H NMR (NaOD-D2O) 
 
13C NMR (NaOD-D2O) 
OHO OH
MeSO3
CO2H
CO2H
5
5-carboxyfluorescein
methanesulfonic acid adduct
4a
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1H NMR (NaOD-D2O) 
 
 
 
13C NMR (NaOD-D2O) 
 
OHO OH
MeSO3
CO2H
HO2C 6
6-carboxyfluorescein
methanesulfonic acid adduct
4b
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Hexaethylene glycol mono-tosylate (15)58 
 
HO
O
OTs
5  
 
Silver oxide (6.2 g, 26.6 mmol), p-toluenesulfonyl chloride (3.7 g, 19.5 mmol) and 
potassium iodide (588 mg, 3.5 mmol) were added to a solution of hexaethylene glycol (5 
g, 17.7 mmol) in CH2Cl2 (50 mL) at 0 ºC.  The reaction mixture was stirred at 0 ºC for 
30 min then filtrated through celite and washed with EtOAc.  The solvents were 
concentrated under the reduced pressure and the residue was purified by flash 
chromatography eluting with 100 % EtOAc then 30 % acetone/EtOAc to afford product 
as a colorless oil (6.2 g, 81 %).  Rf 0.3 (15 % acetone/EtOAc with iodine stain).  1H 
NMR (500 MHz, CDCl3) δ 7.78 (d, 2H, J = 8.0 Hz), 7.33 (d, 2H, J = 8.0 Hz), 4.14 (t, 
2H, J = 5.0 Hz), 3.71-3.57 (m, 20H), 3.28 (bs, 2H), 2.43 (s, 3H); 13C NMR (125 MHz, 
CDCl3) δ 144.8, 132.8, 129.8, 127.9, 72.6, 70.6, 70.5 (2C), 70.41, 70.40, 70.35, 70.34, 
70.1, 69.3, 68.6, 61.6, 21.6. 
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1H NMR (CDCl3) 
 
 
13C NMR (CDCl3) 
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Mono-azido hexaethylene glycol (16)135 
 
HO
O
N3
5  
 
A solution of hexaethylene glycol mono-tosylate 15 (5.75 g, 13.2 mmol) and sodium 
azide (1.46 g, 22.4 mmol) in CH3CN (70 mL) was refluxed at 85 ºC for 42 h.  The 
reaction mixture was cooled down to room temperature and diluted with water (100 mL) 
and extracted with CH2Cl2 (5 x 50 mL).  The combined organic layer was dried over 
MgSO4 and concentrated under the reduced pressure to afford pure product as a colorless 
oil (3.8 g, 95 %).  Rf 0.1 (100 % EtOAc with iodine stain).  1H NMR (500 MHz, CDCl3) 
δ 3.67 (t, 2H, J = 4.5 Hz), 3.64-3.60 (m, 16H), 3.55 (t, 2H, J = 4.5 Hz), 3.35 (t, 2H, J = 
5.5 Hz), 3.25 (s, 2H); 13C NMR (125 MHz, CDCl3) δ 72.6, 70.43, 70.42, 70.40, 70.39, 
70.31, 70.28, 70.26, 69.96, 69.85, 61.4, 50.5. 
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1H NMR (CDCl3) 
 
 
13C NMR (CDCl3) 
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Mono-azido hexaethylene glycol tosylate (17)135 
 
TsO
O
N3
5  
 
Hexaethylene glycol mono-azide 16 (1.8 g, 5.86 mmol), Et3N (1.6 mL, 11.7 mmol) 
and Me3N•HCl (56 mg, 0.59 mmol) were added in CH3CN (20 mL) at 0 ºC.  A solution 
of TsCl (1.67 g, 8.79 mmol) in CH3CN (10 mL) was then added by syringe and the 
reaction mixture was stirred at 0 ºC for 10 min and 1 h at 25 ºC.  The reaction was 
quenched with water (30 mL) and the aqueous layer was extracted with EtOAc (3 x 30 
mL).  The combined organic layer was dried over MgSO4 and solvents were 
concentrated under the reduced pressure.  The residue was purified by flash 
chromatography eluting with 50 % EtOAc/hexanes then 100 % EtOAc to afford product 
as a yellow oil (2.5 g, 93 %).  Rf 0.7 (100 % EtOAc with iodine stain).  1H NMR (500 
MHz, CDCl3) δ 7.76 (d, 2H, J = 6.0 Hz), 7.31 (d, 2H, J = 6.0 Hz), 4.14-4.11 (m, 2H), 
3.67-3.57 (m, 16H), 3.56-3.55 (m, 4H), 3.37-3.34 (m, 2H), 2.42 (s, 3H); 13C NMR (125 
MHz, CDCl3) δ 144.7, 132.8, 129.7, 127.8, 70.6, 70.53, 70.51, 70.46 (2C), 70.43, 70.40, 
70,36, 69.9, 69.2, 68.5, 50.5, 21.5; MS (ESI) m/z 468.19 (M+Li)+. 
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1H NMR (CDCl3) 
 
 
 
13C NMR (CDCl3) 
 
 169 
Mono-propargyl hexaethylene glycol (18) 
 
O
O
OH
5  
 
Sodium hydride (460 mg, 11.5 mmol, 60 % in mineral oil) was slowly added to a 
solution of hexaethylene glycol (5.0 g, 17.7 mmol) in THF (25 mL) at 0 ºC.  The 
reaction was stirred at 0 ºC for 30 min, then propargyl bromide (1.3 g, 8.9 mmol, 80 % 
w/w in toluene) was added dropwise.  After the stirring at 0 ºC for 30 min, the reaction 
mixture was warmed to room temperature and stirred at 25 ºC for additional 1.5 h.  
Water (25 mL) was slowly added at 0 ºC and extracted with CH2Cl2 (3 x 20 mL).  The 
combined organic layer was dried over MgSO4 and concentrated under the reduced 
pressure.  The residue was purified by flash chromatography eluting with 100 % EtOAc 
then 30 % acetone/EtOAc to afford product as a yellow oil (1.9 g, 67 %).  Rf 0.3 (30 % 
acetone/EtOAc with iodine stain).  1H NMR (300 MHz, CDCl3) δ 4.20 (d, 2H, J = 2.4 
Hz), 3.74-3.59 (m, 24H), 2.43 (t, 1H, J = 2.4 Hz); 13C NMR (75 MHz, CDCl3) δ 74.5, 
72.5, 70.6 (2C), 70.5 (6C), 70.4, 70.3, 69.1, 61.7, 58.4; MS (ESI) m/z 327.19 (M+Li)+.  
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1H NMR (CDCl3) 
 
 
 
13C NMR (CDCl3) 
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 Mono-propargyl hexaethylene glycol tert-butyl ester (19) 
 
O
O
O
5
CO2
tBu
 
 
Sodium hydride (177 mg, 4.4 mmol, 60 % in mineral oil) was slowly added to a 
solution of mono-propargylated hexaethylene glycol 18 (942 mg, 2.9 mmol) in THF (10 
mL) at 0 ºC.  The reaction was stirred at 0 ºC for 30 min, then tert-butylbromoacetate 
(0.87 mL, 5.9 mmol) was added dropwise at 0 ºC.  The reaction mixture was warmed to 
room temperature and stirred at 25 ºC for additional 40 min.  Water (10 mL) was slowly 
added at 0 ºC and extracted with CH2Cl2 (5 x 10 mL).  The combined organic layer was 
dried over MgSO4 and concentrated under the reduced pressure.  The residue was 
purified by flash chromatography eluting with 100 % EtOAc then 20 % acetone/EtOAc 
to afford product as a colorless oil (673 mg, 53 %).  Rf 0.7 (20 % acetone/EtOAc with 
iodine stain).  1H NMR (500 MHz, CDCl3) δ 4.17 (d, 2H, J = 2.5 Hz), 3.99 (s, 2H), 3.71-
3.58 (m, 24H), 2.42 (t, 1H, J = 2.5 Hz), 1.44 (s, 9H); 13C NMR (125 MHz, CDCl3) δ 
169.6, 94.6, 81.5, 79.6, 75.3, 74.5, 70.6, 70.5 (3C), 70.41, 70.36, 70.3, 70.2, 69.0, 68.9, 
63.7, 58.3, 28.0; MS (ESI) m/z 441.25 (M+Li)+.  
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1H NMR (CDCl3) 
 
 
13C NMR (CDCl3)
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Triazole-decorated oligoethylene glycol mono-tosylate (20) 
 
TsO
O
N
N N
O
O
O5
5
CO2
tBu
 
 
Copper powder (94 mg, 1.48 mmol), CuSO4 (0.3 mL, 0.30 mmol, 1M in H2O) and 
H2O (8.0 mL) were added to a solution of mono-azido hexaethylene glycol 17 (680 mg, 
1.48 mmol) and alkylated ethylene glycol 19 (771 mg, 1.77 mmol) in THF (8.0 mL).  
The reaction mixture was stirred at 25 ºC for 24 h under nitrogen.  The solvents were 
evaporated under reduced pressure and the residual material was purified by flash 
chromatography eluting with 40 to 90 % acetone/EtOAc then 100 % acetone to afford 
product as a yellow oil (1.27 g, 96 %).  Rf 0.2 (40 % acetone/EtOAc with iodine stain).  
1H NMR (500 MHz, CDCl3) δ 7.77 (d, 2H, J = 8.5 Hz), 7.73 (s, 1H), 7.32 (d, 2H, J = 8.5 
Hz), 4.65 (s, 2H), 4.51 (t, 2H, J = 5.0 Hz), 4.13 (t, 2H, J = 5.0 Hz), 4.00 (s, 2H), 3.85 (t, 
2H, J = 5.5 Hz), 3.70-3.59 (m, 40H), 3.56 (s, 2H), 2.43 (s, 3H), 1.45 (s, 9H); 13C NMR 
(125 MHz, CDCl3) δ 169.6, 144.78, 144.76, 132.8, 129.8, 127.9, 123.8, 81.5, 70.7, 70.6, 
70.5, 70.48 (3C), 70.45 (10C), 70.41, 70.40, 70.38, 69.5, 69.4, 69.2, 68.9, 68.6, 64.5, 
50.1, 28.0, 21.6; MS (ESI) m/z 896.45 (M+H)+. 
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1H NMR (CDCl3) 
 
 
 
13C NMR (CDCl3)
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Triazole-decorated oligoethylene glycol mono-azide (21) 
 
N3
O
N
N N
O
O
O5
5
CO2
tBu
 
 
Sodium azide (0.46 g, 7.09 mmol) was added to a solution of triazole-decorated 
ethylene glycol 20 (1.27 g, 1.42 mmol) in CH3CN (20 mL) and the reaction mixture was 
refluxed at 88 ºC for 48 h under nitrogen.  The reaction mixture was cooled to room 
temperature and diluted with H2O (25 mL).  The aqueous layer was extracted with 
CH2Cl2 (5 x 20 mL) and the combined organic layer was dried over MgSO4.  The 
solvents were concentrated under the reduced pressure at below 40 ºC to afford pure 
product as a brown oil (1.04 g, 95 %).  Rf 0.2 (50 % acetone/EtOAc with iodine stain).  
1H NMR (500 MHz, CDCl3) δ 7.73 (s, 1H), 4.66 (s, 2H), 4.52 (t, 2H, J = 5.0 Hz), 4.01 
(s, 2H), 3.86 (t, 2H, J = 5.0 Hz), 3.71-3.59 (m, 42H), 3.37 (t, 2H, J = 5.0 Hz), 1.46 (s, 
9H); 13C NMR (125 MHz, CDCl3) δ 169.6, 144.8, 123.8, 81.5, 70.64, 70.63, 70.60, 
70.55 (4C), 70.52 (6C), 70.49 (4C), 70.44, 70.41, 70.0, 69.6, 69.4, 69.0, 64.5, 50.6, 50.2, 
28.1; MS (ESI) m/z 767.44 (M+H)+.  
 176 
 
1H NMR (CDCl3) 
 
 
13C NMR (CDCl3)
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Triazole-decorated oligoethylene glycol mono-carboxylic acid (14) 
 
N3
O
N
N N
O
O
O5
5
CO2H
 
 
A solution of ethylene glycol tert-butyl ester 21 (700 mg, 0.91 mmol) in 1:1 
TFA/CH2Cl2 (1.5 mL: 1.5 mL) was stirred at 25 ºC for 2h under nitrogen.  The reaction 
mixture was flashed with nitrogen for overnight to remove TFA/CH2Cl2.  Pure product 
was obtained as a brown oil (649 mg, 99 %).  Rf 0.1 (50 % acetone/EtOAc with iodine 
stain).  1H NMR (300 MHz, DMSO-d6) δ 8.09 (s, 1H), 4.57-4.53 (m, 4H), 4.05 (s, 2H), 
3.85 (t, 2H, J = 5.0 Hz), 3.65-3.47 (m, 42H), 3.42 (t, 2H, J = 5.0 Hz); 13C NMR (75 
MHz, DMSO-d6) δ 172.6, 144.8, 125.2, 70.7 (16C), 70.64, 70.58, 70.5, 70.2, 69.9, 69.7, 
68.5, 64.5, 50.9, 50.3; MS (ESI) m/z 711.37 (M+H)+.  
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1H NMR (DMSO-d6) 
 
13C NMR (DMSO-d6) 
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Propargylated trifluoromethane-BODIPY (22) 
 
CF3
N
B
F2
N
HNCl
 
 
To a solution of dichloro-BODIPY 957 (300 mg, 0.91 mmol) in CH3CN (24 mL) was 
added propargyl amine (100 mg, 1.82 mmol) dissolved in CH3CN (6.0 mL) dropwise at 
25 ºC.  The reaction mixture was stirred at 25 ºC for 30 min and the solvents were 
evaporated under the reduced pressure.  The residual material was purified by short flash 
chromatography eluting with 10 to 20 % EtOAc/hexanes to afford product as a orange 
solid.  Rf 0.5 (20 % EtOAc/hexanes).  1H NMR (500 MHz, CDCl3) δ 7.48 (d, 1H, J = 3.0 
Hz), 6.95 (bs, 1H), 6.84 (s, 1H), 6.50 (d, 1H, J = 5.5 Hz), 6.27 (d, 1H, J = 4.0 Hz), 4.23 
(dd, 2H, J = 6.0, 2.5 Hz), 2.44 (t, 1H, J = 2.5 Hz); 13C NMR (125 MHz, CDCl3) δ 162.7, 
135.7, 132.8, 131.5, 126.9, 126.0, 123.8, 121.6, 120.5, 114.0, 76.7, 74.7, 34.4; MS (ESI) 
m/z 346.02 (M–H)–.  
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1H NMR (CDCl3) 
 
 
 
13C NMR (CDCl3) 
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Triazole-decorated oligoethylene glycol trifluoromethane-BODIPY (23) 
 
CF3
N
B
F2
N
HNCl
N
N
N
O
N
5
N
N
O
O
O
CO2H
5
 
 
Copper powder (18 mg, 0.288 mmol), CuSO4 (58 mL, 0.058 mmol, 1M in H2O) and 
H2O (10.0 mL) were added to a solution of mono-azido ethylene glycol 14 (245 mg, 
0.345 mmol) and propargylated-BODIPY 22 (100 mg, 0.288 mmol) in THF (10.0 mL).  
The reaction mixture was stirred at 25 ºC for 24 h under nitrogen.  The solvents were 
evaporated under the reduced pressure and the residual material was purified by flash 
chromatography eluting with 100 % EtOAc then 30 to 90 % MeOH/CH2Cl2 (columned 2 
times) to afford product as a orange oil (233 mg, 76 %).  Rf 0.2 (10 % MeOH/CH2Cl2 
with iodine stain).  1H NMR (500 MHz, CD3OD) δ 8.01 (s, 1H), 7.87 (s, 1H), 7.33-7.31 
(m, 1H), 6.87 (d, 1H, J = 5.5 Hz), 6.29 (t, 1H, J = 2.5 Hz), 6.08 (d, 1H, J = 4.0 Hz), 4.80 
(s, 2H), 4.62 (s, 2H), 4.55 (t, 4H, J = 5.0 Hz), 3.89 (s, 2H), 3.86 (q, 4H, J = 5.0 Hz), 
3.67-3.61 (m, 24H), 3.59-3.51 (m, 16H); 13C NMR (125 MHz, CDCl3) δ 174.3, 163.4, 
144.6, 143.2, 135.3, 133.7, 129.1, 126.5, 124.4, 124.1, 124.0, 118.5, 116.4, 113.1, 70.50, 
70.43 (3C), 70.40 (3C), 70.34 (3C), 70.28 (2C), 70.26, 70.11, 69.99, 69.84, 69.78, 69.61, 
69.59, 69.50, 69.39, 69.32, 69.28, 69.16, 64.3, 50.3, 50.1, 40.2; MS (MALDI) m/z 
1080.29 (M+Na)+.  
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1H NMR (CD3OD) 
 
 
 
13C NMR (CDCl3) 
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Mono-silylated triethylene glycol (38)85 
 
HO
O
OTBDMS2  
 
To a solution of triethylene glycol (10.0 g, 66.6 mmol) and t-butyldimethylsilyl 
chloride (11.0 g, 73.3 mmol) in CH2Cl2 (100 mL) was added DMAP (0.81 g, 6.66 mmol) 
and Et3N (10.2 ml, 73.3 mmol) at 0 ºC.  The reaction mixture was stirred at 0 ºC for 10 
min and then warmed up to 25 ºC and stirred for 12 h.  The reaction mixture was 
concentrated under reduced pressure and the residual material was purified by flash 
chromatography eluting with 20–50 % EtOAc/hexanes to afford triethylene glycol 
mono-TBDMS (8.9 g, 51 %) as a pale blue liquid.  Rf 0.5 (50 % EtOAc/hexanes, iodine 
stain).  1H NMR (500 MHz, CDCl3) δ 3.76 (t, 2H, J = 4.7 Hz), 3.73–3.70 (m, 2H), 3.65 
(t, 4H, J = 0.6 Hz), 3.60 (t, 2H, J = 4.7 Hz), 3.55 (t, 2H, J = 5.7 Hz), 0.88 (s, 9H), 0.05 
(s, 6H); 13C NMR (125 MHz, CDCl3) δ 72.6, 72.4, 70.7, 70.4, 62.6, 61.7, 25.9, 18.3, –
5.3; MS (CI) m/z 265.1 (M+H)+. 
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1H NMR (CDCl3) 
 
 
 
13C NMR (CDCl3)
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Mono-silylated triethylene glycol tosylate (39)86 
 
TsO
O
OTBDMS
2  
 
To a solution of triethylene glycol mono-TBDMS 38 (3.0 g, 11.3 mmol), Et3N (3.2 
mL, 22.7 mmol) and Me3N•HCl (0.11 g, 1.13 mmol) in CH3CN (15 mL) was added p-
toluenesulfonyl chloride (3.24 g, 17.0 mmol) in CH3CN (10 mL) dropwise at 0 ºC over 5 
min.  This solution was stirred at 25 ºC for 12 h and the reaction was quenched by the 
addition of water (15 mL).  The aqueous phase was extracted with EtOAc (3 x 20 mL) 
and the combined organic layer was dried over Na2SO4, concentrated under reduced 
pressure.  The residual material was purified by flash chromatography eluting with 10–
30 % EtOAc/hexanes to afford compound (4.4 g, 92 %) as a colorless liquid.  Rf 0.4 (20 
% EtOAc/hexanes).  1H NMR (500 MHz, CDCl3) δ 7.79 (d, 2H, J = 8.2 Hz), 7.33 (d, 
2H, J = 8.2 Hz), 4.15 (t, 2H, J = 4.9 Hz), 3.73 (t, 2H, J = 5.4 Hz), 3.68 (t, 2H, J = 4.9 
Hz), 3.60–3.54 (m, 4H), 3.51 (t, 2H, J = 5.4 Hz), 2.43 (s, 3H), 0.87 (s, 9H), 0.04 (s, 6H); 
13C NMR (125 MHz, CDCl3) δ 144.7, 132. 9, 129.8, 127.9, 72.6, 70.7, 70.6, 69.2, 68.6, 
62.6, 25.9, 21.6, 18.3, –5.3; MS (CI) m/z 419.2 (M+H)+.   
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1H NMR (CDCl3) 
 
13C NMR (CDCl3)
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 TBDMS-protected naphthol derivative (40) 
 
2
OH
N
H
O
OTBDMS
 
 
A solution of 5-amino-2-naphthol (0.31 g, 1.95 mmol), tosylated-silylated triethylene 
glycol 39 (1.47 g, 3.51 mmol) and K2CO3 (0.54 g, 3.90 mmol) in DMF (15 mL) was 
heated at 100 ºC for 7 h.  This solution was cooled to room temperature and water (20 
mL) was added.  The aqueous layer was extracted with EtOAc (4 x 12 mL) and the 
combined organic layer was dried over Na2SO4 and concentrated under reduced 
pressure.  The residual material was purified by flash chromatography eluting with 10–
20 % EtOAc/hexanes to afford product (0.61 g, 77 %) as a colorless viscous oil.  Rf 0.4 
(30 % EtOAc/hexanes).  1H NMR (500 MHz, CDCl3) δ 7.73 (d, 1H, J = 9.0 Hz), 7.24 (t, 
1H, J = 7.7 Hz), 7.19 (d, 1H, J = 8.3 Hz), 7.14 (dd, 1H, J = 9.0, 2.5 Hz), 7.09 (d, 1H, J = 
2.5 Hz), 6.65 (dd, 1H, J = 7.2, 1.1 Hz), 4.24 (t, 2H, J = 4.9 Hz), 3.93 (t, 2H, J = 4.9 Hz), 
3.79–3.74 (m, 4H), 3.72–3.70 (m, 2H), 3.58 (t, 2H, J = 5.5 Hz), 0.89 (s, 9H), 0.07 (s, 
6H); 13C NMR (125 MHz, CDCl3) δ 156.7, 142.0, 135.7, 127.0, 122.4, 119.0, 118.1, 
117.7, 108.1, 107.4, 72.7, 70.9, 70.8, 69.7, 67.3, 62.7, 25.9, 18.4, –5.3; MS (ESI) m/z 
406.26 (M+H)+.   
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1H NMR (CDCl3) 
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 Naphthol derivative (37b) 
 
OH
N
H
O
OH
2  
 
To a solution of TBDMS-protected amino-naphthol 40 (0.61 g, 1.5 mmol) in THF 
(10 mL) was added TBAF (1.8 mL, 1.8 mmol, 1.0 M in THF) dropwise at 0 ºC.  This 
solution was warmed up to 25 ºC and stirred for 1 h.  The reaction mixture was 
concentrated under reduced pressure at 35 ºC.  The residual material was purified by 
flash chromatography eluting with 80 % EtOAc/hexanes then with 100 % EtOAc to 
afford product (0.43 g, 98 %) as a gray viscous oil.  Rf 0.4 (EtOAc).  1H NMR (500 
MHz, CDCl3) δ 7.72 (d, 1H, J = 9.2 Hz), 7.24 (t, 1H, J = 7.7 Hz), 7.18 (d, 1H, J = 8.3 
Hz), 7.13 (dd, 1H, J = 9.2, 2.6 Hz), 7.09 (d, 1H, J = 2.4 Hz), 6.64 (dd, 1H, J = 7.3, 1.2 
Hz), 4.24 (t, 2H, J = 4.8 Hz), 3.92 (t, 2H, J = 4.8 Hz), 3.77–3.71 (m, 6H), 3.62 (t, 2H, J = 
4.5 Hz); 13C NMR (125 MHz, CDCl3) δ 156.6, 142.1, 135.6, 127.0, 122.5, 119.0, 118.0, 
117.5, 108.0, 107.4, 72.5, 70.8, 70.3, 69.7, 67.2, 61.7; MS (ESI) m/z 292.15 (M+H)+.  
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APPENDIX B 
 
EXPERIMENTAL DATA FOR CHAPTER III 
 
4-Iodo-2-methoxymethylbenzoate (50) 
 
I
OMe
CO2Me  
 
A solution of 2-hydroxy-4-iodobenzoic acid (4.0 g, 15.2 mmol), iodomethane (9.7 g, 
68.2 mmol) and K2CO3 (9.4 g, 68.2 mmol) in acetone (90 mL) was refluxed at 60 ºC for 
20 h.  The reaction mixture was cooled to room temperature, filtered and the solvents 
were concentrated under the reduced pressure.  Water (50 mL) was added and aqueous 
layer was extracted with EtOAc (1 x 40 mL).  The organic layer was washed with sat. 
NaHCO3 (1 x 40 mL) and brine (1 x 40 mL) and dried over Na2SO4.  The solvents were 
evaporated and the residue was purified by flash chromatography eluting with 10 % 
EtOAc/hexanes to afford product as a yellow oil (4.0 g, 91 %).  Rf 0.5 (20 % 
EtOAc/hexanes).  1H NMR (500 MHz, CDCl3) δ 7.48 (d, 1H, J = 8.1 Hz), 7.33 (d, 1H, J 
= 8.1 Hz), 7.30 (s, 1H), 3.88 (s, 3H), 3.86 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 166.0, 
159.1, 132.7, 129.4, 121.5, 119.4, 100.0, 56.2, 52.1; MS (ESI) m/z 292.97 (M+H)+. 
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4-Iodo-2-methoxybenzylalcohol (51) 
 
I
OMe
OH  
 
To a solution of methyl ester 50 (3.3 g, 11.2 mmol) in THF (70 mL) was added 
DIBAL (33.7 mL, 33.7 mmol) dropwise at –78 ºC.  The reaction mixture was stirred at 
25 ºC for 13 h.  The reaction was quenched by the slow addition of sat. NH4Cl at 0 ºC.  
The reaction mixture was filtered and aqueous layer was extracted with EtOAc (5 x 250 
mL).  The combined organic layer was dried over Na2SO4 and concentrated under the 
reduced pressure to afford pure product as a colorless oil (2.9 g, 98 %).  Rf 0.5 (30 % 
EtOAc/hexanes).  1H NMR (300 MHz, CDCl3) δ 7.29 (dd, 1H, J = 8.0, 1.5 Hz), 7.17 (d, 
1H, J = 1.5 Hz), 7.00 (d, 1H, J = 8.0 Hz), 4.61 (s, 1H), 3.84 (s, 3H); 13C NMR (125 
MHz, CDCl3) δ 157.7, 129.9, 129.8, 128.8, 119.5, 93.2, 61.3, 55.5; MS (ESI) m/z 270.98 
(M+Li)+. 
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1H NMR (CDCl3) 
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4-Iodo-2-methoxybenzaldehyde (52) 
 
I
OMe
CHO  
 
To a slurry of pyridinium chlorochromate (2.7 g, 12.5 mmol) in CH2Cl2 (70 mL) was 
added a solution of alcohol 51 (2.2 g, 8.3 mmol) in CH2Cl2 (20 mL) dropwise at 25 ºC.  
The reaction mixture was stirred at 25 ºC for 2 h.  The reaction mixture was filtered 
through celite and washed with ether.  The solvents were concentrated under the reduced 
pressure and the residue was purified by flash chromatography eluting with 10 % 
EtOAc/hexanes to afford product as an off-white solid (2.0 g, 91 %).  Rf 0.8 (20 % 
EtOAc/hexanes).  1H NMR (500 MHz, CDCl3) δ 10.40 (s, 1H), 7.51 (d, 1H, J = 8.0 Hz), 
7.41 (dd, 1H, J = 8.0, 1.5 Hz), 7.36 (d, 1H, J = 1.5 Hz), 3.92 (s, 3H); 13C NMR (125 
MHz, CDCl3) δ 189.1, 161.4, 130.3, 129.5, 124.2, 121.3, 103.4, 56.0; MS (ESI) m/z 
262.95 (M+H)+.  
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1H NMR (CDCl3) 
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4-Iodo-2-methoxy tetramethyl-BODIPY (53) 
 
N
B
F2
N
I
OMe
 
 
A solution of aldehyde 52 (1.3 g, 5.0 mmol), 2,4-dimethylpyrrole (1.1 g, 11.0 mmol) 
and one drop of TFA in CH2Cl2 (30 mL) was stirred at 25 ºC under nitrogen for 1.5 h.  
Then chloranil (1.5 g, 6.0 mmol) was added to a reaction mixture and the reaction was 
stirred at 25 ºC for 40 min under air.  The reaction mixture was filtered through celite 
and washed with CH2Cl2 and the solvents were evaporated.  The residue was purified by 
flash chromatography (aluminum oxide, activated, basic) eluting with CH2Cl2 and 10 % 
EtOAc/CH2Cl2.  The obtained orange solids were dissolved in toluene (20 mL) and Et3N 
(2.1 mL, 150 mmol) was added and stirred at 25 ºC for 10 min.  BF3•Et2O (3.2 mL, 25.0 
mmol) was added and stirred at 25 ºC for 20 h.  The reaction mixture was diluted with 
CH2Cl2 (30 mL) and washed with water (3 x 30 mL).  The organic layer was dried over 
Na2SO4 and evaporated.  The residue was purified by flash chromatography eluting with 
5 % EtOAc/hexanes to afford product as a orange solid (813 mg, 34 %).  Rf 0.5 (10 % 
EtOAc/hexanes).  1H NMR (500 MHz, CDCl3) δ 7.44 (dd, 1H, J = 8.0, 1.5 Hz), 7.31 (d, 
1H, J = 1.5 Hz), 6.87 (d, 1H, J = 8.0 Hz), 5.97 (s, 2H), 3.76 (s, 3H), 2.54 (s, 6H), 1.46 (s, 
6H); 13C NMR (125 MHz, CDCl3) δ 156.8, 155.2, 142.3, 137.3, 131.2, 130.8, 130.7, 
123.6, 121.0, 120.6, 95.2, 55.9, 14.5, 14.0; MS (MALDI) m/z 479.76 (M)+.  
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1H NMR (CDCl3) 
 
 
 
13C NMR (CDCl3) 
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4-Trimethysilyl-ethynyl tetramethyl-BODIPY (54) 
 
N
B
F2
N
OMe
TMS
 
 
A solution of 4-iodo BODIPY 53 (0.6 g, 1.2 mmol), trimethylsilyl acetylene (1.2 g, 
12.4 mmol), PdCl2(PPh3)2 (88 mg, 0.12 mmol), CuI (24 mg, 0.12 mmol) and Et3N (1.7 
mL, 12.5 mmol) in THF (15 mL) was stirred at 25 ºC for 12 h.  The solvents were 
concentrated under the reduced pressure.  The residue was purified by flash 
chromatography eluting with 3 % EtOAc/hexanes to afford product as orange solids 
(548 mg, 97 %).  Rf 0.4 (10 % EtOAc/hexanes).  1H NMR (500 MHz, CDCl3) δ 7.22 (dd, 
1H, J = 7.7, 1.5 Hz), 7.084 (d, 1H, J = 1.5 Hz), 7.081 (d, 1H, J = 7.7 Hz), 5.96 (s, 2H), 
3.78 (s, 3H), 2.54 (s, 6H), 1.44 (s, 6H), 0.28 (s, 9H); 13C NMR (125 MHz, CDCl3) δ 
156.2, 155.2, 142.4, 137.9, 131.3, 129.5, 125.3, 125.2, 124.6, 120.9, 114.4, 104.3, 95.4, 
55.7, 14.6, 14.0, –0.12; MS (MALDI) m/z 450.28 (M)+.  
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4-Ethynyl tetramethyl-BODIPY (55) 
 
N
B
F2
N
OMe
 
 
To a solution of TMS-protected BODIPY 54 (500 mg, 1.1 mmol) in THF (20 mL) 
was added TBAF (1.3 mL, 1.3 mmol, 1 M in THF) dropwise at –78 ºC.  After the 
stirring at –78 ºC for 5 min, the reaction was quenched with water (20 mL) and aqueous 
layer was extracted with CH2Cl2 (3 x 10 mL).  The combined organic layer was washed 
with water (1 x 15 mL) and dried over Na2SO4.  The solvents were concentrated under 
the reduced pressure and the residue was purified by short flash chromatography eluting 
with 3 % EtOAc/hexanes to afford product as orange solids (388 mg, 92 %).  Rf 0.4 (20 
% EtOAc/hexanes).  1H NMR (500 MHz, CDCl3) δ 7.24 (dd, 1H, J = 7.7, 1.0 Hz), 7.107 
(d, 1H, J = 7.7 Hz), 7.105 (d, 1H, J =  1.0 Hz), 5.97 (s, 2H), 3.78 (s, 3H), 3.18 (s, 1H), 
2.55 (s, 6H), 1.45 (s, 6H); 13C NMR (125 MHz, CDCl3) δ 156.2, 155.2, 142.4, 137.7, 
131.2, 129.6, 125.4, 124.9, 124.3, 121.0, 114.6, 83.0, 78.2, 55.7, 14.6, 14.0; MS 
(MALDI) m/z 378.28 (M)+.  
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13C NMR (CDCl3) 
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4-Iodo tetramethyl-BODIPY (57) 
 
N
B
F2
N
I
O CO2Me
 
 
A solution of aldehyde 56 (600 mg, 1.9 mmol), 2,4-dimethylpyrrole (392 mg, 4.1 
mmol) and one drop of TFA in CH2Cl2 (20 mL) was stirred at 25 ºC under nitrogen for 1 
h.  Then chloranil (553 mg,  2.2 mmol) was added to a reaction mixture and the reaction 
was stirred at 25 ºC under air for 40 min.  The reaction mixture was filtered through 
celite and washed with CH2Cl2 and solvents were evaporated.  The residue was purified 
by flash chromatography (aluminum oxide, activated, basic) eluting with CH2Cl2 and 10 
% EtOAc/CH2Cl2.  The obtained orange solids were dissolved in toluene (15 mL) and 
Et3N (0.8 mL, 5.6 mmol) was added and stirred at 25 ºC for 10 min.  BF3•Et2O (1.2 mL, 
9.4 mmol) was added and stirred at 25 ºC for 20 h.  The reaction mixture was diluted 
with CH2Cl2 (20 mL) and washed with water (3 x 20 mL).  The organic layer was dried 
over Na2SO4 and evaporated.  The residue was purified by flash chromatography eluting 
with 5 to 10 % EtOAc/hexanes to afford product as orange solids (275 mg, 27 %).  Rf 0.4 
(20 % EtOAc/hexanes).  1H NMR (500 MHz, CDCl3) δ 7.48 (d, 1H, J = 8.0 Hz), 7.08 (s, 
1H), 6.91 (d, 1H, J = 8.0 Hz), 5.98 (s, 2H), 4.62 (s, 2H), 3.76 (s, 3H), 2.54 (s, 6H), 1.53 
(s, 6H); 13C NMR (125 MHz, CDCl3) δ 168.5, 155.5, 155.1, 142.7, 136.7, 131.6, 131.2, 
123.9, 121.1 (2C), 120.9, 94.8, 64.7, 52.3, 14.6, 14.0; MS (MALDI) m/z 537.96 (M)+. 
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4-Iodo tetramethyl-BODIPY carboxylic acid (58) 
 
N
B
F2
N
I
O CO2H
 
 
A solution of 4-iodo BODIPY 57 (80 mg, 0.15 mmol) and K2CO3 (62 mg, 0.45 
mmol) in MeOH/THF/H2O (2.5 mL, 2.5 mL, 1.0 mL, respectively) was stirred at 25 ºC 
for 24 h.  The organic solvents were only evaporated and H2O (5.0 mL) was added.  The 
aqueous solution was acidified with 0.1 N HCl to reach pH 2 and extracted with CH2Cl2 
(3 x 10 mL).  The combined organic layer was dried over Na2SO4 and concentrated 
under the reduced pressure to afford pure product as a brown solid (78 mg, 99 %).  Rf 0.1 
(20 % EtOAc/hexanes).  1H NMR (500 MHz, acetone-d6) δ 7.62 (dd, 1H, J = 13.0, 2.5 
Hz), 7.47 (d, 1H, J = 2.5 Hz), 7.09 (d, 1H, J = 13.0 Hz), 6.13 (s, 2H), 4.90 (s, 2H), 2.53 
(s, 6H), 1.62 (s, 6H); 13C NMR (125 MHz, acetone-d6) δ 170.6, 157.2, 156.7, 144.5, 
139.4, 132.9, 132.8, 125.0, 123.1, 122.6 (2C), 96.3, 65.9, 15.3, 14.9; MS (ESI) m/z 
523.06 (M–H)–.  
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5-Iodo tetramethyl-BODIPY (60) 
 
N
B
F2
N
O CO2Me
I
 
 
A solution of 5-iodobenzaldehyde 59 (640 mg, 2.0 mmol, provided by Mr. Liangxing 
Wu), 2,4-dimethylpyrrole (419 mg, 2.2 mmol) and one drop of TFA in CH2Cl2 (20 mL) 
was stirred at 25 ºC under nitrogen for 1.5 h.  Then chloranil (590 mg, 1.2 mmol) was 
added to a reaction mixture and the reaction was stirred at 25 ºC for 40 min under air.  
The reaction mixture was filtered through celite and washed with CH2Cl2 and solvents 
were evaporated.  The residue was purified by flash chromatography (aluminum oxide, 
activated, basic) eluting with CH2Cl2 and 10 % EtOAc/CH2Cl2.  The obtained orange 
solids were dissolved in toluene (15 mL) and Et3N (0.83 mL, 6.0 mmol) was added and 
stirred at 25 ºC for 10 min.  BF3•Et2O (1.27 mL, 10.0 mmol) was added and stirred at 25 
ºC for 19 h.  The reaction mixture was diluted with CH2Cl2 (20 mL) and washed with 
water (3 x 20 mL).  The organic layer was dried over Na2SO4 and evaporated.  The 
residue was purified by flash chromatography eluting with 5 to 20 % EtOAc/hexanes to 
afford product as orange solids (414 mg, 38 %).  Rf 0.2 (5 % EtOAc/hexanes).  1H NMR 
(500 MHz, CDCl3) δ 7.69 (dd, 1H, J = 8.5, 2.5 Hz), 7.52 (d, 1H, J = 2.5 Hz), 6.55 (d, 
1H, J = 8.5 Hz), 5.99 (s, 2H), 4.62 (s, 2H), 3.73 (s, 3H), 2.54 (s, 6H), 1.55 (s, 6H); 13C 
NMR (125 MHz, CDCl3) δ 168.7, 155.6, 154.7, 142.7, 139.1, 138.2, 135.9, 131.2, 126.4, 
121.1, 113.6, 83.8, 64.6, 52.3, 14.6, 14.0; MS (MALDI) m/z 538.13 (M)+.  
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5-Trimethylsilyl-ethynyl tetramethyl-BODIPY (61) 
 
N
B
F2
N
O CO2Me
TMS
 
 
A solution of 5-iodo BODIPY 60 (350 mg, 0.65 mmol), trimethylsilyl acetylene (639 
mg, 6.50 mmol), PdCl2(PPh3)2 (46 mg, 0.065 mmol), CuI (12 mg, 0.065 mmol) and Et3N 
(0.91 mL, 6.50 mmol) in THF (8.0 mL) was stirred at 25 ºC for 12 h.  The reaction 
mixture was concentrated under the reduced pressure.  The residue was purified by flash 
chromatography eluting with 5 to 10 % EtOAc/hexanes to afford product as orange 
solids (312 mg, 94 %).  Rf 0.4 (20 % EtOAc/hexanes).  1H NMR (500 MHz, CDCl3) δ 
7.50 (dd, 1H, J = 8.5, 2.0 Hz), 7.34 (d, 1H, J = 2.0 Hz), 6.69 (d, 1H, J = 8.5 Hz), 5.97 (s, 
2H), 4.64 (s, 2H), 3.73 (s, 3H), 2.54 (s, 6H), 1.54 (s, 6H), 0.22 (s, 9H); 13C NMR (125 
MHz, CDCl3) δ 168.7, 155.4, 154.7, 142.7, 136.7, 134.1, 133.5, 131.3, 124.2, 121.0, 
117.4, 111.4, 103.5, 94.3, 64.7, 52.2, 14.6, 14.0, -0.1; MS (MALDI) m/z 508.32 (M)+.  
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1H NMR (CDCl3) 
 
 
 
13C NMR (CDCl3) 
 211 
5-Ethynyl tetramethyl-BODIPY (62) 
 
N
B
F2
N
O CO2Me
 
 
To a solution of TMS-protected BODIPY 61 (212 mg, 0.42 mmol) in THF (8.0 mL) 
was added TBAF (0.5 mL, 0.50 mmol, 1 M in THF) dropwise at –78 ºC.  After the 
stirring at –78 ºC for 5 min, the reaction was quenched with water (10 mL) and aqueous 
layer was extracted with CH2Cl2 (3 x 10 mL).  The combined organic layer was washed 
with water (1 x 10 mL) and dried over Na2SO4.  The solvents were concentrated under 
the reduced pressure and the residue was purified by short flash chromatography eluting 
with 10 to 15 % EtOAc/hexanes to afford product as orange solids (137 mg, 75 %).  Rf 
0.5 (30 % EtOAc/hexanes).  1H NMR (500 MHz, CDCl3) δ 7.54 (dd, 1H, J = 8.5, 2.5 
Hz), 7.36 (d, 1H, J = 2.5 Hz), 6.72 (d, 1H, J = 8.5 Hz), 5.98 (s, 2H), 4.65 (s, 2H), 3.74 (s, 
3H), 3.05 (s, 1H), 2.55 (s, 6H), 1.54 (s, 6H); 13C NMR (125 MHz, CDCl3) δ 168.7, 
155.5, 154.9, 142.7, 136.5, 134.4, 133.7, 131.3, 124.3, 121.1, 116.2, 111.5, 82.2, 77.4, 
64.7, 52.3, 14.6, 13.9; MS (MALDI) m/z 436.26 (M)+.  
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1H NMR (CDCl3) 
 
 
 
 
13C NMR (CDCl3) 
 213 
5-Ethynyl tetramethyl-BODIPY carboxylic acid (63) 
 
N
B
F2
N
O CO2H
 
 
A solution of 5-ethynyl BODIPY 62 (70 mg, 0.16 mmol) and K2CO3 (67 mg, 0.48 
mmol) in MeOH/THF/H2O (2.5 mL, 2.5 mL, 1.0 mL, respectively) was stirred at 25 ºC 
for 12 h.  The organic solvents were only evaporated and H2O (5.0 mL) was added.  The 
aqueous solution was acidified with 0.1 N HCl to reach pH 2 and extracted with CH2Cl2 
(3 x 10 mL).  The combined organic layer was dried over Na2SO4 and concentrated 
under the reduced pressure to afford pure product as a dark brown solid (68 mg, 99 %).  
Rf 0.1 (50 % EtOAc/hexanes).  1H NMR (300 MHz, acetone-d6) δ 7.68 (dd, 1H, J = 9.0, 
2.1 Hz), 7.45 (d, 1H, J = 2.1 Hz), 7.13 (d, 1H, J = 9.0 Hz), 6.14 (s, 2H), 4.89 (s, 2H), 
3.67 (s, 1H), 2.54 (s, 6H), 1.61 (s, 6H); 13C NMR (75 MHz, acetone-d6) δ 170.5, 157.1, 
156.7, 144.6, 139.2, 136.0, 134.7, 132.9, 125.5, 122.6, 117.6, 114.2, 83.9, 79.8, 65.8, 
15.3, 14.9; MS (MALDI) m/z 422.23 (M)+.  
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1H NMR (acetone-d6) 
 
 
 
 
13C NMR (acetone-d6) 
 
 
 
 215 
1,2,3,3-Tetramethyl-3H-indolium iodide (68)107 
 
N
I
–  
 
A solution of 2,3,3-trimethylindolenine (3.0 g, 18.8 mmol) and iodomethane (3.2 g, 
22.6 mmol) in toluene (60 mL) was heated at 80 ºC for 48 h.  The reaction mixture was 
cooled to room temperature and the solvent was concentrated under the reduced 
pressure.  The residue was suspended in hexanes (100 mL), sonicated for 10 min and 
filtered off to afford product as a brown solid (5.4 g, 95 %).  1H NMR (500 MHz, 
DMSO-d6) δ 7.96-7.95 (m, 1H), 7.88-7.86 (m, 1H), 7.68-7.64 (m, 2H), 4.01 (s, 3H), 2.81 
(s, 3H), 1.57 (s, 6H); 13C NMR (125 MHz, DMSO-d6) δ 196.9, 143.1, 142.5, 130.3, 
129.8, 124.3, 116.1, 54.9, 35.7, 22.6, 15.1. 
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1H NMR (DMSO-d6) 
 
 
13C NMR (DMSO-d6)
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1-(5-Carboxypentyl)-2,3,3-tetramethyl-3H-indolium bromide (76)108 
 
N
Br–
CO2H  
 
6-Bromohexanoic acid (3.7 g, 18.8 mmol) was added to a solution of 2,3,3-
trimethylindolenine (3.0 g, 18.8 mmol) in nitromethane (10 mL).  The reaction mixture 
was heated at 80 ºC for 24 h.  The reaction mixture was cooled to room temperature and 
triturated with ether (60 mL).  The precipitate was filtered off and washed with ether to 
afford product as a purple solid (3.3 g, 49 %).  1H NMR (300 MHz, DMSO-d6) δ 8.03-
8.00 (m, 1H), 7.90-7.87 (m, 1H), 7.68-7.65 (m, 2H), 4.49 (t, 2H, J = 7.9 Hz), 2.88 (s, 
3H), 2.27 (t, 2H, J = 7.1 Hz), 1.93-1.83 (m, 2H), 1.65-1.53 (m, 2H), 1.57 (s, 6H), 1.51-
1.43 (m, 2H); 13C NMR (75 MHz, DMSO-d6) δ 198.1, 176.5, 143.4, 142.4, 131.2, 130.7, 
125.1, 116.9, 55.8, 49.0, 34.9, 28.4, 26.9, 25.5, 23.6, 15.4.  
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1H NMR (DMSO-d6) 
 
 
 
 
13C NMR (DMSO-d6)
 219 
Cyanine 3 (73a)108 
 
N N
I–
CO2H
4
 
 
A solution of indolium bromide 76 (100 mg, 0.28 mmol) and N,N’-
diphenylformamidine (66 mg, 0.34 mmol) in Ac2O (1.5 mL) was heated at 120 ºC for 30 
min.  The reaction mixture was cooled to room temperature and a solution of indolium 
iodide 68 (102 mg, 0.34 mmol) in pyridine (1.5 mL) was added.  The reaction mixture 
was stirred at 25 ºC for 1 h.  Ether (100 mL) was added and dark red oil was obtained 
after the remove of ether.  The residue was purified by flash chromatography eluting 
with 100 % EtOAc and 2 % to 10 % MeOH/CH2Cl2 to afford product as a dark red foam 
(106 mg, 64 %).  Rf 0.3 (10 % MeOH/CH2Cl2).  1H NMR (500 MHz, CDCl3) δ 8.42 (t, 
1H, J = 13.4 Hz), 7.40-7.35 (m, 4H), 7.27-7.22 (m, 4H), 7.18 (d, 1H, J = 13.5 Hz), 7.14 
(dd, 1H, J = 8.3, 3.5 Hz), 4.21 (t, 2H, J = 7.5 Hz), 3.80 (s, 3H), 2.45 (t, 2H, J = 7.0 Hz), 
1.91-1.85 (m, 2H), 1.78-1.63 (m, 4H), 1.71 (s, 6H), 1.70 (s, 6H); 13C NMR (125 MHz, 
CDCl3) δ 178.1, 174.2, 173.5, 150.7, 142.6, 141.9, 140.5, 140.4, 128.9, 128.8, 125.3 
(2C), 122.1, 122.0, 110.9, 110.8, 105.0, 104.4, 48.9, 48.8, 44.7, 33.9, 32.8, 28.14, 28.07, 
27.1, 26.1, 24.4. 
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1H NMR (CDCl3) 
 
13C NMR (CDCl3)
 221 
5-Iodo cyanine 3 (74a) 
 
N N
I–
I
CO2H
4
 
  
A solution of indolium bromide 76 (170 mg, 0.48 mmol) and N,N’-
diphenylformamidine (113 mg, 0.58 mmol) in Ac2O (2 mL) was heated at 120 ºC for 30 
min.  The reaction mixture was cooled to room temperature and a solution of indolium 
iodide 78 (287 mg, 0.67 mmol) in pyridine (7 mL) was added.  The reaction mixture was 
stirred at 25 ºC for 24 h.  Ether (100 mL) was added and the reaction mixture was 
filtered off to afford dark red solids.  The residue was purified by flash chromatography 
eluting with 100 % EtOAc and 4 % to 10 % MeOH/CH2Cl2 to afford product as a dark 
red solid (213 mg, 62 %).  Rf 0.4 (10 % MeOH/CH2Cl2).  1H NMR (500 MHz, CDCl3) δ 
8.40 (t, 1H, J = 13.0 Hz), 7.70 (dd, 1H, J = 8.3, 1.5 Hz), 7,61 (d, 1H, J = 1.5 Hz), 7.43-
7.38 (m, 2H), 7.28 (t, 1H, J = 7.5 Hz), 7.21 (d, 2H, J = 13.5 Hz), 7.16 (d, 1H, J = 8.0 
Hz), 6.91 (d, 1H, J = 8.0 Hz), 4.24 (t, 2H, J = 8.0 Hz), 3.76 (s, 3H), 2.47 (t, 2H, J = 6.5 
Hz), 1.93-1.87 (m, 2H), 1.80-1.65 (m, 4H), 1.72 (s, 6H), 1.70 (s, 6H); 13C NMR (125 
MHz, CDCl3) δ 178.1, 174.3, 172.7, 150.7, 142.6, 142.5, 141.8, 140.7, 137.7, 131.0, 
129.0, 125.7, 122.2, 112.5, 111.3, 105.3, 104.8, 88.2, 49.1, 48.5, 44.9, 33.9, 32.9, 29.6, 
28.1, 27.2, 26.1, 24.4; MS (ESI) m/z 583.18 (M)+.  
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1H NMR (CDCl3) 
 
 
 
13C NMR (CDCl3) 
 223 
Hemicyanine intermediate (79) 
 
N
Ac
N
I–
Ph
 
 
Indolium iodide 68 (1.0 g, 3.3 mmol) and glutaconaldehydedianil hydrochloride (1.4 
g, 5.0 mmol) were added to a solution of Ac2O (5.0 mL) and pyridine (5.0 mL).  The 
reaction mixture was stirred at 25 ºC for 40 min.  Ether (200 mL) was added and the 
reaction mixture was filtered off to afford dark red oil.  The residue was purified by flash 
chromatography eluting with 100 % EtOAc and 4 % to 10 % MeOH/CH2Cl2 to afford 
product as a dark brown solid (1.48 g, 90 %).  Rf 0.5 (10 % MeOH/CH2Cl2).  1H NMR 
(300 MHz, CDCl3) δ 8.17 (d, 1H, J = 13.8 Hz), 7.90-7.81 (m, 1H), 7.64-7.46 (m, 8H), 
7.20-7.17 (m, 3H), 6.94 (m, 1H), 5.45-5.37 (m, 1H), 4.21 (s, 3H), 1.97 (s, 3H), 1.72 (s, 
6H); 13C NMR (75 MHz, CDCl3) δ 180.5, 169.4, 155.9, 151.6, 142.5, 141.5, 141.0, 
137.8, 130.7, 130.1, 129.9, 129.4, 128.8, 128.1, 122.4, 113.9, 113.7, 113.5, 51.4, 35.9, 
27.1, 23.4; MS (ESI) m/z 371.21 (M)+.  
 224 
 
1H NMR (CDCl3) 
 
 
 
 
13C NMR (CDCl3) 
 
 225 
Cyanine 7 (73c) 
 
N N
CO2H
I–
4
 
 
Indolium bromide 76 (200 mg, 0.56 mmol) was added to a solution of hemicyanine 
79 (281 mg, 0.56 mmol) in pyridine (6.0 mL).  The reaction mixture was stirred at 50 ºC 
for 1 h.  After cooling to room temperature, ether (100 mL) was added and the reaction 
mixture was filtered off to afford dark green solids.  The residue was purified by flash 
chromatography eluting with 100 % EtOAc and 2 % to 10 % MeOH/CH2Cl2 to afford 
product as a purple solid (280 mg, 78 %).  Rf 0.5 (10 % MeOH/CH2Cl2).  1H NMR (500 
MHz, DMSO-d6) δ 7.95-7.88 (m, 2H), 7.83-7.78 (m, 1H), 7.63-7.61 (m, 2H), 7.46-7.39 
(m, 4H), 7.29-7.24 (m, 2H), 6.57 (q, 2H, J = 12.5 Hz), 6.38 (dd, 2H, J = 13.5, 4.0 Hz), 
4.09 (t, 2H, J = 7.0 Hz), 3.63 (s, 3H), 2.24 (t, 2H, J = 7.0 Hz), 1.75-1.68 (m, 2H), 1.67 (s, 
6H), 1.66 (s, 6H), 1.62-1.56 (m, 2H), 1.45-1.39 (m, 2H); 13C NMR (125 MHz, DMSO-
d6) δ 175.4, 172.9, 171.8, 157.0, 152.1, 151.8, 150.6, 143.8, 143.2, 141.9, 129.42, 
129.36, 126.2, 125.6, 125.4, 124.9, 123.4, 123.3, 112.0, 111.9, 105.1, 104.5, 49.6, 49.5, 
44.3, 34.5, 32.1, 28.2, 28.0, 27.7, 26.7, 25.2; MS (ESI) m/z 509.32 (M)+.  
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1H NMR (DMSO-d6) 
 
 
 
 
13C NMR (DMSO-d6) 
 
 227 
5-Iodo hemicyanine (80) 
 
N
Ac
N
I–
Ph
I
 
 
Indolium iodide 78 (300 mg, 0.70 mmol) and glutaconaldehydedianil hydrochloride 
(300 mg, 1.05 mmol) were added to a solution of Ac2O (3.0 mL) and pyridine (3.0 mL).  
The reaction mixture was stirred at 25 ºC for 1 h.  Ether (100 mL) was added and the 
reaction mixture was filtered off to afford dark brown solids.  The residue was purified 
by flash chromatography eluting with 100 % EtOAc and 1 % to 5 % MeOH/CH2Cl2 to 
afford product as a dark brown solid (327 mg, 74 %).  Rf 0.4 (10 % MeOH/CH2Cl2).  1H 
NMR (500 MHz, CDCl3) δ 8.20 (d, 1H, J = 14.0 Hz), 7.88-7.82 (m, 2H), 7.77 (d, 1H, J 
= 1.5 Hz), 7.60-7.54 (m, 4H), 7.24 (d, 2H, J = 8.5 Hz), 7.20-7.18 (m, 2H), 6.92-6.87 (m, 
1H), 5.46-5.41 (m, 1H), 4.18 (s, 3H), 1.98 (s, 3H), 1.72 (s, 6H); 13C NMR (125 MHz, 
CDCl3) δ 179.7, 169.5, 156.6, 152.6, 144.2, 141.8, 141.4, 138.5, 137.8, 131.6, 130.8, 
130.7, 130.1, 128.1, 115.3, 113.8, 113.7, 93.7, 51.2, 35.5, 27.2, 23.4; MS (ESI) m/z 
497.11 (M)+.  
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1H NMR (CDCl3) 
 
 
 
13C NMR (CDCl3)
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5-Iodo cyanine 7 (74c) 
 
N N
CO2H
I–
4
I
 
 
Indolium bromide 76 (150 mg, 0.42 mmol) was added to a solution of 5-iodo 
hemicyanine 80 (264 mg, 0.42 mmol) in pyridine (5.0 mL).  The reaction mixture was 
stirred at 50 ºC for 1.5 h.  After cooling to room temperature, ether (100 mL) was added 
and the reaction mixture was filtered off to afford dark green solids.  The residue was 
purified by flash chromatography eluting with 100 % EtOAc and 5 % to 10 % 
MeOH/CH2Cl2 to afford product as a purple solid (234 mg, 72 %).  Rf 0.5 (10 % 
MeOH/CH2Cl2).  1H NMR (500 MHz, DMSO-d6) δ 7.97 (t, 1H, J = 13.0 Hz), 7.95 (d, 
1H, J = 1.5 Hz), 7.86-7.77 (m, 2H), 7.73 (dd, 1H, J = 10.0, 1.5 Hz), 7.66 (d, 1H, J = 7.5 
Hz), 7.50-7.44 (m, 2H), 7.32 (t, 1H, J = 7.5 Hz), 7.17 (d, 1H, J = 8.5 Hz), 6.62 (t, 1H, J 
= 13.0 Hz), 6.57-6.51 (m, 2H), 6.23 (d, 1H, J = 13.0 Hz), 4.16 (t, 2H, J = 7.0 Hz), 3.52 
(s, 3H), 2.23 (t, 2H, J = 7.5 Hz), 1.76-1.70 (m, 2H), 1.68 (s, 6H), 1.65 (s, 6H), 1.61-1.55 
(m, 2H), 1.46-1.40 (m, 2H); 13C NMR (125 MHz, CDCl3) δ 177.9, 173.2, 168.8, 156.7, 
153.0, 149.4, 143.0, 142.6, 141.8, 141.3, 137.2, 131.0, 128.8, 127.3, 126.8, 125.7, 122.3, 
111.5, 111.2, 105.7, 103.1, 86.8, 49.6, 48.2, 44.8, 33.9, 31.8, 28.0, 27.9, 27.3, 26.2, 24.4; 
MS (ESI) m/z 635.21 (M)+.  
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1H NMR (DMSO-d6) 
 
 
 
13C NMR (CDCl3)
 231 
TBET cassette based on Cy3 (75a) 
 
N
I–
N
F2B
N
N
OMe
CO2H
4
 
 
A solution of 5-iodo-Cy3 74a (70 mg, 0.099 mmol), 4-ethynyl BODIPY 55 (63 mg, 
0.17 mmol), Pd(PPh3)4 (23 mg, 0.020 mmol), CuI (3.8 mg, 0.020 mmol) in DMF (4.0 
mL) was freeze-pump-thawed at –78 ºC (x 3 times).  Et3N (70 mL, 0.49 mmol) was 
added to a solution and the reaction mixture was stirred at 40 ºC for 45 min under 
nitrogen.  Ether (100 mL) was added to a reaction mixture and reaction mixture was 
filtered off to afford dark red solid.  The residue was purified by flash chromatography 
eluting with 100 % EtOAc and 10 to 50 % MeOH/CH2Cl2 to afford product as a dark red 
solid (43 mg, 45 %).  Rf 0.5 (10 % EtOAc/hexanes).  1H NMR (500 MHz, CDCl3) δ 8.40 
(t, 1H, J = 13.2 Hz), 7.59 (d, 1H, J = 8.5 Hz), 7.51 (s, 1H), 7.43-7.38 (m, 2H), 7.30-7.27 
(m, 2H), 7.16-7.13 (m, 4H), 7.04 (d, 1H, J = 13.0 Hz), 6.91 (d, 1H, J = 13.0 Hz), 5.97 (s, 
2H), 4.15 (br, 2H), 3.81 (s, 3H), 3.79 (s, 3H), 2.63 (br, 2H), 2.55 (s, 6H), 1.90 (br, 2H), 
1.86-1.83 (m, 2H), 1.74 (s, 6H), 1.73 (s, 6H), 1.67-1.61 (m, 2H), 1.48 (s, 6H); 13C NMR 
(125 MHz, CDCl3) δ 175.9, 174.3, 173.6, 156.4, 155.2, 150.6, 142.9, 142.4, 141.7, 
140.7, 140.6, 137.8, 132.7, 131.3, 129.7, 129.0, 125.7, 125.2, 125.1, 124.8, 124.5, 122.2, 
121.0, 119.3, 114.0, 111.2, 110.9, 105.3, 105.1, 90.0, 89.8, 55.8, 49.2, 48.6, 44.7, 34.5, 
32.3, 28.16, 28.13, 26.5, 26.0, 24.2, 14.6, 14.0; MS (MALDI) m/z 833.29 (M)+. 
 232 
 
1H NMR (CDCl3) 
 
 
 
13C NMR (CDCl3) 
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TBET cassette based on Cy7 (75c) 
 
N
N
I–
N
F2B
N
OMe
CO2H
4
 
 
A solution of 5-iodo-Cy7 74c (80 mg, 0.10 mmol), 4-ethynyl BODIPY 55 (67 mg, 
0.18 mmol), Pd(PPh3)4 (24 mg, 0.021 mmol), CuI (4 mg, 0.021 mmol) in DMF (4.0 mL) 
was freeze-pump-thawed at –78 ºC (x 3 times).  Et3N (70 mL, 0.49 mmol) was added to 
a solution and the reaction mixture was stirred at 40 ºC for 45 min under nitrogen.  Ether 
(100 mL) was added to a reaction mixture and reaction mixture was filtered off to afford 
dark red solids.  The residue was purified by flash chromatography eluting with 100 % 
EtOAc and 10 to 50 % MeOH/CH2Cl2 to afford product as a dark green solid (35 mg, 33 
%).  Rf 0.5 (10 % EtOAc/hexanes).  1H NMR (500 MHz, CD3OD) δ 8.07 (t, 1H, J = 12.0 
Hz), 7.88 (t, 1H, J = 12.0 Hz), 7.66-7.61 (m, 2H), 7.58 (t, 2H, J = 7.5 Hz), 7.48 (t, 1H, J 
= 7.5 Hz), 7.42 (d, 1H, J = 8.0 Hz), 7.37-7.33 (m, 3H), 7.22-7.19 (m, 2H), 6.66 (t, 1H, J 
= 13.0 Hz), 6.59 (t, 1H, J = 13.0 Hz), 6.50 (d, 1H, J = 14.5 Hz), 6.17 (d, 1H, J = 13.0 
Hz), 6.09 (s, 2H), 4.21 (t, 2H, J = 7.5 Hz), 3.88 (s, 3H), 3.55 (s, 3H), 2.52 (s, 6H), 2.36 
(t, 2H, J = 7.5 Hz), 1.91-1.85 (m, 2H), 1.75 (s, 6H), 1.74-1.69 (m, 2H), 1.73 (s, 6H), 1.55 
(s, 6H), 1.54-1.50 (m, 2H); 13C NMR (125 MHz, DMSO-d6) δ 175.3, 174.7, 169.8, 
157.0, 155.7, 154.0, 149.8, 144.8, 143.1, 142.7, 142.6, 141.9, 139.2, 133.1, 131.6, 130.6, 
129.6, 127.3, 126.7, 126.6, 126.4, 126.1, 125.5, 124.1, 123.6, 122.2 (2C), 117.4, 115.3, 
112.9, 111.3, 106.9, 104.0, 92.1, 89.9, 57.0, 50.4, 48.7, 44.9, 34.5, 31.7, 28.2, 28.0, 27.9, 
26.6, 25.2, 15.2, 14.6; MS (MALDI) m/z 885.35 (M)+.  
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1H NMR (CD3OD) 
 
 
 
13C NMR (DMSO-d6) 
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APPENDIX C 
 
EXPERIMENTAL DATA FOR CHAPTER IV 
 
4-Bromomethyl-3-nitro tert-butyl-benzoate (89) 
 
tBuO
O
NO2
Br
 
 
To a solution of 4-bromomethyl-3-nitrobenzoic acid (5.0 g, 0.019 mol), tBuOH (1.85 
g, 0.025 mol) and DMAP (235 mg, 0.0019 mol) in CH2Cl2 (50 mL) was added DIC 
(3.26 mL, 0.021 mol) at 0 ºC.  The reaction mixture was stirred at 25 ºC for 2.5 h.  The 
reaction mixture was filtered and the solvent was evaporated.  The residue was purified 
by short flash chromatography eluting with 15 % EtOAc/hexanes to afford product as a 
yellow solid (3.4 g, 56 %).  Rf 0.9 (20 % EtOAc/hexanes).  1H NMR (500 MHz, CDCl3) 
δ 8.57 (s, 1H), 8.19 (d, 1H, J = 8.0 Hz), 7.63 (d, 1H, J = 8.0 Hz), 4.83 (s, 2H), 1.61 (s, 
9H); 13C NMR (125 MHz, CDCl3) δ 163.3, 148.2, 136.8, 134.3, 134.0, 132.9, 126.7, 
83.2, 28.41, 28.34; MS (CI) m/z 316.1 (M+H)+.  
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1H NMR (CDCl3) 
 
13C NMR (CDCl3) 
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Photo linker (90) 
 
tBuO
O
NO2
O
OH
 
 
A solution of tert-butyl ester 89 (802 mg, 2.54 mmol), 3-hydroxybenzyl alcohol (300 
mg, 2.42 mmol) and K2CO3 (835 mg, 6.04 mmol) in acetone (16 mL) was stirred at 25 
ºC for 12 h in dark (2 batches).  The reaction mixture was filtered and the solvent was 
evaporated.  The residue was purified by flash chromatography eluting with 15 to 25 % 
EtOAc/hexanes to afford product as a light yellow solid (1.8 g, quantitative).  Rf 0.4 (30 
% EtOAc/hexanes).  1H NMR (500 MHz, CDCl3) δ 8.61 (d, 1H, J = 2.0 Hz), 8.16 (dd, 
1H, J = 8.0, 2.0 Hz), 7.87 (d, 1H, J = 8.0 Hz), 7.01-7.17 (m, 1H), 6.92-6.89 (m, 2H), 
6.79 (dd, 1H, J = 8.0, 2.0 Hz), 5.42 (s, 2H), 4.58 (d, 2H, J = 5.5 Hz), 1.81 (t, 1H, J = 5.5 
Hz), 1.53 (s, 9H); 13C NMR (125 MHz, CDCl3) δ 163.7, 158.4, 147.0, 143.2, 138.2, 
134.7, 132.9, 130.2, 128.9, 126.3, 120.4, 114.2, 113.6, 83.0, 67.0, 65.3, 28.4; MS (CI) 
m/z 360.3 (M+H)+.   
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1H NMR (CDCl3) 
 
 
13C NMR (CDCl3) 
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Photo linker (91) 
 
tBuO
O
NO2
O
Br
 
 
To a solution of alcohol 90 (1.0 g, 2.78 mmol) and PPh3 (803 mg, 3.06 mmol) in 
CH2Cl2 (30 mL) was added carbon tetrabromide (1.02 g, 3.06 mmol) at 0 ºC.  The 
reaction mixture was stirred at 25 ºC for 24 h in dark.  The solvent was concentrated 
under the reduced pressure.  The residue was purified by short flash chromatography 
eluting with 10 % EtOAc/hexanes to afford product as a light yellow solid (1.02 g, 86 
%).  Rf 0.4 (10 % EtOAc/hexanes).  1H NMR (500 MHz, acetone-d6) δ 8.66 (d, 1H, J = 
2.0 Hz), 8.34 (dd, 1H, J = 8.0, 1.5 Hz), 8.06 (d, 1H, J = 8.0 Hz), 7.36 (t, 1H, J = 8.0 Hz), 
7.22 (t, 1H, J = 2.0 Hz), 7.14 (d, 1H, J = 8.0 Hz), 7.05 (dd, 1H, J = 8.0, 2.0 Hz), 5.64 (s, 
2H), 4.66 (s, 2H), 1.66 (s, 9H); 13C NMR (125 MHz, acetone-d6) δ 163.7, 158.9, 148.0, 
140.6, 138.2, 134.5, 133.2, 130.6, 129.8, 125.9, 123.0, 116.2, 115.5, 82.7, 67.2, 33.8, 
28.0; MS (APCI) m/z 422.1 (M+H)+.  
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1H NMR (acetone-d6) 
 
 
 
 
13C NMR (acetone-d6) 
 
 241 
Dimethylester Nile Red derivative (93) 
 
tBuO
O
NO2
O
O
N
O
O
N
CO2Me
CO2Me
 
 
A solution of benzylbromide 91 (244 mg, 0.577 mmol), Nile Red 92 (200 mg, 0.444 
mmol, provided by Mr. Jiney Jose) and Cs2CO3 (289 mg, 0.888 mmol) in acetone (20 
mL) was refluxed at 70 ºC for 5 h under nitrogen.  After the cooling to room 
temperature, small amount of silica gel was added to a solution and the solvent was 
evaporated.  The obtained dark red powder was purified by flash chromatography eluting 
with 20 to 50 % EtOAc/hexanes to afford product as a red solid (199 mg, 57 %).  Rf 0.7 
(60 % EtOAc/hexanes).  1H NMR (300 MHz, DMSO-d6) δ 8.54 (d, 1H, J = 1.8 Hz), 8.27 
(dd, 1H, J = 8.0, 1.8 Hz), 8.10 (s, 1H), 8.09 (d, 1H, J = 8.0 Hz), 7.96 (d, 1H, J = 8.0 Hz), 
7.68 (d, 1H, J = 8.0 Hz), 7.43-7.37 (m, 2H), 7.26 (s, 1H), 7.19 (d, 1H, J = 7.5 Hz), 7.06 
(dd, 1H, J = 9.0, 2.0 Hz), 6.88 (dd, 1H, J = 9.0, 2.0 Hz), 6.78 (d, 1H, J = 2.0 Hz), 6.26 (s, 
1H), 5.62 (s, 2H), 5.34 (s, 2H), 3.78 (t, 4H, J = 7.2 Hz), 3.66 (s, 6H), 2.70 (t, 4H, J = 7.2 
Hz), 1.61 (s, 9H); MS (MALDI) m/z 793.17 (M+H)+.  13C NMR was difficult to obtain 
because of poor solubility of compound 93 in any organic solvents.  
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1H NMR (DMSO-d6) 
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Carboxylic acid Nile red derivative (94) 
 
HO
O
NO2
O
O
N
O
O
N
CO2Me
CO2Me
 
 
To a solution of Nile Red derivative 93 (171 mg, 0.216 mmol) in CH2Cl2 (22 mL) 
was added 2,6-lutidine (0.06 mL, 0.54 mmol) and then added TMSOTf (0.42 mL, 2.16 
mmol) dropwise at 0 ºC.  The reaction mixture was stirred at 25 ºC for 30 h under 
nitrogen.  The solvent was evaporated at 30 ºC and EtOAc (30 mL) was added to this 
residue.  The organic layer was washed with water (1 x 30 mL) and brine (1 x 30 mL).  
The organic layer was dried over Na2SO4 and small amount of silica gel was added to 
this solution and the solvent was concentrated under the reduced pressure.  The obtained 
dark red powder was purified by flash chromatography eluting with 70 % 
EtOAc/hexanes and 5 to 20 % MeOH/EtOAc to afford product as a dark red solid (123 
mg, 77 %).  Rf 0.5 (10 % MeOH/EtOAc).  1H NMR (300 MHz, DMSO-d6) δ 8.54 (d, 
1H, J = 1.2 Hz), 8.22 (dd, 1H, J = 8.0, 1.2 Hz), 8.11 (s, 1H), 8.09 (d, 1H, J = 8.0 Hz), 
7.77 (d, 1H, J = 8.0 Hz), 7.68 (d, 1H, J = 8.0 Hz), 7.42-7.37 (m, 2H), 7.26 (s, 1H), 7.18 
(d, 1H, J = 7.5 Hz), 7.04 (dd, 1H, J = 9.0, 1.8 Hz), 6.88 (dd, 1H, J = 9.0, 1.8 Hz), 6.77 
(d, 1H, J = 2.4 Hz), 6.25 (s, 1H), 5.53 (s, 2H), 5.33 (s, 2H), 3.78 (t, 4H, J = 7.2 Hz), 3.66 
(s, 6H), 2.70 (t, 4H, J = 7.2 Hz); MS (MALDI) m/z 737.13 (M+H)+.  13C NMR was 
difficult to obtain because of poor solubility of compound 94 in any organic solvents.  
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1H NMR (DMSO-d6) 
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3-(tert-butyldiphenylsilyloxy)benzaldehyde (97) 
 
TBDPSO CHO
 
 
To a solution of 3-hydroxybenzaldehyde (3.0 g, 0.025 mol) and imidazole (2.5 g, 
0.037 mol) in DMF (40 mL) was added TBDPSCl (8.1 g, 0.030 mol) at 25 ºC.  The 
reaction was stirred at 25 ºC for 3.5 h.  Water (50 mL) was added to a reaction mixture 
and the aqueous layer was extracted with EtOAc (3 x 20 mL).  The combined organic 
layer was dried over Na2SO4 and concentrated in vacuo.  The residual material was 
purified by flash chromatography eluting with 100 % hexanes and 5 % EtOAc/hexanes 
to afford product as a colorless oil (8.0 g, 90 %).  Rf 0.6 (10 % EtOAc/hexanes).  1H 
NMR (500 MHz, CD3OD) δ 9.78 (s, 1H), 7.75-7.73 (m, 4H), 7.48-7.38 (m, 8H), 7.29-
7.26 (m, 1H), 7.03 (dd, 1H, J = 10.0, 2.5 Hz), 1.13 (s, 9H); 13C NMR (125 MHz, 
CD3OD) δ 193.5, 157.6, 139.3, 136.6, 133.3, 131.4, 131.1, 129.1, 127.1, 124.3, 120.6, 
27.0, 20.2; MS (CI) m/z 361.2 (M+H)+.  
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1H NMR (CD3OD) 
 
 
 
13C NMR (CD3OD) 
 
 
 247 
3-(tert-butyldiphenylsilyloxy)benzylalcohol (98) 
 
TBDPSO
OH
 
 
To a solution of TBDPS-protected-hydroxybenzaldehyde 97 (6.3 g, 0.017 mol) in 
MeOH (120 mL) was slowly added NaBH4 (793 mg, 0.021 mol) at 0 ºC.  The reaction 
was stirred at 25 ºC for 1 h.  Water (30 mL) was added to a reaction mixture and MeOH 
was only evaporated under reduced pressure.  The aqueous layer was extracted with 
EtOAc (5 x 50 mL) and the combined organic layer was dried over Na2SO4 and 
concentrated in vacuo to afford pure product as a colorless oil (6.2 g, 98 %).  Rf 0.4 (20 
% EtOAc/hexanes).  1H NMR (500 MHz, CD3OD) δ 7.75 (dd, 4H, J = 5.0, 1.5 Hz), 
7.47-7.44 (m, 2H), 7.41-7.38 (m, 4H), 7.03 (t, 1H, J = 8.0 Hz), 6.89-6.87 (m, 2H), 6.60 
(dd, 1H, J = 8.0, 3.0 Hz), 4.45 (s, 2H), 1.11 (s, 9H); 13C NMR (125 MHz, CD3OD) δ 
157.0, 144.3, 136.6, 134.0, 131.1, 130.1, 128.9, 120.8, 119.5, 119.2, 64.8, 27.0, 20.2; 
MS (CI) m/z 363.3 (M+H)+.  
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13C NMR (CD3OD)
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3-(tert-butyldiphenylsilyloxy)benzylbromide (99) 
 
TBDPSO
Br
 
 
To a solution of alcohol 98 (6.19 g, 0.017 mol) and PPh3 (4.93 g, 0.019 mol) in 
CH2Cl2 (120 mL) was added carbon tetrabromide (6.23 g, 0.019 mol) at 0 ºC.  The 
reaction was stirred at 25 ºC for 19 h under nitrogen.  The solvent was evaporated under 
the reduced pressure and the residual material was purified by flash chromatography 
eluting with 100 % hexanes and 10 % EtOAc/hexanes to afford product as a colorless oil 
(6.0 g, 83 %).  Rf 0.7 (10 % EtOAc/hexanes).  1H NMR (500 MHz, CD3OD) δ 7.74-7.72 
(m, 4H), 7.47-7.44 (m, 2H), 7.41-7.38 (m, 4H), 7.03 (t, 1H, J = 8.0 Hz), 6.91 (d, 1H, J = 
8.0 Hz), 6.85 (t, 1H, J = 2.5 Hz), 6.65 (dd, 1H, J = 8.0, 2.5 Hz), 4.35 (s, 2H), 1.12 (s, 
9H); 13C NMR (125 MHz, CD3OD) δ 157.0, 140.9, 136.6, 133.8, 131.2, 130.4, 128.9, 
123.0, 121.5, 120.7, 33.6, 27.0, 20.2; MS (CI) m/z 425.2 (M+H)+.  
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 251 
Silyloxy Nile Red derivative (100) 
 
O
N
ON O
MeO2C
CO2Me
OTBDPS
 
 
A solution of Nile Red dimethylester 92 (350 mg, 0.78 mmol, provided by Mr. Jiney 
Jose), benzylbromide 99 (1.7 g, 3.89 mmol) and Cs2CO3 (2.5 g, 7.77 mmol) in acetone 
(20 mL) was refluxed at 70 ºC for 3.5 h.  After cooling to room temperature, the solvent 
was evaporated under the reduced pressure and the residual material was purified by 
flash chromatography (2 times column) eluting with 20 to 50 % EtOAc/hexanes to 
afford product as a red oil (236 mg, 38 % yield, 90 % purity).  Rf 0.6 (60 % 
EtOAc/hexanes).  1H NMR (500 MHz, DMSO-d6) δ 8.04 (d, 1H, J = 8.5 Hz), 7.96 (d, 
1H, J = 2.5 Hz), 7.69-7.68 (m, 4H), 7.64 (d, 1H, J = 9.0 Hz), 7.53-7.48 (m, 2H), 7.46-
7.43 (m, 4H), 7.24 (dd, 1H, J = 8.5, 2.5 Hz), 7.19 (t, 1H, J = 7.5 Hz), 7.06 (d, 1H, J = 7.5 
Hz), 6.99 (s, 1H), 6.85 (dd, 1H, J = 9.0, 2.5 Hz), 6.75 (d, 1H, J = 2.5 Hz), 6.69 (dd, 1H, J 
= 8.0, 2.5 Hz), 6.23 (s, 1H), 5.20 (s, 2H), 3.77 (t, 4H, J = 7.0 Hz), 3.66 (s, 6H), 2.59 (t, 
4H, J = 7.0 Hz), 1.06 (s, 9H); MS (MALDI) m/z 796.13 (M+H)+.  
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1H NMR (DMSO-d6) 
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Hydroxy Nile Red derivative (101) 
 
O
N
ON O
MeO2C
CO2Me
OH
 
 
To a solution of TBDPS-protected Nile Red dimethylester 100 (236 mg, 0.297 
mmol) in THF (20 mL) was added TBAF (0.36 mL, 0.356 mmol, 1 M in THF) dropwise 
at 0 ºC.  After the stirring for 10 min, the solvent was evaporated under the reduced 
pressure at 35 ºC.  The residual dark red material was purified by flash chromatography 
eluting with 40 to 70 % EtOAc/hexanes to afford product as a red solid (116 mg, 70 % 
yield, 90 % purity).  Rf 0.3 (70 % EtOAc/hexanes).  1H NMR (300 MHz, DMSO-d6) δ 
9.54 (s, 1H), 8.10 (d, 1H, J = 8.0 Hz), 8.08 (s, 1H), 7.69 (d, 1H, J = 8.0 Hz), 7.39 (dd, 
1H, J = 8.4, 2.4 Hz), 7.24 (t, 1H, J = 7.5 Hz), 6.98-6.96 (m, 2H), 6.89 (dd, 1H, J = 8.4, 
2.4 Hz), 6.78-6.75 (m, 2H), 6.25 (s, 1H), 5.28 (s, 2H), 3.78 (t, 4H, J = 7.5 Hz), 3.66 (s, 
6H), 2.70 (t, 4H, J = 7.5 Hz); MS (MALDI) m/z 558.08 (M+H)+.  
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1H NMR (DMSO-d6) 
 
 
 255 
Nile Red derivative (102) 
 
O
N
ON O
HO2C
CO2H
OH
 
 
A solution of Nile Red dimethylester 101 (50 mg, 0.090 mmol) and K2CO3 (99 mg, 
0.719 mmol) in 1:1 MeOH/H2O (5 mL:5 mL) was stirred at 40 ºC for 12 h.  MeOH was 
only evaporated and water (5 mL) was added to a solution.  The aqueous layer was 
extracted with EtOAc (3 x 10 mL) and the aqueous layer was acidified with 1 N HCl to 
reach pH 2.  The aqueous layer was again extracted with EtOAc (2 x 10 mL) and the 
combined organic layer was dried over Na2SO4.  The solvent was concentrated under the 
reduced pressure to afford product as a red solid (36 mg, 77 %).  Rf 0.1 (100 % EtOAc).  
1H NMR (300 MHz, DMSO-d6) δ 9.54 (s, 1H), 8.08 (d, 1H, J = 6.5 Hz), 8.07 (s, 1H), 
7.67 (d, 1H, J = 9.0 Hz), 7.38 (dd, 1H, J = 9.0, 2.5 Hz), 7.23 (d, 1H, J = 7.8 Hz), 6.98-
6.95 (m, 2H), 6.90-6.86 (m, 1H), 6.79-6.73 (m, 2H), 6.24 (s, 1H), 5.27 (s, 2H), 3.76 (t, 
4H, J = 7.0 Hz), 2.61 (t, 4H, J = 7.0 Hz); 13C NMR (75 MHz, DMSO-d6) δ 182.5, 173.8, 
162.0, 158.5, 152.7, 151.5, 147.2, 140.3, 138.9, 134.4, 131.8, 130.5, 128.3, 126.0, 125.2, 
119.3, 119.2, 115.9, 115.4, 111.2, 108.0, 105.4, 97.8, 70.5, 47.5, 32.8; MS (ESI) m/z 
527.15 (M–H)–.  
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13C NMR (DMSO-d6) 
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4-Benzyloxy-3-methoxybenzaldehyde (104)149 
 
BnO
OMe
O  
 
A solution of vanillin (30 g, 0.197 mol), benzyl bromide (25.8 mL, 0.217 mol) and 
K2CO3 (27.3 g, 0.197 mol) in acetone (400 mL) was refluxed at 66 ºC for 20 h and then 
this reaction mixture was added into DI water (400 mL).  Acetone was only evaporated 
and aqueous phase was extracted with EtOAc (3 x 200 mL).  The combined organic 
layer was dried over Na2SO4 and concentrated under the reduced pressure.  The residue 
was purified by flash chromatography eluting with 10 % to 40% EtOAc/hexanes to 
afford product as a colorless crystals (43.6 g, 91 %).  Rf 0.7 (40 % EtOAc/hexanes).  1H 
NMR (500 MHz, CDCl3) δ 9.83 (s, 1H), 7.45-7.43 (m, 3H), 7.40-7.37 (m, 3H), 7.34-
7.31 (m, 1H), 6.98 (d, 1H, J = 8.5 Hz), 5.25 (s, 2H), 3.95 (s, 3H); 13C NMR (125 MHz, 
CDCl3) δ 190.9, 153.5, 150.0, 135.9, 130.2, 128.7, 128.2, 127.1, 126.6, 112.2, 109.2, 
70.8, 56.0.  
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1H NMR (CDCl3) 
 
 
 
13C NMR (CDCl3) 
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4-Benzyloxy-5-methoxy-2-nitrobenzaldehyde (105)149 
 
BnO
OMe
O
NO2  
 
Powdered O-benzylvanillin 104 (10 g, 41.3 mmol) was slowly added to nitric acid 
(50 mL) at 0 ºC for 10 min.  The reaction mixture was stirred at 0 ºC for 2 h.  The 
precipitates were filtrated and the collected brown solid was recrystallized from ethyl 
acetate to afford product as a yellow crystals (6.2 g, 52 %).  1H NMR (500 MHz, CDCl3) 
δ 10.4 (s, 1H), 7.67 (s, 1H), 7.47-7.45 (m, 2H), 7.43-7.40 (m, 3H), 7.38-7.35 (m, 1H), 
5.27 (s, 2H), 4.02 (s, 3H);  13C NMR (125 MHz, CDCl3) δ 187.8, 153.6, 151.3, 143.5, 
134.7, 128.9, 128.7, 127.6, 125.6, 110.0, 108.8, 71.5, 56.7.    
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1H NMR (CDCl3) 
 
 
 
13C NMR (CDCl3) 
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4-Hydroxy-5-methoxy-2-nitrobenzaldehyde (106)149 
 
HO
OMe
O
NO2  
 
A mixture of O-benzyl-6-nitrovanillin 105 (6.0 g, 20.9 mmol) and acetic acid (40 
mL) was stirred at 85 ºC and 48 % hydrobromic acid (11 mL) was added by auto syringe 
for 10 min.  The reaction mixture was stirred at 85 ºC for 1 h and cooled to room 
temperature.  The precipitates were filtrated and washed with hexanes to afford product 
as a yellow crystals (3.5 g, 86 %).  Rf 0.4 (40 % EtOAc/hexanes).  1H NMR (500 MHz, 
DMSO-d6) δ 11.1 (br, 1H), 10.2 (s, 1H), 7.52 (s, 1H), 7.36 (s, 1H), 3.97 (s, 3H);  13C 
NMR (125 MHz, DMSO-d6) δ 189.3, 152.8, 152.0, 144.7, 124.4, 112.0, 111.5, 57.3.  
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4-(Hydroxymethyl)-2-methoxy-5-nitrophenol (107)135 
 
HO
OMe
OH
NO2  
 
Aldehyde 106 (2.0 g, 10.1 mmol) was added in 1:1 THF/EtOH (25 mL:25 mL) at 0 
ºC.  Sodium borohydride (0.77 g, 20.3 mmol) was slowly added into the solution.  The 
reaction mixture was stirred at 25 ºC for 17 h and poured into DI water (50 mL) 
carefully.  THF and EtOH were only evaporated and aqueous layer was extracted with 
EtOAc (15 x 30 mL).  The combined organic layer was washed with water (1 x 50 mL) 
and brine (1 x 50 mL) and dried over Na2SO4.  The solvents were concentrated under the 
reduced pressure to afford product as a yellow solid (1.9 g, 95 %).  Rf 0.2 (40 % 
EtOAc/hexanes).  1H NMR (500 MHz, DMSO-d6) δ 9.97 (s, 1H), 7.59 (s, 1H), 7.37 (s, 
1H), 5.55 (t, 1H, J = 5.0 Hz), 4.83 (d, 2H, J = 5.0 Hz), 3.94 (s, 3H);  13C NMR (125 
MHz, DMSO-d6) δ 153.8, 145.9, 139.3, 133.5, 112.3, 110.9, 61.2, 57.0.  
 264 
 
1H NMR (DMSO-d6) 
 
 
 
13C NMR (DMSO-d6) 
 265 
tert-Butyl 2-(4-(hydroxymethyl)-2-methoxy-5-nitrophenoxy)acetate (108) 
 
O
OMe
OH
NO2
O
tBuO
 
 
A solution of photolinker 107 (1.0 g, 5.0 mmol), tert-butylbromoacetate (1.48 mL, 
10.0 mmol) and K2CO3 (1.7 g, 12.6 mmol) in CH3CN (50 mL) was stirred at 70 ºC for 
2.5 h.  The reaction mixture was cooled to room temperature and filtered to remove 
K2CO3.  The solvents were concentrated under the reduced pressure and the residue was 
purified by flash chromatography eluting with 20 % to 50 % EtOAc/hexanes to afford 
product as a yellow solid (1.5 g, 95 %).  Rf 0.5 (50 % EtOAc/hexanes).  1H NMR (500 
MHz, CDCl3) δ 7.61 (s, 1H), 7.22 (s, 1H), 4.96 (s, 2H), 4.64 (s, 2H), 3.99(s, 3H), 1.49 (s, 
9H); 13C NMR (125 MHz, CDCl3) δ 166.9, 154.2, 145.9, 139.2, 133.5, 111.2, 109.9, 
83.1, 66.2, 62.6, 56.5, 28.0; MS (ESI) m/z 320.13 (M+Li)+.  
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Photolinker (109a) 
 
O
OMe
O
NO2
O
tBuO
O  
 
Photolinker 108 (1.2 g, 3.83 mmol) was dissolved in CH2Cl2 (50 mL) and then DIC 
(725 mg, 5.75 mmol) and DMAP (47 mg, 0.38 mmol) were added to this solution at 0 
ºC.  After stirring at 0 ºC for 15 min, propiolic acid (402 mg, 5.75 mmol) dissolved in 
CH2Cl2 (10 mL) was added.  The reaction mixture was stirred at 25 ºC for additional 4 h.  
The solvents were concentrated under the reduced pressure at 35 ºC and the residue was 
purified by flash chromatography eluting with 15 to 30 % EtOAc/hexanes to afford 
product as a yellow semi-solid (1.17 g, 84 %).  Rf 0.5 (30 % EtOAc/hexanes).  1H NMR 
(500 MHz, CDCl3) δ 7.64 (s, 1H), 7.05 (s, 1H), 5.62 (s, 2H), 4.65 (s, 2H), 4.00 (s, 3H), 
2.99 (s, 1H), 1.48 (s, 9H); 13C NMR (125 MHz, CDCl3) δ 166.7, 153.9, 151.9, 146.5, 
139.3, 126.6, 110.7, 109.9, 83.2, 75.9, 74.0, 66.1, 64.5, 56.5, 28.0; MS (ESI) m/z 372.13 
(M+Li)+.  
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Carboxylate photolinker (110a) 
 
O
OMe
O
NO2
O
HO
O  
 
A solution of photolinker 109a (100 mg, 0.27 mmol) in 1:1 TFA/CH2Cl2 (1.0 mL:1.0 
mL) was stirred at 25 ºC for 1 h.  The reaction mixture was flashed with nitrogen to 
remove TFA and CH2Cl2 at 25 ºC for overnight.  Pure product was obtained as an off-
white solid (90 mg, quantitative yield).  1H NMR (500 MHz, DMSO-d6) δ 7.70 (s, 1H), 
7.32 (s, 1H), 5.52 (s, 2H), 4.92 (s, 2H), 4.71 (s, 1H), 3.97 (s, 3H); 13C NMR (125 MHz, 
DMSO-d6) δ 170.6, 154.1, 152.8, 147.7, 140.9, 125.7, 114.3, 110.7, 80.8, 75.3, 66.1, 
65.6, 57.4; MS (ESI) m/z 308.05 (M–H)–.   
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Photolinker (109b) 
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Photolinker 108 (100 mg, 0.319 mmol) was dissolved in CH2Cl2 (4.0 mL) and then 
DIC (40 mg, 0.319 mmol) and DMAP (3.9 mg, 0.032 mmol) were added to this solution 
at 0 ºC.  After stirring at 0 ºC for 15 min, 4-pentynoic acid (31 mg, 0.319 mmol) 
dissolved in CH2Cl2 (2.0 mL) was added.  The reaction mixture was stirred at 25 ºC for 
additional 3 h.  The solvents were concentrated under the reduced pressure at 35 ºC and 
the residue was purified by flash chromatography eluting with 10 to 30 % 
EtOAc/hexanes to afford product as a colorless oil (115 mg, 91 %, 95 % purity).  Rf 0.3 
(30 % EtOAc/hexanes).  1H NMR (500 MHz, CDCl3) δ 7.63 (s, 1H), 7.05 (s, 1H), 5.55 
(s, 2H), 4.65 (s, 2H), 3.99 (s, 3H), 2.70-2.66 (m, 2H), 2.58-2.54 (m, 2H), 1.98 (t, 1H, J = 
2.5 Hz), 1.49 (s, 9H); 13C NMR (125 MHz, CDCl3) δ 171.0, 166.7, 153.8, 146.3, 139.5, 
127.8, 110.9, 109.9, 83.2, 82.2, 69.3, 66.1, 63.4, 56.5, 33.3, 28.0, 14.3; MS (ESI) m/z 
400.16 (M+Li)+.  
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Carboxylate photolinker (110b) 
 
O
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O
NO2
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A solution of photolinker 109b (94 mg, 0.24 mmol) in 1:1 TFA/CH2Cl2 (1.5 mL:1.5 
mL) was stirred at 25 ºC in dark for 1 h.  The reaction mixture was flashed with nitrogen 
to remove TFA and CH2Cl2 at 25 ºC for overnight.  Pure product was obtained as a 
yellow solid (83 mg, quantitative yield).  Rf 0.2 (100 % EtOAc).  1H NMR (500 MHz, 
DMSO-d6) δ 7.54 (s, 1H), 7.20 (s, 1H), 5.44 (s, 2H), 4.48 (s, 2H), 3.95 (s, 3H), 2.88 (t, 
1H, J = 2.5 Hz), 2.67 (t, 2H, J = 7.0 Hz), 2.50-2.47 (m, 2H); 13C NMR (125 MHz, 
DMSO-d6) δ 172.0, 171.0, 154.2, 148.4, 140.3, 126.5, 112.2, 110.1, 84.0, 72.7, 68.2, 
63.8, 57.2, 33.6, 14.7; MS (ESI) m/z 336.02 (M–H)–.   
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1H NMR (DMSO-d6) 
 
 
 
13C NMR (DMSO-d6) 
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Azidomethyl benzene (111)150 
 
N3  
 
A solution of benzylbromide (1.0 g, 5.85 mmol) and sodium azide (760 mg, 11.7 
mmol) in DMSO (6.0 mL) was stirred at 25 ºC for 2 h.  Water (10 mL) was added into 
reaction mixture and aqueous phase was extracted with EtOAc (5 x 4 mL).  The 
combined organic layer was dried over Na2SO4 and concentrated under the reduced 
pressure at 35 ºC.  The residual material was purified by flash chromatography eluting 
with 100 % hexanes to 10 % EtOAc/hexanes to afford product as a colorless oil (636 
mg, 82 %).  Rf 0.7 (20 % EtOAc/hexanes).  1H NMR (500 MHz, CDCl3) δ 7.44-7.34 (m, 
5H), 4.36 (s, 2H); 13C NMR (125 MHz, CDCl3) δ 135.3, 128.8, 128.2, 128.1, 54.7.  
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1H NMR (CDCl3) 
 
 
 
13C NMR (CDCl3) 
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Triazole (112) 
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O
O
N
NN
OMeO
tBuO
 
 
A solution of photolinker 109a (78 mg, 0.21 mmol), benzylazide 111 (43 mg, 0.32 
mmol), CuSO4 (43 mL, 0.043 mmol, 1M in H2O) and sodium ascorbate (0.5 mL, 1.07 
mmol, 2M in H2O) in THF/iPrOH/H2O (2 mL:1 mL:1 mL, respectively) was stirred at 25 
ºC for 22 h in dark.  Water (10 mL) was added into reaction mixture and aqueous layer 
was ectracted with EtOAc (5 x 5 mL).  The combined organic layer was dried over 
MgSO4 and concentrated under the reduced pressure.  The residual material was purified 
by flash chromatography eluting with 40 to 60 % EtOAc/hexanes to afford product as a 
colorless solid (72 mg, 68 %).  Rf 0.2 (40 % EtOAc/hexanes).  1H NMR (500 MHz, 
DMSO-d6) δ 9.01 (s, 1H), 7.69 (s, 1H), 7.44-7.38 (m, 6H), 5.70 (s, 2H), 5.65 (s, 2H), 
4.90 (s, 2H), 3.95 (s, 3H), 1.47 (s, 9H); 13C NMR (125 MHz, CDCl3) δ 166.8, 160.0, 
154.0, 146.4, 140.0, 139.3, 133.4, 129.4, 129.3, 128.3, 127.9, 127.8, 110.9, 109.9, 83.1, 
66.2, 63.5, 56.5, 54.6, 28.0; MS (ESI) m/z 499.19 (M+H)+.   
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1H NMR (DMSO-d6) 
 
 
 
 
13C NMR (CDCl3) 
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Azidolysine derivative (134) 
 
N3 CO2H
NH2  
 
A solution of Boc-protected azido lysine 121 (500 mg, 1.84 mmol, provided by Ms. 
Eunhwa Ko) in 1:1 TFA/CH2Cl2 (3 mL:3 mL) was stirred at 25 ºC for 1.5 h.  The 
reaction mixture was flashed with nitrogen to remove TFA and CH2Cl2 at 25 ºC for 
overnight.  Pure product was obtained as a brown oil (320 mg, quantitative yield).  1H 
NMR (500 MHz, DMSO-d6) δ 9.03 (s, 1H), 7.87 (bs, 2H), 4.15 (q, 1H, J = 3.0 Hz),  
2.84-2.80 (m, 2H), 1.81-1.63 (m, 2H), 1.63-1.55 (m, 2H), 1.45-1.38 (m, 2H); 13C NMR 
(125 MHz, DMSO-d6) δ 172.8, 62.1, 39.6, 31.3, 27.6, 23.3; MS (ESI) m/z 173.09 
(M+H)+.  
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1H NMR (DMSO-d6) 
 
 
 
13C NMR (DMSO-d6)
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BODIPY derivative (137) 
 
N
B
F2
N
O NH
CO2HN3
 
 
A solution of tetramethyl BODIPY 135 (200 mg, 0.625 mmol, provided by Mr. 
Cliferson Thivierge), N-hydroxysuccinimide (72 mg, 0.625 mmol) and N,N’-
diisopropylcarbodiimide (79 mg, 0.625 mmol) in DMF (4.0 mL) was stirred at 25 ºC for 
24 h under nitrogen.  A solution of azido lysine 134 (183 mg, 1.06 mmol) in DMF (2.0 
mL) and DIPEA (0.44 mL, 2.50 mmol) was added to a reaction mixture and the reaction 
was stirred at 25 ºC for additional 16 h.  The solvents were evaporated under reduced 
pressure and the residue was purified by flash chromatography eluting with 100 % 
EtOAc and 10 % to 30 % MeOH/EtOAc (columned 2 times) to afford product as a 
orange semi-solid (225 mg, 76 %).  Rf 0.3 (100 % EtOAc).  1H NMR (500 MHz, 
CD3OD) δ 6.18 (s, 2H), 3.78 (q, 1H, J =  4.0 Hz), 3.38 (t, 2H, J = 4.5 Hz), 3.22 (t, 2H, J 
= 6.5 Hz), 2.53 (s, 6H), 2.48 (s, 6H), 1.89-1.83 (m, 1H), 1.77-1.69 (m, 1H), 1.58-1.42 
(m, 5H), 1.37-1.32 (m, 1H); 13C NMR (75 MHz, DMSO-d6) δ 170.8, 154.3, 146.7, 
142.0, 131.6, 122.7, 64.6, 39.4, 37.4, 32.2, 29.7, 26.1, 25.1, 24.4, 17.0, 15.1; MS (ESI) 
m/z 473.15 (M–H)–.  
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1H NMR (CD3OD) 
 
 
 
13C NMR (DMSO-d6) 
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Propargyl tosylate (142)152 
 
TsO  
 
Propargyl alcohol (2.8 g, 50.0 mmol) and TsCl (11.4 g, 60 mmol) were added in 
ether (50 mL) at 0 ºC.  KOH (14.0 g, 250.0 mmol) was added in 10 portions and the 
reaction mixture was stirred at 0 ºC for 1 h and at 25 ºC for 4 h.  Cold water (25 mL) was 
added at 0 ºC and aqueous layer was extracted with ether (2 x 25 mL).  The combined 
organic layer was washed with brine (1 x 25 mL) and dried over Na2SO4.  The solvents 
were concentrated under the reduced pressure to afford product as a brown liquid (8.7 g, 
83 %).  1H NMR (300 MHz, CDCl3) δ 7.81 (d, 2H, J = 8.5 Hz), 7.35 (d, 2H, J = 8.5 Hz), 
4.69 (d, 2H, J = 2.5 Hz), 2.47 (t, 1H, J = 2.5 Hz), 2.45 (s, 3H); 13C NMR (75 MHz, 
CDCl3) δ 145.2, 132.8, 129.8, 128.1, 77.3, 75.3, 57.3, 21.6.  
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1H NMR (CDCl3) 
 
 
 
13C NMR (CDCl3) 
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Mono-propargyl resorcinol (143)151 
 
HO O  
 
A solution of resorcinol (2.0 g, 18.2 mmol) and K2CO3 (1.6 g, 11.8 mmol) in acetone 
(20 mL) was stirred at 25 ºC for 5 min.  A solution of propargyl tosylate 142 (1.9 g, 9.1 
mmol) in acetone (10 mL) was added dropwise for 5 min and the reaction mixture was 
refluxed at 65 ºC for 7 h.  The reaction mixture was filtrated and the solvents were 
evaporated.  The residue was purified by flash chromatography eluting with 10 % to 20 
% EtOAc/hexanes to afford product as a colorless oil (723 mg, 54 %).  Rf 0.4 (30 % 
EtOAc/hexanes).  1H NMR (500 MHz, CDCl3) δ 7.15 (t, 1H, J = 7.6 Hz), 6.59-6.56 (m, 
1H), 6.51-6.48 (m, 2H), 4.65 (d, 2H, J = 2.3 Hz), 2.53 (t, 1H, J = 2.3 Hz); 13C NMR (125 
MHz, CDCl3) δ 158.7, 156.5, 130.2, 108.8, 107.2, 102.5, 78.3, 75.7, 55.8.  
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1H NMR (CDCl3) 
 
 
13C NMR (CDCl3) 
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Tosylate (144) 
 
O
OMe
OTs
NO2
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Photolinker 108 (300 mg, 0.96 mmol), Et3N (0.27 mL, 1.92 mmol) and Me3N•HCl 
(9 mg, 0.096 mmol) were added in CH3CN (9.0 mL) at 0 ºC.  A solution of TsCl (237 
mg, 1.24 mmol) in CH3CN (3.0 mL) was then added by syringe and the reaction mixture 
was stirred at 0 ºC for 20 min.  The reaction was quenched with water (15 mL) at 0 ºC 
and the aqueous layer was extracted with EtOAc (3 x 15 mL).  The combined organic 
layer was washed with water (1 x 10 mL) and brine (1 x 10 mL).  The organic layer was 
dried over Na2SO4 and solvents were concentrated under the reduced pressure to afford 
pure product as a yellow solid (429 mg, 99 %).  Rf 0.5 (20 % EtOAc/hexanes).  1H NMR 
(500 MHz, CDCl3) δ 7.84 (d, 2H, J = 8.3 Hz), 7.60 (s, 1H), 7.37 (d, 2H, J = 8.3 Hz), 
7.16 (s, 1H), 5.46 (s, 2H), 4.63 (s, 2H), 3.98 (s, 3H), 2.45 (s, 3H), 1.48 (s, 9H); 13C NMR 
(125 MHz, CDCl3) δ 166.6, 154.2, 146.5, 145.3, 138.6, 132.5, 130.0, 127.9, 126.6, 
110.1, 109.8, 83.2, 68.5, 66.2, 56.6, 28.0, 21.6; MS (ESI) m/z 474.14 (M+Li)+.  
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1H NMR (CDCl3) 
 
13C NMR (CDCl3) 
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Propargylated photolinker (145) 
 
O
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O
NO2
O
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A solution of tosylate 144 (303 mg, 0.65 mmol), propargyl-resorcinol 143 (80 mg, 
0.54 mmol) and K2CO3 (149 mg, 1.08 mmol) in acetone (10 mL) was stirred at 25 ºC in 
dark for 6 h.  The reaction mixture was filtrated and the solvents were evaporated.  The 
residue was purified by flash chromatography eluting with 30 % to 80 % 
CH2Cl2/hexanes to afford product as a yellow solid (230 mg, 96 %).  Rf 0.3 (70 % 
CH2Cl2/hexanes).  1H NMR (500 MHz, CDCl3) δ 7.68 (s, 1H), 7.34 (s, 1H), 7.22 (t, 1H, 
J = 8.8 Hz), 6.65-6.61 (m, 3H), 5.47 (s, 2H), 4.67 (d, 2H, J = 2.4 Hz), 4.65 (s, 2H), 3.95 
(s, 3H), 2.52 (t, 1H, J = 2.4 Hz), 1.50 (s, 9H); 13C NMR (125 MHz, CDCl3) δ 166.8, 
159.1, 158.8, 154.2, 145.9, 138.6, 130.3, 130.1, 109.9, 109.8, 108.1, 107.6, 102.5, 83.1, 
78.3, 75.6, 67.1, 66.2, 56.4, 55.8, 28.0; MS (ESI) m/z 444.17 (M+H)+.  
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1H NMR (CDCl3) 
 
13C NMR (CDCl3) 
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Photolinker (146) 
 
O
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O
NO2
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A solution of photolinker 145 (57 mg, 0.13 mmol) in 1:1 TFA/CH2Cl2 (1.5 mL:1.5 
mL) was stirred at 25 ºC in dark for 1 h.  The reaction mixture was flashed with nitrogen 
to remove TFA and CH2Cl2 at 25 ºC for overnight.  Pure product was obtained as a light 
brown solid (53 mg, quantitative yield).  Rf 0.2 (40 % EtOAc/hexanes).  1H NMR (500 
MHz, acetone-d6) δ 7.81 (s, 1H), 7.46 (s, 1H), 7.28 (t, 1H, J = 7.6 Hz), 6.74-6.72 (m, 
2H), 6.69-6.67 (m, 1H), 5.51 (s, 2H), 4.95 (s, 2H), 4.81 (d, 2H, J = 2.4 Hz), 4.00 (s, 3H), 
3.11 (t, 1H, J = 2.4 Hz), ; 13C NMR (125 MHz, acetone-d6) δ 170.5, 161.2, 160.7, 155.8, 
148.1, 141.1, 131.7, 130.7, 112.7, 112.1, 109.38, 109.35, 103.9, 80.4, 77.8, 68.4, 67.0, 
57.5, 57.1; MS (APCI) m/z 387.87 (M+H)+.  
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1H NMR (acetone-d6) 
 
 
 
 
13C NMR (acetone-d6) 
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APPENDIX D 
 
PROCEDURES OF SOLID-PHASE SYNTHESIS AND PHOTOLYSIS 
FOR CHAPTER IV 
 
Solid-supported Nile Red derivatives (95-PEGA and 95-CPG) 
 
N
H
O
NO2
O
O
N
O
O
N
CO2Me
CO2Me
PEGA resin
or
aminopropyl-CPG
 
 
Solid-supported Nile Red derivative 95-PEGA 
PEGA resin (700 mg, 0.020 mmol, 5 wt % in MeOH, 0.59 mmol/g) was washed with 
DMF (4 x 3 mL).  A solution of Nile Red derivative 94 (30 mg, 0.041 mmol), DIC (13 
mg, 0.102 mmol), DMAP (0.2 mg, 0.002 mmol) and PEGA resin (washed with DMF) in 
DMF (2 mL) was shaken in reaction vessel at 25 ºC in dark for 24 h.  Excess amount of 
chemicals were washed off with DMF (5 x 2 mL), MeOH (5 x 2 mL), acetone (5 x 2 
mL) and CH2Cl2 (5 x 2 mL), then PEGA resin was dried under the vacuum to afford 
purple beads (95-PEGA).  Ninhydrin test resulted in about 50 % conversion (purple and 
brown beads).  Resin was shaken with Ac2O and pyridine in CH2Cl2 (2 mL) for 2 h.  
Excess chemicals were washed off with CH2Cl2 (3 x 5 mL), MeOH (3 x 5 mL), CH2Cl2 
(3 x 5 mL), ether (3 x 5 mL).  Then ninhydrin test gave brown beads (negative). 
 
Solid-supported Nile Red derivative 95-CPG  
A solution of Nile Red derivative 94 (36 mg, 0.049 mmol), DIC (10 mg, 0.081 
mmol), DMAP (0.2 mg, 0.002 mmol) and aminopropyl-CPG (100 mg, 0.016 mmol, 
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0.162 mmol/g) in DMF (2 mL) was shaken in reaction vessel at 25 ºC in dark for 24 h.  
Excess amount of chemicals were washed off with DMF (10 x 3 mL), MeOH (10 x 3 
mL), acetone (3 x 3 mL) and CH2Cl2 (3 x 3 mL), then CPG was dried under the vacuum 
to afford purple beads (95-CPG).  Then ninhydrin test gave brown beads (negative). 
 
 
Solid-supported Nile red derivative (96-PEGA and 96-CPG) 
 
N
H
O
NO2
O
O
N
O
O
N
CO2H
CO2H
PEGA resin
or
aminopropyl-CPG
 
 
Solid-supported Nile Red derivative 96-PEGA 
A solution of 95-PEGA (35 mg, 0.020 mmol) and K2CO3 (28 mg, 0.205 mmol) in 
1:1 MeOH/H2O (1 mL:1 mL) was shaken in round bottom flask at 40 ºC in dark for 24 
h.  Excess amount of chemicals were washed off with H2O (3 x 2 mL), MeOH (3 x 2 
mL), CH2Cl2 (3 x 2 mL) and ether (3 x 2 mL), then PEGA resin was dried under the 
vacuum to afford purple beads (96-PEGA). 
 
Solid-supported Nile Red derivative 96-CPG 
A solution of 95-CPG (30 mg, 0.0049 mmol) and K2CO3 (6.7 mg, 0.049 mmol) in 
4:1 MeOH/H2O (0.8 mL:0.2 mL) was shaken in reaction vessel at 25 ºC in dark for 24 h.  
Excess amount of chemicals were washed off with H2O (3 x 3 mL), MeOH (3 x 3 mL), 
CH2Cl2 (3 x 3 mL) and ether (3 x 3 mL), then beads were dried under the vacuum to 
afford light pink beads (96-CPG). 
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CPG-supported photolinker (115) 
 
N
H
O
O
OMe
NO2
O
O  
 
A solution of photolinker 110a (25 mg, 0.081 mmol), DIC (20 mg, 0.162 mmol),  
DMAP (0.4 mg, 0.0032 mmol) and CPG (100 mg, 0.0162 mmol, loading: 0.162 
mmol/g) in DMF (2 mL) was shaken in reaction vessel at 25 ºC in dark for 24 h.  Excess 
chemicals were washed off with DMF (5 x 2 mL), MeOH (5 x 2 mL) and CH2Cl2 (5 x 2 
mL), then beads were dried under the vacuum to afford orange beads (compound 115).  
Ninhydrin test gave negative results (brown beads). 
 
 
 
Model compound (117) 
 
N
H
O
O
OMe
NO2
O
O
N
NN
N
BF2
N
 
 
A solution of CPG-support photolinker 115 (20 mg, 0.0032 mmol), 4-azido-
BODIPY 116 (3.5 mg, 0.0097 mmol, provided by Mrs. Lingling Li), CuSO4 (0.6 µL, 0.6 
µmol, 1 M in H2O), and sodium ascorbate (8.1 µL, 0.016 mmol, 2 M in H2O) in 4:1:1 
THF/iPrOH/H2O (1 mL:0.25 mL:0.25 mL, respectively) was shaken in reaction vessel at 
25 ºC in dark for 24 h.  Excess chemicals were washed off with H2O (5 x 2 mL), MeOH 
(5 x 2 mL), THF (5 x 2 mL) and CH2Cl2 (5 x 2 mL), then beads were dried under the 
vacuum to afford brown beads (compound 117).  
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CPG-supported photolinker (120) 
 
N
H
O
O
OMe
NO2
O
O  
 
A solution of photolinker 110a (14 mg, 0.045 mmol), DIC (5.6 mg, 0.045 mmol),  
DMAP (0.2 mg, 0.0018 mmol) and CPG (100 mg, 0.0089 mmol, pore size: 1000 Å, 
loading: 0.089 mmol/g) in DMF (2 mL) was shaken in reaction vessel at 25 ºC in dark 
for 24 h.  Excess chemicals were washed off with DMF (5 x 2 mL), MeOH (5 x 2 mL) 
and CH2Cl2 (5 x 2 mL), then beads were dried under the vacuum to afford light yellow 
beads (compound 120).  Ninhydrin test gave negative results (brown beads). 
 
 
CPG-supported triazole (122) 
 
NO2
O
O
N
NN
NHBoc
CO2H
OMe
O
O
N
H
 
 
A solution of CPG-support 120 (111 mg, 0.0099 mmol, loading: 0.089 mmol/g), 
azido-lysine derivative 121 (8.0 mg, 0.030 mmol), CuSO4 (5.0 µL, 5.0 µmol, 1 M in 
H2O) and sodium ascorbate (25 µL, 49 µmol, 2 M in H2O) in 5:1 THF/H2O (total 
volume 2 mL) was shaken in reaction vessel at 25 ºC in dark for 24 h.  Excess chemicals 
were washed off with H2O (5 x 2 mL), MeOH (5 x 2 mL), THF (5 x 2 mL) and CH2Cl2 
(5 x 2 mL), then beads were dried under the vacuum to afford colorless beads 
(compound 122).  
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CPG-supported lysine derivative (123) 
 
NO2
O
O
N
NN
NH2
CO2H
OMe
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O
N
H
 
 
A solution of CPG-supported triazole 122 (101 mg, 0.009 mmol, loading: 0.089 
mmol/g) in 50 % TFA/CH2Cl2 (1 mL:1 mL) was shaken in reaction vessel at 25 ºC in 
dark for 2 h.  The obtained beads were washed with CH2Cl2 (5 x 2 mL), then beads were 
dried under the vacuum to afford colorless beads (compound 123).  Ninhydrin test gave 
positive results (purple beads). 
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CPG-supported Nile Red derivative (126) 
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A solution of Nile Red derivative 124 (17 mg, 0.043 mmol), NHS (4.7 mg, 0.041 
mmol) and DIC (5.2 mg, 0.041 mmol) in DMF (2 mL) was stirred at 25 ºC for 24 h.  
Reaction was followed by TLC (100 % conversion after 24 h).  Crude compound 125 (1 
mL) was shaken with CPG-supported lysine 123 (50 mg, 0.0045 mmol), DIPEA (2.9 
mg, 0.022 mmol), DMAP (0.1 mg, 0.9 mmol) in additional DMF (1 mL) in reaction 
vessel at 25 ºC in dark for 24 h.  The beads were washed with DMF (7 x 2 mL), MeOH 
(7 x 2 mL) and CH2Cl2 (7 x 2 mL), then dried under the vacuum to afford purple beads.  
A solution of beads (20 mg), NHS (2.0 mg, 0.018 mmol) and DIC (2.2 mg, 0.018 mmol) 
in DMF (2 mL) was shaken in reaction vessel at 25 ºC in dark for 24 h.  The beads were 
washed with DMF (5 x 2 mL) and CH2Cl2 (5 x 2 mL) and dried under the vacuum to 
afford purple beads (compound 126). 
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CPG-supported dye-ubiquitin conjugate (127) 
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A solution of CPG-supported Nile Red derivative 126 (19 mg, 0.0017 mmol) and 
ubiquitin (7.2 mg, 0.85 mmol) in pH 8.3 sodium bicarbonate buffer (0.5 mL) was shaken 
in reaction vessel at 25 ºC in dark for 4 h.  CPG was washed with pH 8.3 buffer (5 x 2 
mL) and H2O (5 x 2 mL) to afford CPG-supported dye-protein conjugate 127 and the 
beads were directly used for next photocleavage reaction.  
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CPG-support succinimide (130) 
 
N
H
O
O
N
O
O
 
 
A solution of LCAA CPG (300 mg, 0.029 mmol, pore size: 1000 Å, loading: 0.097 
mmol/g), N,N’-disuccinimidyl carbonate (37 mg, 0.146 mmol) and DIPEA (19 mg, 
0.146 mmol) in DMF (5.0 mL) was shaken in reaction vessel at 25 ºC in dark for 5 h.  
CPG was washed with DMF (5 x 2 mL), EtOH (3 x 2 mL) and pH 7.4 phosphate buffer 
(3 x 2 mL) to afford colorless beads (compound 130).  These beads were directly used 
for next reaction. 
 
 
BSA-coated CPG (131) 
 
N
H
N
H
O
BSA
NH2
 
 
A solution of CPG-supported succinimide 130 (300 mg, 0.029 mmol, loading: 0.097 
mmol/g) and BSA (60 mg, 0.87 mmol) in pH 7.4 phosphate buffer (6.0 mL) was shaken 
in reaction vessel at 25 ºC in dark for 16 h.  CPG was washed with pH 7.4 phosphate 
buffer (5 x 2 mL), H2O (5 x 2 mL), EtOH (5 x 2 mL) and ether (5 x 2 mL) then dried 
under vacuum to afford BSA-coated CPG (131) as colorless beads.  Ninhydrin test gave 
positive result (purple bead). 
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CPG-support photolinker (132) 
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A solution of BSA-coated CPG 131 (100 mg, 0.0097 mmol, loading: 0.097 mmol/g), 
photolinker 110b (6.5 mg, 0.019 mmol), DIC (3.7 mg, 0.029 mmol) and DMAP (1.2 mg, 
0.0097 mmol) in DMF (2.0 mL) was shaken in reaction vessel at 25 ºC in dark for 24 h.  
CPG was washed with DMF (5 x 2 mL), EtOH (5 x 2 mL) and ether (3 x 2 mL) to afford 
BSA-coated CPG (132) as light orange beads. 
 
CPG-support photolinker (133) 
 
N
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N
H
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Capping of carboxylic acid for aspartate and glutamate 
A solution of BSA-coated CPG 132 (100 mg, 0.0097 mmol, loading: 0.097 mmol/g), 
NHS (11 mg, 0.1 mmol) and DIC (12 mg, 0.1 mmol) in DMF (1.5 mL) was shaken in 
reaction vessel at 25 ºC in dark for 12 h.  CPG was washed with DMF (3 x 2 mL).  The 
beads were shaken with ethanolamine (3.0 mg, 0.05 mmol) and DIPEA (13 mg, 0.1 
mmol) in DMF (2.0 mL) at 25 ºC in dark for 6 h.  CPG was washed with DMF (5 x 2 
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mL), EtOH (5 x 2 mL) and ether (3 x 2 mL) and dried under the vacuum to afford light 
orange beads (compound 133).  
 
 
 
CPG-support BODIPY (138) 
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A solution of CPG-supported photolinker 133 (100 mg, 0.0097 mmol, loading: 0.097 
mmol/g), BODIPY derivative 137 (14 mg, 0.029 mmol), CuSO4 (4.9 µL, 4.9 µmol, 1 M 
in H2O) and sodium ascorbate (24 µL, 49 µmol, 2 M in H2O) in 5:1 THF/H2O (total 
volume 2 mL) was shaken in reaction vessel at 25 ºC in dark for 30 h.  Excess chemicals 
were washed off with H2O (10 x 2 mL), DMF (10 x 2 mL), THF (5 x 2 mL), EtOH (5 x 
2 mL) and ether (5 x 2 mL), then beads were dried under the vacuum to afford light 
green beads (compound 138). 
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CPG-support dye-ubiquitin conjugate (139) 
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A solution of CPG-supported BODIPY 138 (63 mg, 0.0061 mmol), NHS (7.0 mg, 
0.061 mmol) and DIC (7.7 mg, 0.061 mmol) in DMF (1 mL) was shaken in reaction 
vessel at 25 ºC in dark for 16 h.  The beads were washed with DMF (5 x 2 mL) and ether 
(3 x 2 mL) and dried under the vacuum to afford light orange beads (succinimidyl ester 
of 138).  A solution of these beads (56 mg, 0.0054 mmol) and ubiquitin (9.3 mg, 1.1 
mmol) in pH 8.3 sodium bicarbonate buffer (0.7 mL) was shaken in reaction vessel at 25 
ºC in dark for 4.5 h.  CPG was washed with pH 8.3 buffer (7 x 2 mL), H2O (7 x 2 mL), 
EtOH (5 x 2 mL) and ether (3 x 2 mL), and dried under the vacuum to afford CPG-
supported dye-protein conjugate (139) as light orange beads.  These beads were used for 
next photocleavage reaction.  
 304 
CPG-supported photolinker (147) 
 
N
H
O
O
OMe
O
NO2
O
 
 
A solution of photolinker 146 (11 mg, 0.029 mmol), DIC (3.7 mg, 0.029 mmol),  
DMAP (0.2 mg, 0.002 mmol) and LCAA CPG (100 mg, 0.0097 mmol, pore size: 1000 
Å, loading: 0.097 mmol/g) in DMF (2 mL) was shaken in reaction vessel at 25 ºC in 
dark for 24 h.  CPG was washed with DMF (5 x 2 mL), MeOH (3 x 2 mL), CH2Cl2 (3 x 
2 mL) and ether (3 x 2 mL), then dried under the vacuum to afford colorless beads.  
Ninhydrin test gave positive results (purple beads).  Therefore, the beads were capped 
with Ac2O (2.0 mg, 0.019 mmol) and pyridine (1.5 mg, 0.019 mmol) in CH2Cl2 (1.5 mL) 
for 2 h.  The beads were washed with CH2Cl2 (5 x 2 mL) and ether (5 x 2 mL), and dried 
under the vacuum to afford colorless beads (compound 147).  Ninhydrin test gave 
negative results (brown beads). 
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CPG-supported BODIPY derivative (148) 
 
N
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A solution of CPG-support photolinker 147 (50 mg, 0.0049 mmol, loading: 0.097 
mmol/g), BODIPY derivative 137 (6.9 mg, 0.015 mmol), CuSO4 (2.4 µL, 2.4 µmol, 1 M 
in H2O) and sodium ascorbate (12 µL, 24 µmol, 2 M in H2O) in 5:1 THF/H2O (total 
volume 2 mL) was shaken in reaction vessel at 25 ºC in dark for 24 h.  Excess chemicals 
were washed off with H2O (10 x 2 mL), DMF (10 x 2 mL), THF (5 x 2 mL), MeOH (5 x 
2 mL), CH2Cl2 (3 x 2 mL) and ether (3 x 2 mL), then beads were dried under the vacuum 
to afford orange beads (compound 148). 
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CPG-supported BODIPY derivative (149) 
 
OO
OMe
NO2
O
N
H
O N
BF2
N
O
CO2H
 
 
A solution of CPG-support photolinker 147 (40 mg, 3.9 µmol), 4-iodo BODIPY 41 
(6.1 mg, 12 µmol), PdCl2(PPh3)2 (0.8 mg, 1.2 µmol), CuI (0.2 mg, 1.2 µmol) and Et3N 
(5.4 µL, 39 µmol) in THF (1 mL) was shaken in reaction vessel at 25 ºC for 24 h.  CPG 
was washed with THF (10 x 2 mL), CH3CN (10 x 2 mL), CH2Cl2 (5 x 2 mL) and ether 
(5 x 2 mL), then dried under the vacuum to afford light brown beads (compound 149). 
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CPG-support succinimide (150) 
 
N
H
O
O
N
O
O
 
 
A solution of LCAA CPG (300 mg, 0.050 mmol, pore size: 500 Å, loading: 0.165 
mmol/g), N,N’-disuccinimidyl carbonate (63 mg, 0.248 mmol) and DIPEA (32 mg, 
0.248 mmol) in DMF (5.0 mL) was shaken in reaction vessel at 25 ºC in dark for 5 h.  
CPG was washed with DMF (5 x 2 mL), EtOH (3 x 2 mL) and pH 7.4 phosphate buffer 
(3 x 2 mL) to afford colorless beads (compound 150).  These beads were directly used 
for next reaction. 
 
 
 
 
BSA-coated CPG (151) 
 
N
H
N
H
O
BSA
NH2  
 
A solution of CPG-support succinimide 150 (300 mg, 0.050 mmol, loading: 0.165 
mmol/g) and BSA (103 mg, 1.5 mmol) in pH 7.4 phosphate buffer (6.0 mL) was shaken 
in reaction vessel at 25 ºC in dark for 16 h.  CPG was washed with pH 7.4 phosphate 
buffer (5 x 2 mL), H2O (5 x 2 mL), EtOH (5 x 2 mL) and ether (5 x 2 mL) then dried 
under vacuum to afford BSA-coated CPG (151) as colorless beads.  Ninhydrin test gave 
positive result (purple bead).  
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BSA-CPG with diazobenzene linker (153) 
 
N
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A solution of diazobenzene linker 152 (13 mg, 0.050 mmol, provided by Mr. Jiney 
Jose), DIC (6.2 mg, 0.050 mmol), DMAP (0.4 mg, 0.003 mmol) and BSA-coated CPG 
151 (100 mg, 0.0165 mmol, pore size: 500 Å, loading: 0.165 mmol/g) in DMF (2 mL) 
was shaken in reaction vessel at 25 ºC in dark for 24 h.  CPG was washed with DMF (5 
x 2 mL), EtOH (5 x 2 mL) and ether (5 x 2 mL), then dried under the vacuum to afford 
orange beads (compound 153).  Ninhydrin test gave negative result (brown bead). 
 
 
BSA-CPG with diazobenzene linker (154) 
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Capping of carboxylic acid for aspartate and glutamate 
A solution of BSA-coated CPG 153 (50 mg, 0.008 mmol, loading: 0.165 mmol/g), 
NHS (9.5 mg, 0.083 mmol) and DIC (10 mg, 0.083 mmol) in DMF (2.0 mL) was shaken 
in reaction vessel at 25 ºC in dark for 5 h.  CPG was washed with DMF (5 x 2 mL).  The 
beads were shaken with ethanolamine (2.5 mg, 0.041 mmol) and DIPEA (11 mg, 0.083 
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mmol) in DMF (2.0 mL) at 25 ºC in dark for 5 h.  CPG was washed with DMF (5 x 2 
mL), EtOH (3 x 2 mL) and ether (3 x 2 mL) and dried under the vacuum to afford light 
orange beads (compound 154).   
 
 
BSA-CPG with BODIPY derivative (155) 
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A solution of BSA-CPG diazobenzene linker 154 (30 mg, 0.0050 mmol, loading: 
0.165 mmol/g), BODIPY derivative 46 (2.1 mg, 0.0050 mmol), CuSO4 (2.5 µL, 2.5 
µmol, 1 M in H2O) and sodium ascorbate (13 µL, 25 mmol, 2 M in H2O) in 5:1 
THF/H2O (total volume 2 mL) was shaken in reaction vessel at 25 ºC in dark for 24 h.  
Excess chemicals were washed off with H2O (10 x 2 mL), DMF (10 x 2 mL), THF (5 x 2 
mL), EtOH (5 x 2 mL) and ether (5 x 2 mL), then the beads were dried under the 
vacuum to afford dark brown beads (compound 155). 
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CPG-support diazobenzene linker (156) 
 
N
H
O
N
N
N3  
 
A solution of diazobenzene linker 152 (13 mg, 0.050 mmol), DIC (6.2 mg, 0.050 
mmol),  DMAP (0.4 mg, 0.003 mmol) and LCAA CPG (100 mg, 0.0165 mmol, pore 
size: 500 Å, loading: 0.165 mmol/g) in DMF (2 mL) was shaken in reaction vessel at 25 
ºC in dark for 24 h.  CPG was washed with DMF (5 x 2 mL), EtOH (5 x 2 mL) and ether 
(5 x 2 mL), then dried under the vacuum to afford orange beads (compound 156).  
Ninhydrin test gave negative result (brown bead).  IR (solid state): ν (cm–1) 1072, 1655, 
2125. 
 
 
CPG-support BODIPY derivative (157) 
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A solution of CPG-diazobenzene 156 (50 mg, 0.008 mmol, loading: 0.165 mmol/g), 
BODIPY derivative 46 (6.1 mg, 0.015 mmol), CuSO4 (2.0 µL, 2.0 mmol, 1 M in H2O) 
and sodium ascorbate (12 µL, 24 µmol, 2 M in H2O) in 5:1 THF/H2O (total volume 2 
mL) was shaken in reaction vessel at 25 ºC in dark for 24 h.  Excess chemicals were 
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washed off with H2O (10 x 2 mL), DMF (10 x 2 mL), THF (5 x 2 mL), EtOH (5 x 2 mL) 
and ether (3 x 2 mL), then beads were dried under the vacuum to afford brown beads 
(compound 157).  IR (solid state): a peak at 2125 cm–1 (N3 stretch) was not seen. 
 
 
 
 
 
General Procedure for Photolysis of Compounds (96-CPG), (112), (117), (127), 
and (139) 
 
Strip UV light designed to emit at 360 nm (Southern New England Ultraviolet 
Company) was used for all photochemical reactions.  Compound (96-CPG, 112, 117, 
127, or 139) (10 mg), ethanolamine (10 eq.), solvent (MeOH or CH3CN; 0.5 mL), and 
small magnetic spin bar were added into quartz cuvette.  Quartz cuvette was set inside of 
photo reactor; the distance between cuvette and light is 0.5 cm.  Then the reaction was 
irradiated at 360 nm with continuous stirring.  In photolysis of solid-phase, beads were 
filtered off after the reaction and then the obtained solution was analyzed by CE, 
MALDI, and LCMS. 
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APPENDIX E 
 
FLUORESCENT DYE TERMINATORS FOR DNA SEQUENCING 
 
6.1 DNA Sequencing 
The most important property of DNA molecules is their nucleoside sequence.  Until 
the late 1970s, determining the sequence of a nucleic acid containing even five or ten 
nucleotides was difficult and very laborious.  In 1977, two new techniques of DNA 
sequencing were developed.  One was by Maxam and Gilbert,154 the other was by 
Sanger.155  Their methods made possible the sequencing of even larger DNA molecules 
with an ease unimagined just a few decades ago.  In both Sanger and Maxam-Gilbert 
sequencing, the general principle is to reduce the DNA to four sets of labeled fragments.  
The reaction producing each set is base-specific, so that the lengths of the fragments 
correspond to positions in the DNA sequence where a certain base occurs. 
The Sanger method for DNA sequencing is the most widely used technique in high 
throughput analysis.  The basis of this method is the use of four different  
dideoxynucleoside triphosphates (ddNTP) which are ddATP, ddTTP, ddGTP and ddCTP 
and the use of four different deoxynucleoside triphosphate (dNTP) which are dATP, 
dTTP, dGTP and dCTP reducing the DNA to four sets of labeled fragments (Figure 6.1). 
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Figure 6.1.  Structures of deoxynucleotides and dideoxynucleotides.   
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DNA polymerases require both a primer (a short oligonucleotide strand), to which 
nucleotides are added, and a template strand to guide selection of each new nucleotide.  
In cells, the 3’-hydroxy group of the primer reacts with an incoming deoxynucleoside 
triphosphate (dNTP) to form a new phosphodiester bond.  The Sanger sequencing 
procedure uses dideoxynucleoside triphosphate (ddNTP) analogs (Figure 6.1) to 
interrupt DNA synthesis.  When a ddNTP is inserted in place of a dNTP, strand 
elongation is halted after the analog is added because of the lack of 3’-hydroxy group 
needed for the next step to do DNA synthesis. 
The DNA to be sequenced is used as the template strand, and a short primer, 
radioactively or fluorescently labeled, is annealed to it.  After DNA polymerase is 
performed, each fragments are separated by different-sized using electrophoresis gel and 
the sequence can be read directly from an autoradiogram of the gel (Figure 6.2).  
Because shorter DNA fragments migrate faster and the fragments near the bottom of the 
gel represent the nucleotide positions closest to the primer (the 5’ end), the sequence is 
read from bottom to top. 
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Figure 6.2.  Representative autoradiogram of electrophoresis gel. 
 
 
Each ddNTP used in the Sanger method can be linked to a fluorescent molecule that 
gives all the fragments terminating in that nucleotide a particular color.  Therefore, four 
dNTPs and four ddNTPs labeled by fluorescent tags are required to do this procedure.  
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The resulting colored DNA fragments are applied to a capillary gel and subjected to 
electrophoresis to separate each fragment.  All fragments of a given length migrate 
through the capillary gel in a single peak, and each peak with color is detected using a 
laser beam.  The DNA sequence is read by determining the sequence of colors in the 
peaks as they pass the detector.  Then these information are directly monitored to a 
computer.  Therefore, this automated DNA sequencing method give the unknown DNA 
sequence much faster. 
 
6.2 Syntheses of ddT and ddC 
Four modified dideoxynucleosides (adenosine, guanosine, cytidine and thymidine) 
are definitely necessary to prepare four nucleoside triphosphates (Figure 6.3).  2’, 3’-
Dideoxy-8-deazaiodoadenosine 160 has been synthesized by one of our group members, 
and 2’,3’-dideoxy-8-deazaiodoguanosine 161 was a gift from an other group.  These 
compounds are extremely difficult to make.  In the following section, the synthesis of 
2’,3’-dideoxy-5-iodouridine 163 and 2’,3’-dideoxy-5-iodocytidine 162 will be described. 
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Figure 6.3.  Structures of four iodo-dideoxynucleosides. 
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2’,3’-Dideoxy-5-iodouridine 163 was synthesized from commercially available 
uridine.  5’-Hydroxy-group of uridine was selectively protected with trityl-group to give 
compound 164.  This 164 was reacted with 1,1’-thiocarbonyldiimidazole (TCDI) 
followed by the reaction with trimethylphosphite to afford olefin 166 (Corey-Winter 
olefination).156-158  Trityl-group of olefin 166 was deprotected under the acidic condition 
to give compound 167.  This olefin was then hydrogenated with palladium catalyst to 
afford 2’,3’-dideoxyuridine 168.  Compound 168 was iodinated with iodine-
monochloride159 to form 2’,3’-dideoxy-5-iodouridine 163 and this was obtained in 6 
steps and 10 % overall yield (Scheme 6.1). 
 
 
Scheme 6.1.  Synthesis of 2’,3’-dideoxy-5-iodouridine 163. 
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2’,3’-Dideoxy-5-iodocytidine 162 was synthesized from commercially available 
cytidine.  The acetylation of cytidine followed by the protection of 5’-hydroxy-group by 
TBDMS-group afforded compound 170.160-162  Dihydroxy-groups of compound 170 was 
reacted with MsCl to give dimesylates 171.60  The reaction of dimesylate 171 with 
telluride dianion generated by tellurium and Et3BHLi (Super-Hydride) afforded olefin 
172.163  The TBDMS-group was then deprotected with TBAF to form alcohol 173.  The 
hydrogenation of olefin 173 followed by the deprotection of acetyl-group and the 
iodination afforded the final product, 2’,3’-dideoxy-5-iodocytidine 162 and this was 
obtained in 8 steps and 18 % overall yield (Scheme 6.2). 
 
 
Scheme 6.2.  Synthesis of 2’,3’-dideoxy-5-iodocytidine 162. 
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6.3 Syntheses of Nucleoside Triphosphates 
Nucleotides have three characteristic components: (i) a nitrogenous base, (ii) a 
pentose, and (iii) a phosphate.  Triphosphate which has three phosphate in its structure, 
is useful compound to make DNA strand.  However, it is difficult to make those 
compounds and to date, only two methods have been developed to synthesize them: the 
Kovacs method164 and the Eckstein method.165  In previous work from our group, the 
Eckstein protocol has consistently given better yields and cleaner reaction mixtures than 
the Kovacs method (Figure 6.4).  Therefore, this method was chosen to synthesize the 
modified nucleoside triphosphates so far. 
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Figure 6.4.  Triphosphorylation of dideoxynucleosides via Eckstein or Kovacs method. 
 
 
We now have in our hand the four dideoxyiodo nucleosides and can start making the 
corresponding triphosphates.  ddIATP, ddIUTP and ddICTP were first synthesized via 
the Eckstein method.  
Dideoxyiodo nucleosides were treated with 2-chloro-4H-1,3,2-benzodioxa-
phosphorin-4-one, tributylammonium pyrophosphate and iodine for oxidation (Scheme 
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5.3).165  Triphosphorylation of 2’,3’-dideoxy-5-iodouridine 163 gave its triphosphate 177 
(ddIUTP) in 55 % yield.  However, it was difficult to obtain the 2’,3’-dideoxy-8-
deazaiodoadenosine triphosphate 176 (ddIATP) and 2’,3’-dideoxy-5-iodocytidine 
triphosphate 178 (ddICTP) (trace and 9 % yield, respectively; >90 % purity).  This is 
probably due to the presence of the reactive amine-group in the DNA bases.  It is 
therefore necessary to improve the reaction conditions or purification method for the 
synthesis of these triphosphates. 
For the purification of triphosphates, ion exchange chromatography was used as a 
common method.  After the reaction was performed, the reaction mixture was applied to 
a DEAE (diethylaminoethyl) Sephadex column and eluted with 0 to 1.0 M lithium 
chloride or TEAB (triethylammonium bicarbonate). 
 
 
Scheme 6.3.  Triphosphorylation of dideoxyiodo adenosine, cytidine, and uridine. 
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6.4 Synthesis of Control Compound for DNA Sequencing 
Before attempting four nucleoside triphosphates with TBET cassette, we synthesized 
a model compound 183.  Fluorescein derivative was chosen as a probe instead of 
cassette.  6-Carboxyfluorescein diacetate 179 (synthesized from 6-carboxyfluorescein) 
was activated with NHS and EDCI in DMF followed by the addition of propargy amine 
and base to afford crude material of alkyne 181.  This crude material containing 
diacetate 181 was deprotected with K2CO3 to give 6-carboxyfluorescein derivative 182 
(Scheme 6.4).  Compounds 180 and 181 were not isolated due to the difficult 
chromatographic separation.  
 
 
Scheme 6.4.  Synthesis of fluorescein derivative 182. 
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A propargylic 6-carboxyfluorescein 182 and ddIUTP 177 were reacted via 
Sonogashira coupling in phosphate buffer at 25 ºC.  Preparative HPLC purification was 
used to purify target molecule 183 (reverse phase C18-column, H2O/CH3CN) (Scheme 
6.5). 
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Scheme 6.5.  Synthesis of model nucleotide compound 183. 
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6.5 Synthesis of TBET Cassette for DNA sequencing 
Previous work in our group has shown that longer linker gives better effect for the 
incorporation to DNA.166  Moreover, if it is water-soluble, it should help the water-
solubility of dye-terminators.  The azide 25 has been synthesized in our laboratories 
from commercially available hexaethylene glycol (Scheme 6.6).  This 25 was alkylated 
followed by the protection of alkyne by TBDMS-group to afford 185.  The azido-group 
of 185 was transferred to primary amine 186 via Staudinger ligation. 
 
 
Scheme 6.6.  Synthesis of TBDMS-protected amino-hexaethylene glycol 186. 
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3-Bromo-5-iodobenzoic acid chloride 187 was synthesized from its benzoic acid.  
This acid chloride 187 was coupled with ethylene glycol linker 186 to afford compound 
188 in 93 % yield (Scheme 6.7). 
 
 
Scheme 6.7.  Synthesis of modified ethylene glycol linker 188. 
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5-Bromofluorescein diacetate 189 was previously synthesized in our group.38  This 
5-isomer 189 was reacted with trimethylsilyl acetylene via Sonogashira coupling 
followed by the deprotection of TMS-group with TBAF to give 5-ethynylfluorescein 
diacetate 191 in 70 % yield (Scheme 6.8). 
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Scheme 6.8.  Synthesis of 5-ethynylfluorescein diacetate 191. 
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The ethylene glycol linker 188 and 5-ethynylfluorescein diacetate 191 were reacted 
via the palladium-catalyzed cross coupling (Sonogashira) to afford dye 192 in 80 % 
yield (Scheme 6.9).  The first cross-coupling reaction with iodine worked smoothly at 25 
ºC and the chromatographic purification was not hard because of clean reaction.  
However, the second cross-coupling with bromine resulted in a messy reaction under the 
Sonogashira and Suzuki conditions, even though we tried to use several different 
palladium catalysts and different reaction conditions (temperature, solvents and 
equivalents).  This is due to the reactivity of bromine and less stability of 192.  The 
coupling reaction at higher temperature (above 90 ºC) was attempted, but it led to the 
decomposition of molecule 192. 
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Scheme 6.9.  Synthesis of precursor 192 for TBET cassette. 
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APPENDIX F 
 
RELATED ATTEMPTED REACTIONS 
 
7.1 Synthesis of Water-soluble Rosamine Dye 
We also attempted to make rosamine derivative 199 as an acceptor fragment for 
synthesizing TBET cassette.  Dye 199 has iodine on 5-positon to couple with ethynyl-
donor component.  Compound 199 has two carboxylic acids to increase water-solubility 
and act as a handle for attachment of biomolecules.  First of all, m-anisidine was chosen 
as a starting material and this was reacted with acetone and catalytic amount of iodine to 
afford cyclized anisidine 193.  Compound 193 was alkylated with bromo methylacetate 
to give ester 194 in 98 % yield (Scheme 7.1).  The deprotection of methyl ester was 
attempted using BBr3, however, the reaction was messy and purification was difficult. 
 
Scheme 7.1.  Synthesis of cyclized anisidine 194. 
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We planed an other synthetic route to make cyclized aminophenol.  The synthesis 
was started from 3-aminophenol and this was first protected with TBDMS-group to 
afford compound 195.  Protected-aminophenol 195 was cyclized with acetone and cat. 
iodine followed by the alkylation to give compound 197.  The TBDMS-group was first  
deprotected with TBAF, however, it resulted in the decomposition of molecule 197. 
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Deprotection with Cs2CO3 in DMF/H2O at 25 ºC afforded product 198 and this method 
was previously reported by Wang et al.167  Finally, the condensation reaction of 198 and 
iodo-benzaldehyde 35 was carried out with several acids (sulfonic acid, trifluoromethane 
sulfonic acid, methanesulfonic acid, and TFA), but all cases resulted in messy reaction 
and it was really difficult to purify (Scheme 7.2). Further investigation of reaction 
conditions could be possible, however, this kind of cyclized rosamine dye synthesis 
usually gives low yields and purification is difficult, because many side-products are 
formed in condensation step.168,169 
 
Scheme 7.2.  Synthesis of 5-iodo rosamine derivative 199. 
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7.2 Synthesis of Water-soluble Nile Blue Derivative 
We have expertise in synthesis of functionalized ethylene glycol linkers.  We tried to 
make oligoethylene glycol modified Nile Blue derivative to increase water-solubility of 
dye and photophysical properties in aqueous media.  Hexaethylene glycol was first 
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mono-protected with PMB-group to give compound 200.58  Alkylation of ethylene 
glycol 200 followed by click reaction with azido ethylene glycol 25 afforded triazole-
decorated ethylene glycol 202 in 94 % yield.  Primary alcohol of 202 was tosylated to 
afford ethylene glycol derivative 203 (Scheme 7.3). 
 
 
Scheme 7.3.  Synthesis of triazole-decorated oligoethylene glycol 203. 
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Next, the Eastern part of Nile Blue was synthesized in three steps as shown in Scheme 
7.4.  5-Amino-2-naphthol was protected with TBDMS-group followed by the alkylation 
to give functionalized aminonaphthol 205.  Compound 205 was deprotected with TBAF 
to afford product 206 in moderate yield. 
 
 
Scheme 7.4.  Synthesis of functionalized aminonaphthol derivative 206. 
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Scheme 7.5 represents the synthesis of water-soluble Nile Blue derivative 209.  At 
first, aminonaphthol 206 and ethylene glycol 203 will be reacted via simple SN2 reaction.  
The condensation reaction of compound 207 and nitroso dialkyl-aminophenol 208 
followed by the deprotection of methyl ester will afford final product 209 (Scheme 7.5). 
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Scheme 7.5.  Plan for the synthesis of water-soluble Nile Blue derivative 209. 
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7.3 Photolysis of Triazole-mediated Photolinker 
Surprisingly, only one example of photochemical reaction for heterocyclic 
compounds have been found.170  o-Nitrobenzyl group was introduced into the imidazole 
side chain of histidine and this compound was photo-cleaved by a irradiation with 
mercury lamp.  We focused on the photolysis of triazole moiety and activated o-
nitrobenzyl group was used for this study.  5-Methoxy-2-nitrobenzyl alcohol was 
brominated to give compound 210 and bromine was then transferred to azide to afford 
compound 211.  Azide 211 was cyclyzed with phenylacetylene via 2+3 cycloaddition to 
give triazole 212 in 84 % yield.  Triazole 212 was irradiated with simple strip UV light 
or mercury lamp and the reaction was followed by TLC.  However, even after long 
irradiation periods , the reaction was not completed and mass spectrometry did not detect 
any desired compound (Scheme 7.6). 
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Scheme 7.6.  Synthesis of triazole 212 and its photolysis. 
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APPENDIX G 
 
EXPERIMENTAL DATA FOR APPENDIX E & F 
 
5’-Tritylated Nucleoside (164) 
 
N
O
NH
O
O
OH OH
TrtO
 
 
A solution of uridine (15.0 g, 0.061 mol), trityl chloride (51.0 g, 0.183 mol) and 
DMAP (2.98 g, 0.024 mol) in pyridine (100 mL) was stirred at 25 ºC for 3 d.  The 
solvents were evaporated under the reduced pressure and the residual material was 
purified by flash chromatography eluting with 100 % CH2Cl2, 70 % EtOAc/hexanes and 
100 % EtOAc to afford product as a colorless solid (25.9 g, 87 %).  Rf 0.4 (100 % 
EtOAc).  1H NMR (500 MHz, CD3OD) δ 8.00 (d, 1H, J = 8.5 Hz), 7.45 (d, 6H, J = 8.0 
Hz), 7.34-7.25 (m, 9H), 5.91 (d, 1H, J = 3.5 Hz), 5.27 (d, 1H, J = 8.0 Hz), 4.44 (t, 1H, J 
= 5.5 Hz), 4.28-4.26 (m, 1H), 4.14-4.12 (m, 1H), 3.53-3.45 (m, 2H);  13C NMR (125 
MHz, CD3OD) δ 166.0, 152.1, 144.8, 142.3, 129.9, 129.0, 128.4, 102.4, 91.0, 88.6, 84.2, 
76.0, 70.9, 63.7; MS (ESI) m/z 493.20 (M+Li)+.  
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1H NMR (CD3OD) 
 
 
  
13C NMR (CD3OD)
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Thiocarbonate derivative (165) 
 
N
O
NH
O
O
O O
TrtO
S  
 
A solution of 5’-tritylated uridine 164 (10.0 g, 0.021 mol) and 1,1’-
thiocarbonyldiimidazole (TCDI) (4.05 g, 0.023 mol) in 1,2-dichloroethane (160 mL) was 
refluxed at 97 ºC for 1 h.  The solvents were evaporated under the reduced pressure and 
the residual material was purified by flash chromatography eluting with 100 % ether and 
70 % EtOAc/hexanes to afford product as a colorless solid (6.4 g, 59 %).  Rf 0.5 (60 % 
EtOAc/hexanes).  1H NMR (500 MHz, DMSO-d6) δ 11.50 (d, 1H, J = 2.0 Hz), 7.81 (d, 
1H, J = 8.0 Hz), 7.42-7.28 (m, 15H), 6.10 (s, 1H), 6.03 (dd, 1H, J = 8.0, 1.0 Hz), 5.71 
(dd, 1H, J = 10.0, 2.5 Hz), 5.62 (q, 1H, J = 3.5 Hz), 4.48-4.45 (m, 1H), 3.46-3.42 (m, 
1H), 3.25 (dd, 1H, J = 10.0, 5.0 Hz);  13C NMR (125 MHz, DMSO-d6) δ 191.1, 164.2, 
151.3, 144.8, 144.4, 129.1, 128.9, 128.1, 102.9, 93.9, 89.8, 87.2, 87.1, 86.8, 64.7; MS 
(ESI) m/z 535.13 (M+Li)+.  
 333 
 
1H NMR (DMSO-d6) 
 
 
 
13C NMR (DMSO-d6)
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2’, 3’-Dedihydro Nucleoside (166) 
 
N
O
NH
O
OTrtO
 
 
Method A (thermal condition) 
A solution of thiocarbonate 165 (5.89 g, 0.011 mol) in trimethylphosphite (40 mL) 
was refluxed at 125 ºC for 4 h under nitrogen.  The solvents were evaporated under the 
reduced pressure and the residual material was purified by flash chromatography eluting 
with 70 % EtOAc/hexanes to afford product as a light yellow solid (4.15 g, 83 %). 
 
Method B (microwave) 
A solution of thiocarbonate 165 (100 mg, 0.19 mmol) in trimethylphosphite (2.0 mL) 
was irradiated with microwave reactor at 130 ºC for 20 min (sealed tube).  The solvents 
were evaporated under the reduced pressure and the residual material was purified by 
flash chromatography eluting with 70 % EtOAc/hexanes to afford product as a light 
yellow solid (82 mg, 96 %). 
 
Rf 0.6 (70 % EtOAc/hexanes).  1H NMR (500 MHz, DMSO-d6) δ 11.44 (s, 1H), 7.60 (d, 
1H, J = 8.0 Hz), 7.38-7.29 (m, 15H), 6.86-6.85 (m, 1H), 6.58 (d, 1H, J = 6.0 Hz), 6.05 
(d, 1H, J = 5.5 Hz), 4.97 (bs, 1H), 4.95 (d, 1H, J = 8.0 Hz), 3.37-3.33 (m, 1H), 3.16 (dd, 
1H, J = 10.8, 2.5 Hz); 13C NMR (75 MHz, CDCl3) δ 163.5, 150.7, 143.0, 141.2, 134.3, 
128.7, 127.9, 127.3, 126.3, 102.2, 89.6, 87.3, 85.9, 64.4; MS (ESI) m/z 459.19 (M+Li)+.   
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1H NMR (DMSO-d6) 
13C NMR (CDCl3) 
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2’, 3’-Dedihydro-5’-hydroxy Nucleoside (167) 
 
N
O
NH
O
OHO
 
 
A solution of olefin 166 (4.15 g, 9.17 mmol) in 90 % AcOH in H2O (AcOH:72 mL, 
H2O:8 mL) was heated at 50 ºC for 3.5 h under nitrogen.  The solvents were evaporated 
under the reduced pressure and the residual material was purified by flash 
chromatography eluting with 5 % to 15 % MeOH/CHCl3 to afford product as a colorless 
solid (1.31 g, 68 %).  Rf 0.2 (10 % MeOH/CHCl3).  1H NMR (500 MHz, DMSO-d6) δ 
11.37 (s, 1H), 7.79 (d, 1H, J = 8.0 Hz), 6.85 (s, 1H), 6.44 (d, 1H, J = 6.0 Hz), 5.96 (d, 
1H, J = 5.5 Hz), 5.63 (d, 1H, J = 8.0 Hz), 5.04 (t, 1H, J = 5.0 Hz), 4.82 (bs, 1H), 3.62 (t, 
2H, J = 4.5 Hz); 13C NMR (125 MHz, DMSO-d6) δ 164.3, 151.8, 142.1, 136.1, 126.8, 
102.6, 90.1, 88.4, 63.2; MS (APCI) m/z 211.0 (M+H)+, 421.0 (2M+H)+.  
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1H NMR (DMSO-d6) 
 
 
13C NMR (DMSO-d6)
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2’, 3’-Dideoxyuridine (168)159 
 
N
O
NH
O
OHO
 
 
A solution of olefin 167 (200 mg, 0.95 mmol) and 10 % Pd/C (101 mg, 0.95 mmol) 
in MeOH (8.0 mL) with hydrogen balloon was stirred at 25 ºC for 7 h.  The reaction 
mixture was filtered with silica-pad and washed with MeOH.  The solvents were 
evaporated under the reduced pressure and the residual material was purified by flash 
chromatography eluting with 5 to 10 % MeOH/CHCl3 to afford product as a colorless 
solid (132 mg, 65 %).  Rf 0.2 (10 % MeOH/CHCl3).  1H NMR (300 MHz, DMSO-d6) δ 
11.30 (bs, 1H), 7.98 (d, 1H, J = 8.0 Hz), 5.98 (q, 1H, J = 3.0 Hz), 5.62 (d, 1H, J = 8.0 
Hz), 5.07 (t, 1H, J = 5.4 Hz), 4.09-4.02 (m, 1H), 3.74-3.67 (m, 1H), 3.59-3.53 (m, 1H), 
2.37-2.25 (m, 1H), 2.04-1.82 (m, 3H); 13C NMR (75 MHz, DMSO-d6) δ 164.0, 151.1, 
141.3, 101.7, 85.8, 82.3, 62.7, 32.5, 25.5.  
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1H NMR (DMSO-d6) 
 
 
 
 
 
 
13C NMR (DMSO-d6)
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2’, 3’-Dideoxy-5-iodouridine (163)159 
 
N
O
NH
O
OHO
I
 
 
2’,3’-Dideoxyuridine 168 (103 mg, 0.49 mmol) was dissolved in MeOH (5.0 mL) 
and iodine monochloride (0.68 mL, 0.68 mmol, 1 M in CH2Cl2) was added to a solution 
dropwise.  The reaction mixture was heated at 50 ºC for 10 h.  After cooling to room 
temperature, sat. Na2S2O3 was added to a reaction mixture dropwise until orange color 
disappeared (12 drops).  The white precipitates were filtered off with celite and the 
solvents were evaporated under the reduced pressure.  The residual material was purified 
by flash chromatography eluting with 10 % MeOH/CHCl3 to afford product as a 
colorless solid (90 mg, 55 %).  Rf 0.2 (10 % MeOH/CHCl3).  1H NMR (500 MHz, 
DMSO-d6) δ 11.67 (s, 1H), 8.63 (s, 1H), 5.92 (dd, 1H, J = 6.5, 3.0 Hz), 5.28 (t, 1H, J = 
5.0 Hz), 4.10-4.07 (m, 1H), 3.81-3.77 (m, 1H), 3.58-3.54 (m, 1H), 2.33-2.26 (m, 1H), 
2.08-2.03 (m, 1H), 1.94-1.85 (m, 2H); 13C NMR (75 MHz, DMSO-d6) δ 161.6, 151.1, 
146.2, 86.8, 83.1, 69.1, 62.1, 33.5, 24.8. 
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1H NMR (DMSO-d6) 
 
 
 
13C NMR (DMSO-d6) 
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N-Acetyl cytidine (169)160 
 
N
O
N
NHAc
O
OH OH
HO
 
 
Cytidine (40 g, 0.16 mol) was suspended in MeOH (800 mL) and the solution was 
refluxed at 90 ºC for 1.5 h under nitrogen.  Ac2O (160 mL, 1.69 mol) was added to a 
solution with addition funnel over a period of 1 h.  The reaction mixture was refluxed for 
additional 3 h.  After cooling to room temperature, precipitates were filtered to afford 
product as a colorless solid (38.4 g, 82 %).  Rf 0.7 (20 % MeOH/CH2Cl2).  1H NMR (500 
MHz, DMSO-d6) δ 10.93 (s, 1H), 8.46 (d, 1H, J = 7.5 Hz), 7.22 (d, 1H, J = 7.5 Hz), 5.81 
(d, 1H, J = 3.0 Hz), 5.54 (d, 1H, J = 5.0 Hz), 5.21 (t, 1H, J = 5.0 Hz), 5.11 (d, 1H, J = 
6.0 Hz), 4.02-3.97 (m, 2H), 3.94-3.92 (m, 1H), 3.79-3.75 (m, 1H), 3.65-3.61 (m, 1H), 
2.13 (s, 3H); 13C NMR (125 MHz, DMSO-d6) δ 172.0, 163.3, 155.6, 146.4, 96.1, 91.1, 
85.1, 75.5, 69.6, 60.8, 25.3; MS (ESI) m/z 308.07 (M+Na)+. 
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1H NMR (DMSO-d6) 
 
 
 
13C NMR (DMSO-d6) 
 344 
5’-Silylated cytidine (170)161 
 
N
O
N
NHAc
O
OH OH
TBDMSO
 
 
To a solution of N-acetyl cytidine 169 (30 g, 0.105 mol) and imidazole (19.3 g, 0.284 
mol) in DMF (600 mL) was added TBDMSCl (20.6 g, 0.137 mol) slowly.  The reaction 
mixture was stirred at 25 ºC for 26 h.  The solvents were evaporated under reduced 
pressure and the residual material was purified by flash chromatography eluting with 
100 % EtOAc and 5 to 10 % MeOH/CHCl3 to afford product as a colorless solid (36.4 g, 
87 %).  Rf 0.1 (100 % EtOAc).  1H NMR (500 MHz, DMSO-d6) δ 10.95 (s, 1H), 8.37 (d, 
1H, J = 7.5 Hz), 7.23 (d, 1H, J = 8.0 Hz), 5.80 (d, 1H, J = 2.0 Hz), 5.65 (d, 1H, J = 5.0 
Hz), 5.13 (d, 1H, J = 5.0 Hz), 4.00 (d, 1H, J = 10.0 Hz), 3.99-3.98 (m, 3H), 3.81 (d 1H, J 
= 10.0 Hz), 2.13 (s, 3H), 0.93 (s, 9H), 0.133 (s, 3H), 0.126 (s, 3H); 13C NMR (125 MHz, 
DMSO-d6) δ 172.1, 163.3, 155.5, 145.5, 96.0, 91.2, 84.3, 75.6, 69.1, 62.5, 26.8, 25.4, 
19.1, -4.56, -4.62; MS (ESI) m/z 400.19 (M+H)+.   
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1H NMR (DMSO-d6) 
 
 
13C NMR (DMSO-d6) 
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2’, 3’-Dimesyl Nucleoside (171) 
 
N
O
N
NHAc
O
OMs OMs
TBDMSO
 
 
5’-Silylated cytidine 170 (10 g, 25.0 mmol), Et3N (14.0 mL, 100.1 mmol) and 
Me3N•HCl (1.2 g, 12.5 mmol) were added in toluene (100 mL) at 0 ºC.  A solution of 
MsCl (7.8 mL, 100.1 mmol) in toluene (60 mL) was then added by syringe over a period 
of 10 min.  The reaction mixture was stirred at 0 ºC for 3 h.  The reaction was quenched 
with water (60 mL) at 0 ºC and the aqueous layer was extracted with EtOAc (3 x 60 
mL).  The organic layer was dried over MgSO4 and solvent was concentrated under the 
reduced pressure.  The residue was purified by flash chromatography eluting with 50 % 
EtOAc/hexanes and 100 % EtOAc to afford product as a yellow solid (12.3 g, 88 %).  Rf 
0.5 (100 % EtOAc).  1H NMR (500 MHz, DMSO-d6) δ 9.04 (d, 1H, J = 7.5 Hz), 8.16 (d, 
1H, J = 7.5 Hz), 7.01 (d, 1H, J = 6.0 Hz), 6.00 (d, 1H, J = 6.0 Hz), 5.66 (s, 1H), 4.75 (s, 
1H), 3.67-3,64 (m, 1H), 3.50 (s, 3H), 3.43-3.40 (m, 1H), 2.36 (s, 3H), 2.29 (s, 3H), 0.87 
(s, 9H), -0.01 (s, 6H); 13C NMR (125 MHz, DMSO-d6) δ 172.6, 166.1, 161.1, 147.9, 
105.6, 93.5, 89.9, 89.4, 83.4, 61.5, 40.7, 38.7, 26.7, 25.8, 18.8, -2.2; MS (ESI) m/z 
556.11 (M+H)+.  
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1H NMR (DMSO-d6) 
 
 
 
13C NMR (DMSO-d6)
 348 
2’, 3’-Dedihydro Nucleoside (172) 
 
N
O
N
NHAc
OTBDMSO
 
 
Tellurium (1.8 g, 14.1 mmol) and Et3BHLi (30.2 mL, 30.2 mmol, 1 M in THF) were 
stirred at 40 ºC for 30 min under nitrogen.  To this solution, dimesylate 171 (3.73 g, 6.7 
mmol) dissolved in THF (70 mL) was added by syringe.  The reaction mixture was 
stirred at 25 ºC for 18 h.  The solvent was evaporated under reduced pressure at 25 ºC 
and the residual material was purified by flash chromatography eluting with 100 % 
EtOAc and 5 to 10 % MeOH/CHCl3 to afford product as a colorless solid (1.95 g, 80 %).  
Rf 0.2 (100 % EtOAc).  1H NMR (500 MHz, DMSO-d6) δ 8.16 (d, 1H, J = 7.5 Hz), 7.21 
(d, 1H, J = 7.5 Hz), 6.91 (bs, 1H), 6.42 (d, 1H, J = 6.0 Hz), 6.05 (d, 1H, J = 6.0 Hz), 
4.94 (bs, 1H), 3.90-3.82 (m, 2H), 2.13 (s, 3H), 0.88 (s, 9H), 0.07 (s, 3H), 0.06 (s, 3H); 
13C NMR (125 MHz, DMSO-d6) δ 172.1, 163.5, 155.8, 146.4, 135.0, 127.7, 96.5, 91.6, 
88.4, 65.1, 26.8, 25.4, 19.1, -4.47, -4.52; MS (ESI) m/z 366.16 (M+H)+.  
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1H NMR (DMSO-d6) 
 
13C NMR (DMSO-d6)
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2’, 3’-Dedihydro-5’-hydroxy Nucleoside (173) 
 
N
O
N
NHAc
OHO
 
 
To a solution of olefin 172 (3.9 g, 10.7 mmol) in THF (100 mL) was added TBAF 
(12.8 mL, 12.8 mmol, 1 M in THF) at 0 ºC.  The reaction mixture was stirred at 25 ºC 
for 1 h.  The solvent was evaporated under reduced pressure at 25 ºC.  The residual 
material was purified by flash chromatography eluting with 100 % CHCl3 then 5 % 
MeOH/CHCl3 to afford product as a colorless solid (2.54 g, 94 %).  Rf 0.3 (10 % 
MeOH/CHCl3).  1H NMR (300 MHz, DMSO-d6) δ 10.93 (s, 1H), 8.25 (d, 1H, J = 7.5 
Hz), 7.20 (d, 1H, J = 7.5 Hz), 6.92-6.91 (m, 1H), 6.45-6.42 (m, 1H), 6.04-6.01 (m, 1H), 
5.09 (t, 1H, J = 5.5 Hz), 4.91-4.88 (m, 1H), 3.66-3.63 (m, 2H), 2.13 (s, 3H); 13C NMR 
(75 MHz, DMSO-d6) δ 172.0, 163.5, 155.9, 146.9, 135.6, 127.2, 96.4, 91.7, 88.9, 63.2, 
25.4; MS (ESI) m/z 252.08 (M+H)+. 
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13C NMR (DMSO-d6) 
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2’, 3’-Dideoxy-5’-hydroxy Nucleoside (174) 
 
N
O
N
NHAc
OHO
 
 
A solution of olefin 173 (500 mg, 1.99 mmol) and Pd/CaCO3 (420 mg, 10 mol %) in 
EtOH (50 mL) with hydrogen balloon was stirred at 25 ºC for 5 h (2 batches).  The two 
reaction batches were combined and filtered with celite and washed with EtOH.  The 
solvent was evaporated under the reduced pressure and the residual material was purified 
by flash chromatography eluting with 10 to 15 % MeOH/CHCl3 to afford product as a 
colorless solid (678 mg, 67 %).  Rf 0.3 (10 % MeOH/CHCl3).  1H NMR (500 MHz, 
CD3OD) δ 8.66 (d, 1H, J = 7.5 Hz), 7.45 (d, 1H, J = 7.5 Hz), 6.06 (dd, 1H, J = 5.0, 2.0 
Hz), 4.27-4.23 (m, 1H), 3.99-3.96 (m, 1H), 3.77-3.74 (m, 1H), 2.58-2.50 (m, 1H), 2.20 
(s, 3H), 2.16-2.11 (m, 1H), 2.00-1.88 (m, 2H); 13C NMR (125 MHz, CD3OD) δ 173.0, 
164.2, 158.0, 146.5, 97.3, 89.5, 84.6, 63.1, 34.5, 25.0, 24.5; MS (ESI) m/z 253.82 
(M+H)+.  
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2’, 3’-Dideoxycytidine (175)157 
 
N
O
N
NH2
OHO
 
 
A solution of N-acetyl dideoxycytidine (678 mg, 2.68 mmol) in 30 mL of NH3 (7 N 
in MeOH) in pressure vessel was stirred at 53 ºC for 13 h.  After cooling to room 
temperature, the solvent was evaporated under the reduced pressure.  The residual 
material was recrystallized from MeOH/CH2Cl2/hexanes to afford product as a colorless 
solid (451 mg, 80 %).  Rf 0.5 (20 % MeOH/CH2Cl2).  1H NMR (300 MHz, DMSO-d6) δ 
7.94 (d, 1H, J = 7.5 Hz), 7.12 (br, 2H), 5.98-5.95 (m, 1H), 5.72 (d, 1H, J = 7.5 Hz), 5.05 
(t, 1H, J = 5.0 Hz), 4.07-4.00 (m, 1H), 3.74-3.67 (m, 1H), 3.60-3.53 (m, 1H), 2.35-2.21 
(m, 1H), 1.93-1.75 (m, 3H); 13C NMR (75 MHz, DMSO-d6) δ 166.6, 156.2, 142.0, 94.2, 
86.7, 82.5, 63.1, 33.4, 25.7.  
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1H NMR (DMSO-d6) 
 
 
 
 
 
 
 
13C NMR (DMSO-d6) 
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2’, 3’-Dideoxy-5-iodocytidine (162)171 
 
N
O
N
NH2
OHO
I
 
 
2’,3’-Dideoxycytidine 175 (200 mg, 0.95 mmol) and pyridine (0.15 mL, 1.89 mmol) 
were dissolved in MeOH (16.0 mL) and iodine monochloride (1.33 mL, 1.33 mmol, 1 M 
in CH2Cl2) was added to a solution dropwise at 0 ºC.  The reaction mixture was stirred at 
0 ºC for 30 min, 25 ºC for 30 min and 50 ºC for 2 h under nitrogen.  After cooling to 
room temperature, the solvent was evaporated under the reduced pressure.  The residual 
material was purified by flash chromatography eluting with 10 to 15 % MeOH/CH2Cl2 
to afford product (>90 % purity).  This impure material was recrystallized from MeOH/ 
CH2Cl2/hexanes to afford pure product as a colorless solid (225 mg, 71 %).  Rf 0.7 (20 % 
MeOH/CH2Cl2).  1H NMR (300 MHz, DMSO-d6) δ 8.54 (s, 1H), 7.76 (br, 1H), 6.57 (br, 
1H), 5.89 (q, 1H, J = 6.3, 2.4 Hz), 5.23 (t, 1H, J = 5.0 Hz), 4.10-4.05 (m, 1H), 3.82-3.76 
(m, 1H), 3.60-3.53 (m, 1H), 2.36-2.23 (m, 1H), 1.97-1.80 (m, 3H); 13C NMR (75 MHz, 
DMSO-d6) δ 164.7, 154.9, 148.3, 87.1, 83.1, 62.1, 56.5, 34.0, 24.7. 
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2’,3’-Dideoxy-5-iodouridine triphosphate (177)166 
 
O
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2’,3’-Dideoxy-5-iodouridine 163 (50 mg, 0.148 mmol) was taken in round bottom 
flask and dissolved in dry pyridine (2 mL) then concentrated in vacuo three times then 
dissolved in 1 mL 1:4 pyridine/DMF.  2-Chloro-4H-1,3,2-benzodioxa-phosphorin-4-one 
(36 mg, 0.178 mol) was added as a solution in DMF (300 µL), and the reaction was 
stirred at 25 ºC under nitrogen for 10 min.  Tributylammonium pyrophosphate (108 mg, 
0.237 mmol) dissolved in DMF (500 µL) and distilled tributylamine (115 mg, 0.622 
mmol) were simultaneously added into the reaction mixture.  The reaction was stirred at 
25 ºC for 10 min.  Iodine (60 mg, 0.237 mmol) was added as a solution in 3 mL 95:5 
pyridine/H2O.  The reaction was stirred at 25 ºC for additional 20 min.  Sodium 
thiosulfate was added dropwise as a saturated aqueous solution (ca. 15 drops) until the 
iodine color disappeared.  The reaction mixture was concentrated in vacuo then 
partitioned between CH2Cl2 (10 mL) and water (10 mL).  The layers were separated and 
the organic extracts were discarded.  The crude reaction mixture was dissolved in 10 mL 
water then applied to a DEAE Sephadex column (1 x 30 cm) and eluted with 0 to 1 M 
lithium chloride.  The absorbance of the elute was monitored at 310 nm.  The desired 
product eluted approximately 0.5 M LiCl.  Fractions containing product were 
concentrated in vacuo at 25 ºC and the product was precipitated from acetone to afford 
2’,3’-dideoxy-5-iodouridine triphosphate 177 as an off-white solid (tetralithium salt, 49 
mg, 55 %).  1H NMR (300 MHz, D2O) δ 8.22 (s, 1H), 6.08 (dd, 1H, J = 6.5, 3.0 Hz),  
4.45-4.38 (m, 1H), 4.34-4.24 (m, 1H), 4.19-4.10 (m, 1H), 2.51-2.40 (m, 1H), 2.21-2.11 
(m, 2H), 2.04-1.93 (m, 1H); 31P NMR (121 MHz, D2O) δ –6.5 (d, 1P, J = 24.3 Hz), –
11.8 (d, 1P, J = 18.3 Hz), –21.5 (t, 1P, J = 18.3 Hz). 
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Nucleoside Triphosphate (183) 
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A solution of 6-propargylated carboxyfluorescein 182 (14 mg, 33.2 µmol), 2’,3’-
dideoxy-5-iodouridine triphosphate tetralithium salt 177 (10 mg, 16.6 µmol), water-
soluble palladium catalyst (4 mg, 1.7 µmol), CuI (0.3 mg, 1.7 µmol), and Et3N (84 mg, 
830 µmol) in degassed 0.3 M phosphate buffer (800 µL, pH 7.2) was stirred at 25 ºC for 
24 h under nitrogen.  The product was purified by preparative HPLC then concentrated 
in vacuo to afford the title compound 183 as a fluffy yellow-orange solid 
(tetra(triethylammonium) salt, 32 mg, quantitative, >95 % purity).  1H NMR (300 MHz, 
D2O) δ 8.96 (s, 1H), 8.13 (d, 2H, J = 6.1 Hz), 8.05 (s, 1H), 7.78 (s, 1H), 7.29 (d, 2H, J = 
9.0 Hz), 6.92-6.80 (m, 3H), 6.20-6.16 (m, 1H), 4.72 (s, 2H), 4.58-4.50 (m, 1H), 4.49-
4.41 (m, 1H), 4.35-4.28 (m, 1H), 3.24 (q, 24H, J = 7.3 Hz), 2.70-2.57 (m, 1H), 2.24-2.09 
(m, 2H), 1.98-1.91 (m, 1H), 1.32 (t, 36H, J = 7.3 Hz); 31P NMR (121 MHz, 0.1 M 
EDTA in D2O) δ –9.5 (d, 1P, J = 19.4 Hz), –10.1 (d, 1P, J = 18.6 Hz), –21.8 (t, 1P, J = 
18.6 Hz); MS (ESI) m/z 431.10 (M–2H)–2.  
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Propargylated hexaethylene glycol mono-azide (184)172 
 
N3
O
O
5  
 
To a solution of hexaethylene glycol mono-azide 25 (8.55 g, 0.028 mol) in THF (210 
mL) was slowly added NaH (1.56 g, 0.039 mol, 60 % in mineral oil) at 0 ºC.  After the 
stirring for 40 min, propargyl bromide (6.2 g, 0.042 mol, 80 % w/w in toluene) was 
added dropwise at 0ºC.  The reaction mixture was stirred at 25 ºC for 18 h.  MeOH (40 
mL) was added dropwise to a reaction mixture at 0ºC and H2O (150 mL) was added.  
The aqueous layer was extracted with CH2Cl2 (7 x 150 mL) and the combined organic 
layer was dried over Na2SO4.  The solvents were concentrated under the reduced 
pressure and the residual material was purified by flash chromatography eluting with 
100 % CH2Cl2 and then 30 to 50 % acetone/EtOAc to afford product 184 as a yellow oil 
(9.6 g, 99 %).  Rf 0.5 (20 % acetone/EtOAc, with iodine stain).  1H NMR (300 MHz, 
CDCl3) δ 4.20-4.19 (m, 2H), 3.68-3.64 (m, 22H), 3.38 (t, 2H, J = 4.8 Hz), 2.43 (t, 1H, J 
= 1.8 Hz).  
 
1H NMR (CDCl3) 
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Silylated, hexaethylene glycol mono-azide (185) 
 
N3
O
O
5
TBDMS
 
 
To a solution of propargylated ethylene glycol 184 (5.0 g, 14.5 mmol) in THF (175 
mL) was added nBuLi (11.8 mL, 18.9 mmol, 1 M in hexane) dropwise at –78 ºC.  After 
the stirring for 30 min, a solution of TBDMSCl (3.5 g, 23.2 mmol) in THF (50 mL) was 
added to a reaction dropwise (note: concentration is important for this reaction).  The 
reaction mixture was stirred at 25 ºC for 5 h.  MeOH (5 mL) was added dropwise to a 
reaction mixture at 0ºC and H2O (100 mL) was added.  The aqueous layer was extracted 
with CH2Cl2 (7 x 100 mL) and the combined organic layer was dried over Na2SO4. The 
solvents were concentrated under the reduced pressure and the residual material was 
purified by flash chromatography eluting with 100 % CH2Cl2 and then 60 to 80 % 
EtOAc/hexanes to afford product as a colorless oil (5.8 g, 87 %).  Rf 0.3 (50 % 
EtOAc/hexanes, with iodine stain).  1H NMR (300 MHz, CDCl3) δ 4.17 (s, 2H), 3.65-
3.62 (m, 22H), 3.35 (t, 2H, J = 5.0 Hz), 0.90 (s, 9H), 0.07 (s, 6H);  13C NMR (75 MHz, 
CDCl3) δ 102.1, 89.5, 70.64 (2C), 70.61 (3C), 70.57 (3C), 70.52 (3C), 70.3, 70.0, 68.8, 
59.1, 50.6, 26.0,16.4, -4.7; MS (ESI) m/z 466.27 (M+Li)+.  
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Silylated, aminohexaethylene glycol (186) 
 
H2N
O
O
5
TBDMS
 
 
Triphenylphosphine (5.08 g, 19.4 mmol) was added to a solution of azido-ethylene 
glycol 185 (4.05 g, 8.8 mmol) in 9:1 THF/H2O (81 mL: 9 mL) at 25 ºC.  The reaction 
mixture was stirred at 25 ºC for 48 h.  The solvent was concentrated under the reduced 
pressure and the residual material was purified by short flash chromatography eluting 
with 100 % EtOAc and 100 % MeOH to afford product as a yellow oil (3.5 g, 92 %).  Rf 
0.1 (100 % MeOH with iodine stain).  1H NMR (300 MHz, CDCl3) δ 4.21 (s, 2H), 3.68-
3.61 (m, 20H), 3.53 (t, 2H, J = 4.7 Hz), 2.88 (t, 2H, J = 4.7 Hz), 0.93 (s, 9H), 0.11 (s, 
6H);  13C NMR (75 MHz, CDCl3) δ 101.6, 70.11 (4C), 70.06 (3C), 69.92 (3C), 69.8, 
68.4, 58.7, 41.2, 25.5, 15.9, -5.2; MS (ESI) m/z 434.31 (M+H)+.  
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3-Bromo-5-iodobenzoic acid chloride (187) 
 
Br
I
Cl
O  
 
A solution of 3-bromo-5-iodobenzoic acid (5.0 g, 0.015 mol), thionylchloride (47 
mL) and DMF (5 drops) was refluxed at 90 ºC for 12 h.  The excess of thionylchloride 
was distilled off with benzene.  After the distillation, the residual material (5.5 g) was 
dissolved in EtOAc and hexanes.  The white precipitate was filtered off and the solvent 
was evaporated under the reduced pressure and the residue was dried under the vacuum 
to afford pure product as brown solid (4.97 g, 94 %).  Rf 0.9 (100 % EtOAc).  1H NMR 
(500 MHz, CDCl3) δ 8.34 (t, 1H, J = 1.5 Hz), 8.19 (t, 1H, J = 1.5 Hz), 8.15 (t, 1H, J = 
1.5 Hz);  13C NMR (125 MHz, CDCl3) δ 165.8, 145.9, 138.3, 136.0, 133.2, 123.5, 94.4;  
MS (GCMS) m/z 345 (M+H)+.  
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Silylated, hexaethylene glycol linker (188) 
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To a solution of acid chloride 187 (2.54 g, 7.36 mmol) in CH2Cl2 (60 mL) was added 
a solution of silylated-aminohexaethylene glycol 186 (3.51 g, 8.09 mmol) in CH2Cl2 (20 
mL) and DMAP (988 mg, 8.09 mmol) at 0 ºC.  The reaction mixture was stirred at 25 ºC 
for 24 h.  The solvent was evaporated under the reduced pressure and the residue was 
purified by flash chromatography eluting with 100 % CH2Cl2 and 100 % EtOAc to 
afford product as a yellow oil (5.1 g, 93 %).  Rf 0.5 (100 % EtOAc with iodine stain).  1H 
NMR (500 MHz, CDCl3) δ 8.10 (t, 1H, J = 1.5 Hz), 7.95-7.93 (m, 2H), 7.30 (br, 1H), 
4.18 (s, 2H), 3.66-3.59 (m, 24H), 0.91 (s, 9H), 0.09 (s, 6H);  13C NMR (125 MHz, 
CDCl3) δ 164.6, 142.0, 137.9, 135.0, 129.8, 123.0, 101.9, 94.2, 89.7, 70.49, 70.47, 70.45 
(2C), 70.43 (4C), 70.3, 70.1, 69.6, 68.8, 59.1, 40.1, 26.0, -4.7;  MS (ESI) m/z 748.14 
(M+Li)+.  
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Fluorescein derivative (192) 
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O
O
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5-Ethynyl fluorescein diacetate 191 (1.60 g, 3.64 mmol), Pd(PPh3)4 (191 mg, 0.17 
mmol), CuI (32 mg, 0.17 mmol) were taken in 200 mL round bottom flask and vacuum-
pump-thawed (x 3 times).  To this flask, a solution of ethylene glycol linker 188 (2.46 g, 
3.31 mmol) in THF (40 mL) and Et3N (4.6 mL, 33.13 mmol) was added.  The reaction 
mixture was stirred at 25 ºC for 24 h.  The solvent was evaporated under the reduced 
pressure and the residue was purified by flash chromatography eluting with 100 % 
CH2Cl2 and 80 % EtOAc/hexanes, and then 100 % EtOAc to afford product as a semi-
yellow solid (2.8 g, 80 %).  Rf 0.5 (100 % EtOAc).  1H NMR (500 MHz, CDCl3) δ 8.13 
(m, 1H), 7.99 (t, 1H, J = 1.5 Hz), 7.96 (t, 1H, J = 1.5 Hz), 7.80 (d, 1H, J = 1.5 Hz), 7.79-
7.78 (m, 1H), 7.24 (t, 1H, J = 5.5 Hz), 7.18 (d, 1H, J = 8.0 Hz), 7.09-7.08 (m, 2H), 6.85-
6.81 (m, 4H), 4.17 (s, 2H), 3.68-3.58 (m, 24H), 2.30 (s, 6H), 0.90 (s, 9H), 0.08 (s, 6H);  
13C NMR (125 MHz, CDCl3) δ 168.7, 168.0, 165.1, 152.4, 152.1, 151.4, 138.2, 136.7, 
136.6, 130.7, 129.2, 128.8, 128.1, 126.5, 124.8, 124.4, 124.3, 122.3, 117.8, 115.8, 110.4, 
101.9, 89.6, 89.4, 89.1, 81.7, 70.44, 70.43 (2C), 70.39 (4C), 70.3, 70.1, 69.5, 68.7, 59.0, 
40.0, 25.9, 21.0, 16.4, -4.8; MS (MALDI) m/z 1054.37 (M+H)+.  
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Cyclized anisidine (193) 
 
N
H
OMe
 
 
A solution of m-anisidine (3.0 g, 24.4 mmol) and iodine (216 mg, 0.85 mmol) in 
acetone (40 mL) was refluxed at 66 ºC for 1 h and stirred at 25 ºC for 12 h.  The solvent 
was evaporated and the residual material was purified by flash chromatography eluting 
with 100 % hexanes and 4 % EtOAc/hexanes to afford product as an off-white solid (2.6 
g, 53 %).  Rf 0.6 (10 % EtOAc/hexanes).  1H NMR (500 MHz, CDCl3) δ 6.99 (d, 1H, J = 
8.0 Hz), 6.21 (dd, 1H, J = 8.0, 2.5 Hz), 6.03 (d, 1H, J = 2.5 Hz), 5.20 (s, 1H), 3.76 (s, 
3H),  1.97 (s, 3H), 1.27 (s, 6H); 13C NMR (125 MHz, CDCl3) δ 160.1, 144.6, 128.1, 
125.9, 124.6, 115.3, 102.2, 98.5, 55.0, 51.9, 31.0, 18.6; MS (ESI) m/z 204.14 (M+H)+.    
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N-Alkylated, cyclized anisidine (194) 
 
N OMe
MeO2C  
 
A solution of cyclized anisidine 193 (1.0 g, 4.92 mmol), Cs2CO3 (8.0 g, 24.6 mmol), 
methyl bromoacetate (5.3 g, 34.4 mmol), and tetra-n-butylammonium iodide (2.0 g, 5.41 
mmol) in CH3CN (15.0 mL) was refluxed at 93 ºC for 30 h.  After cooling to room 
temperature, the reaction mixture was filtered and washed with acetone and then the 
solvent was evaporated.  The residual material was purified by flash chromatography 
eluting with 100 % hexanes and 5 % EtOAc/hexanes to afford product as a yellow oil 
(1.32 g, 98 %).  Rf 0.4 (10 % EtOAc/hexanes).  1H NMR (500 MHz, CDCl3) δ 6.98 (d, 
1H, J = 8.5 Hz), 6.19 (dd, 1H, J = 8.5, 2.5 Hz), 5.85 (d, 1H, J = 2.5 Hz), 5.14 (s, 1H), 
4.00 (s, 2H), 3.75 (s, 3H), 3.74 (s, 3H), 1.96 (s, 3H), 1.32 (s, 6H); 13C NMR (125 MHz, 
CDCl3) δ 171.8, 160.4, 144.7, 127.2, 126.5, 124.5, 116.2, 100.1, 97.3, 57.0, 55.0, 52.2, 
46.5, 28.9, 18.8; MS (ESI) m/z 276.15 (M+H)+.    
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 377 
3-(tert-Butyldimethylsilyloxy)aniline (195) 
 
H2N OTBDMS  
 
To a solution of 3-aminophenol (10 g, 0.092 mol) and TBDMSCl (15.2 g, 0.10 mol) 
in CH2Cl2 (150 mL) was added Et3N (14.0 mL, 0.10 mol) and DMAP (1.1 g, 0.009 mol) 
at 0 ºC.  The reaction was warmed to room temperature and stirred at 25 ºC for 16 h.  
Water (150 mL) was added to a reaction mixture and the aqueous layer was extracted 
with CH2Cl2 (3 x 150 mL).  The combined organic layer was dried over Na2SO4 and 
concentrated under the reduced pressure.  The residual material was purified by flash 
chromatography eluting with 10 to 30 % EtOAc/hexanes to afford product as a colorless 
oil (20.1 g, 98 %, 95 % purity).  Rf 0.7 (20 % EtOAc/hexanes).  1H NMR (500 MHz, 
CDCl3) δ 7.00 (t, 1H, J = 8.0 Hz), 6.33-6.30 (m, 1H), 6.28-6.26 (m, 1H), 6.22-6.21 (m, 
1H), 0.98 (s, 9H), 0.19 (s, 6H); 13C NMR (125 MHz, CDCl3) δ 156.6, 147.3, 129.9, 
110.6, 108.6, 107.2, 25.6, 18.1, -4.4; MS (ESI) m/z 224.14 (M+H)+.  
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Silylated, dihydroquinoline (196) 
 
N
H
OTBDMS
 
 
A solution of TBDMS-protected 3-aminophenol 195 (17.3 g, 77.4 mmol) and iodine 
(688 mg, 27.1 mmol) in acetone (300 mL) was stirred at 25 ºC for 27 h.  The solvent was 
evaporated under the reduced pressure at 35 ºC and the residual material was purified by 
flash chromatography eluting with 100 % hexanes and 3 to 4 % EtOAc/hexanes to afford 
product as a brown oil (13.7 g, 58 %).  Rf 0.9 (10 % EtOAc/hexanes).  1H NMR (500 
MHz, CDCl3) δ 6.91 (d, 1H, J = 8.0 Hz), 6.14 (dd, 1H, J = 8.0, 2.5 Hz), 5.98 (d, 1H, J = 
2.5 Hz), 5.19 (s, 1H), 1.96 (s, 3H), 1.26 (s, 6H), 0.98 (s, 9H), 0.19 (s, 6H); 13C NMR 
(125 MHz, CDCl3) δ 156.3, 144.8, 128.6, 126.3, 124.7, 116.1, 109.1, 104.9, 52.1, 31.1, 
26.0, 18.8, 18.4, -4.1; MS (ESI) m/z 304.21 (M+H)+.   
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N-Alkylate dihydroquinoline (197) 
 
N OTBDMS
MeO2C  
 
A solution of TBDMS-protected dihydroquinoline 196 (3.0 g, 9.88 mmol), Cs2CO3 
(16.1 g, 49.4 mmol), methyl bromoacetate (10.6 g, 69.2 mmol), and tetra-n-
butylammonium iodide (4.7 g, 12.8 mmol) in CH3CN (50.0 mL) was refluxed at 93 ºC 
for 13 h.  After cooling to room temperature, the reaction mixture was filtered and 
washed with acetone and then the solvent was evaporated.  The residual material was 
purified by flash chromatography eluting with 100 % hexanes and 2 % EtOAc/hexanes 
to afford product as a yellow oil (3.3 g, 89 %).  Rf 0.4 (10 % EtOAc/hexanes).  1H NMR 
(500 MHz, CDCl3) δ 6.91 (d, 1H, J = 8.0 Hz), 6.13 (dd, 1H, J = 8.0, 2.0 Hz), 5.76 (d, 
1H, J = 2.0 Hz), 5.12 (s, 1H), 3.96 (s, 2H), 3.73 (s, 3H), 1.94 (s, 3H), 1.31 (s, 6H), 0.96 
(s, 9H), 0.16 (s, 6H); 13C NMR (125 MHz, CDCl3) δ 171.9, 156.4, 144.6, 127.4, 126.4, 
124.5, 116.4, 107.8, 102.4, 57.0, 52.1, 46.6, 28.9, 25.7, 18.8, 18.2, -4.5; MS (ESI) m/z 
376.22 (M+H)+.   
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N-Alkylated dihydroquinoline (198) 
 
N OH
MeO2C  
 
A solution of TBDMS-protected dihydroquinoline 197 (716 mg, 1.91 mmol) and 
Cs2CO3 (621 mg, 1.91 mmol) in 10:1 DMF/H2O (2.0 mL/0.2 mL) was stirred at 25 ºC 
for 12 h.  The reaction mixture was diluted with Et2O (15 mL) and the organic layer was 
washed with brine (1 x 5 mL).  This aqueous layer was back-extracted with Et2O (1 x 5 
mL) and EtOAc (3 x EtOAc).  The combined organic layer was dried over Na2SO4 and 
concentrated under the reduced pressure.  The residual material was purified by flash 
chromatography eluting with 100 % hexanes and 10 to 20 % EtOAc/hexanes to afford 
product as a yellow oil (493 mg, 99 %).  Rf 0.5 (40 % EtOAc/hexanes).  1H NMR (500 
MHz, CDCl3) δ 6.91 (d, 1H, J = 8.0 Hz), 6.11 (dd, 1H, J = 8.0, 2.0 Hz), 5.78 (d, 1H, J = 
2.0 Hz), 5.36 (bs, 1H), 5.12 (s, 1H), 3.99 (s, 2H), 3.74 (s, 3H), 1.94 (s, 3H), 1.31 (s, 6H); 
13C NMR (125 MHz, CDCl3) δ 172.3, 156.5, 145.0, 127.3, 126.1, 124.9, 115.9, 102.9, 
97.5, 57.0, 52.3, 46.6, 28.9, 18.8; MS (APCI) m/z 262.14 (M+H)+.    
 384 
 
1H NMR (CDCl3) 
 
13C NMR (CDCl3) 
 
 385 
p-Methoxybenzyl hexaethylene glycol (200)58 
 
HO
O
OPMB
5  
 
To a solution of hexaethylene glycol (4.3 g, 15.2 mmol), Ag2O (5.29 g, 22.8 mmol) 
and potassium iodide (1.52 g, 9.14 mmol) in toluene (40 mL) was added p-
methoxybenzyl chloride (2.62 g, 16.8 mmol) dropwise at 25 ºC.  The reaction mixture 
was refluxed at 120 ºC for 22 h.  After cooling to room temperature, the reaction was 
filtered through celite and washed with EtOAc.  The solvent was evaporated and the 
residual material was purified by flash chromatography eluting with 50 % 
EtOAc/hexanes, 100 % EtOAc and 50 % acetone/EtOAc to afford product as a yellow 
oil (3.68 g, 60 %).  Rf 0.1 (100 % EtOAc with iodine stain).  1H NMR (500 MHz, 
CDCl3) δ 7.25 (d, 2H, J = 8.5 Hz), 6.85 (d, 2H, J = 8.5 Hz), 4.48 (s, 2H), 3.79 (s, 3H), 
3.79-3.69 (m, 2H), 3.67-3.64 (m, 18H), 3.60-3.57 (m, 4H); 13C NMR (125 MHz, CDCl3) 
δ 159.1, 130.2, 129.3, 113.7, 72.8, 72.5, 70.6, 70.53, 70.51 (3C), 70.49 (2C), 70.46, 70.3, 
69.0, 61.7, 55.2; MS (ESI) m/z 409.24 (M+Li)+.  
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Propargylated hexaethylene glycol (201) 
 
O
O
OPMB
5  
 
Sodium hydride (278 mg, 6.96 mmol, 60 % in mineral oil) was slowly added to a 
solution of mono-PMB-protected hexaethylene glycol 200 (2.0 g, 4.97 mmol) in THF 
(15 mL) at 0 ºC.  The reaction was stirred at 0 ºC for 30 min, then propargyl bromide 
(1.1 g, 7.45 mmol, 80 % w/w in toluene) was added dropwise.  After the stirring at 0 ºC 
for 30 min, the reaction mixture was warmed to room temperature and stirred at 25 ºC 
for additional 6 h.  MeOH (1 mL) was added carefully at 0 ºC and water (5 mL) was 
added.  The aqueous layer was extracted with CH2Cl2 (5 x 20 mL) and the combined 
organic layer was dried over MgSO4 and concentrated under the reduced pressure.  The 
residue was purified by flash chromatography eluting with 50 % EtOAc/hexanes and 
100 % EtOAc to afford product as a yellow oil (1.81 g, 83 %).  Rf 0.5 (100 % EtOAc 
with iodine stain).  1H NMR (500 MHz, CDCl3) δ 7.26 (d, 2H, J = 8.5 Hz), 6.87 (d, 2H, 
J = 8.5 Hz), 4.49 (s, 2H), 4.20 (d, 2H, J = 2.5 Hz), 3.80 (s, 3H), 3.70-3.64 (m, 22H), 
3.60-3.58 (m, 2H), 2.43 (t, 1H, J = 2.5 Hz); 13C NMR (125 MHz, CDCl3) δ 159.1, 130.3, 
129.4, 113.7, 79.6, 74.5, 72.8, 70.6, 70.57 (2C), 70.54 (6C), 70.4, 69.1, 69.0, 58.4, 55.2; 
MS (ESI) m/z 447.26 (M+Li)+.   
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Triazole-decorated oligoethylene glycol (202) 
 
HO
O
N
N N
O
O
5
5
OPMB
 
 
Copper powder (244 mg, 3.84 mmol), CuSO4 (0.77 mL, 0.77 mmol, 1M in H2O) and 
H2O (12 mL) were added to a solution of hexaethylene glycol mono-azide 25 (1.18 g, 
3.84 mmol) and propargylated hexaethylene glycol 201 (2.2 g, 4.99 mmol) in THF (12 
mL).  The reaction mixture was stirred at 25 ºC for 24 h under nitrogen.  The solvents 
were evaporated under the reduced pressure and the residual material was purified by 
flash chromatography eluting with 50 % acetone/EtOAc, 100 % acetone and 5 to 10 % 
MeOH/CH2Cl2 to afford product as a yellow oil (2.7 g, 94 %).  Rf 0.2 (50 % 
acetone/EtOAc with iodine stain).  1H NMR (300 MHz, CDCl3) δ 7.75 (s, 1H), 7.26 (d, 
2H, J = 9.0 Hz), 6.86 (d, 2H, J = 9.0 Hz), 4.67 (s, 2H), 4.53 (t, 2H, J = 5.1 Hz), 4.48 (s, 
2H), 3.86 (t, 2H, J = 5.1 Hz), 3.79 (s, 3H), 3.73-3.57 (m, 44H); 13C NMR (125 MHz, 
CDCl3) δ 158.9, 144.6, 130.1, 129.2, 123.7, 113.5, 72.6, 72.4, 70.4, 70.32 (8C), 70.26 
(8C), 70.0, 69.4, 69.2, 68.8, 64.3, 61.4, 55.1, 50.0; MS (ESI) m/z 748.44 (M+H)+.   
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Triazole-decorated oligoethylene glycol (203) 
 
TsO
O
N
N N
O
O
5
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Triazole-decorated oligoethylene glycol 202 (1.5 g, 2.01 mmol), Et3N (0.56 mL, 4.01 
mmol) and Me3N•HCl (19 mg, 0.20 mmol) were added in CH3CN (20 mL) at 0 ºC.  A 
solution of TsCl (574 mg, 3.01 mmol) in CH3CN (12 mL) was then added by syringe 
and the reaction mixture was stirred at 0 ºC for 10 min and 12 h at 25 ºC.  The reaction 
was quenched with water (12 mL) and the aqueous layer was extracted with EtOAc (3 x 
20 mL).  The combined organic layer was dried over MgSO4 and solvents were 
concentrated under the reduced pressure.  The residue was purified by flash 
chromatography eluting with 50 % acetone/EtOAc and then 100 % acetone to afford 
product as a brown oil (1.6 g, 89 %).  Rf 0.3 (50 % acetone/EtOAc with iodine stain).  1H 
NMR (300 MHz, CDCl3) δ 7.74 (d, 2H, J = 8.0 Hz ), 7.72 (s, 1H), 7.30 (d, 2H, J = 8.0 
Hz), 7.22 (d, 2H, J = 9.0 Hz), 6.82 (d, 2H, J = 9.0 Hz), 4.62 (s, 2H), 4.48 (t, 2H, J = 5.0 
Hz), 4.44 (s, 2H), 4.10 (t, 2H, J = 5.0 Hz), 3.82 (t, 2H, J = 5.0 Hz), 3.75 (s, 3H), 3.65-
3.53 (m, 42H), 2.40 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 158.9, 144.7, 132.7, 130.1, 
129.7, 129.2, 127.8, 123.7, 113.5, 72.7, 70.5, 70.43, 70.39, 70.37, 70.34 (10C), 70.28 
(3C), 70.25, 69.4, 69.3, 69.1, 68.9, 68.5, 64.4, 55.1, 50.0, 21.5 (1 carbon is missing for 
aromatic region); MS (ESI) m/z 902.45 (M+H)+.  
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Silylated, aminonaphthol (204) 
 
OTBDMS
NH2  
 
To a solution of 5-amino-2-naphthol (1.0 g, 6.28 mmol) and TBDMSCl (1.04 g, 6.91 
mmol) in DMF (7.0 mL) was added DMAP (77 mg, 0.63 mmol) and imidazole (470 mg, 
6.91 mmol) at 0 ºC.  The reaction mixture was stirred at 25 ºC for 24 h.  Water (15 mL) 
was added to a reaction mixture and the aqueous layer was extracted with EtOAc (3 x 5 
mL).  The combined organic layer was dried over MgSO4 and concentrated under the 
reduced pressure.  The residual material was purified by flash chromatography eluting 
with 100 % hexanes and 10 % EtOAc/hexanes to afford product as a brown oil (1.47 g, 
85 %).  Rf 0.8 (50 % EtOAc/hexanes).  1H NMR (300 MHz, CDCl3) δ 7.75 (d, 1H, J = 
9.0 Hz), 7.31-7.28 (m, 1H), 7.23-7.21 (m, 2H), 7.10 (dd, 1H, J = 9.0, 2.4 Hz), 6.69 (dd, 
1H, J = 7.2, 1.5 Hz), 1.08 (s, 9H), 0.31 (s, 6H); 13C NMR (75 MHz, CDCl3) δ 153.5, 
142.1, 135.8, 126.8, 122.3, 120.7, 119.4, 117.9, 115.6, 107.9, 25.7, 18.3, -4.4; MS (ESI) 
m/z 274.17 (M+H)+.  
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N-Alkylated aminonaphthol (205) 
 
OTBDMS
N
H
CO2Me  
 
A solution of TBDMS-protected 5-amino-2-naphthol 204 (1.19 g, 4.35 mmol), 
K2CO3 (902 mg, 6.53 mmol) and methyl bromoacetate (999 mg, 6.53 mmol in DMF (20 
mL) was heated at 90 ºC for 2 h.  After cooling to room temperature, the reaction 
mixture was filtered and washed with acetone and then the solvent was evaporated.  The 
residual material was purified by flash chromatography eluting with 100 % hexanes and 
5 to 7 % EtOAc/hexanes to afford product as a light brown solid (1.31 g, 87 %).  Rf 0.6 
(20 % EtOAc/hexanes).  1H NMR (500 MHz, CDCl3) δ 7.81 (d, 1H, J = 9.0 Hz), 7.31-
7.26 (m, 1H), 7.17-7.14 (m, 2H), 7.06 (dd, 1H, J = 9.0, 2.0 Hz), 6.35 (d, 1H, J = 7.5 Hz), 
4.07 (s, 2H), 3.84 (s, 3H), 1.03 (s, 9H), 0.25 (s, 6H); 13C NMR (125 MHz, CDCl3) δ 
171.6, 153.6, 142.3, 135.7, 126.9, 121.6, 120.7, 119.1, 117.3, 115.8, 102.8, 52.4, 45.8, 
25.7, 18.3, -4.4; MS (ESI) m/z 346.17 (M+H)+.  
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N-Alkylated aminonaphthol (206) 
 
OH
N
H
CO2Me  
 
To a solution of N-alkylated 5-amino-2-naphthol 205 (600 mg, 1.74 mmol) in THF 
(20 mL) was added TBAF (1.9 mL, 1.91 mmol, 1 M in THF) dropwise at 0 ºC.  The 
reaction mixture was stirred at 0 ºC for 5 min.  The solvent was evaporated at 35 ºC and 
the residual material was purified by short flash chromatography eluting with 30 to 50 % 
EtOAc/hexanes to afford product as a yellow solid (327 mg, 81 %).  Rf 0.5 (40 % 
EtOAc/hexanes).  1H NMR (500 MHz, CD3OD) δ 7.91 (d, 1H, J = 9.0 Hz), 7.19 (t, 1H, J 
= 8.0 Hz), 7.05-7.02 (m, 3H), 6.26 (d, 1H, J = 7.5 Hz), 4.11 (s, 2H), 3.78 (s, 3H); 13C 
NMR (125 MHz, CD3OD) δ 174.0, 156.3, 144.6, 137.6, 127.9, 123.5, 119.8, 117.4 (2C), 
110.7, 102.7, 52.5, 46.4; MS (ESI) m/z 232.10 (M+H)+.  
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5-Methoxy-2-nitrobenzyl bromide (210) 
 
OMe
NO2
Br
 
 
To a solution of 5-methoxy-2-nitrobenzyl alcohol (1.02 g, 5.57 mmol) and PPh3 
(1.75 g, 66.8 mmol) in CH2Cl2 (20 mL) was added carbon tetrabromide (2.22 g, 66.8 
mmol) at 0 ºC.  The reaction mixture was stirred at 25 ºC for 30 h.  The solvent was 
evaporated under the reduced pressure and the residual material was purified by flash 
chromatography eluting with 100 % hexanes and 5 to 10 % EtOAc/hexanes to afford 
product as a brown solid (1.29 g, 94 %).  Rf 0.7 (30 % EtOAc/hexanes).  1H NMR (500 
MHz, CDCl3) δ 8.13 (d, 1H, J = 9.0 Hz), 7.01 (d, 1H, J = 2.5 Hz), 6.91 (dd, 1H, J = 9.0, 
2.5 Hz), 4.85 (s, 2H), 3.91 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 163.4, 140.6, 135.6, 
128.4, 117.6, 114.0, 56.0, 29.9; MS (CI) m/z 245.2 (M+H)+.  
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5-Methoxy-2-nitrobenzyl azide (211) 
 
OMe
NO2
N3
 
 
A solution of 5-methoxy-2-nitrobenzyl bromide 210 (280 mg, 1.14 mmol) and 
sodium azide (148 mg, 2.28 mmol) in DMF (2.0 mL) was stirred at 25 ºC for 16 h.  The 
reaction was quenched with water (5 mL) and the aqueous layer was extracted with 
EtOAc (7 x 2 mL).  The combined organic layer was dried over Na2SO4 and 
concentrated under the reduced pressure at 30 ºC.  The residual material was purified by 
flash chromatography eluting with 100 % hexanes to 5 % EtOAc/hexanes to afford 
product as a colorless oil (177 mg, 75 %).  Rf 0.6 (20 % EtOAc/hexanes).  1H NMR (500 
MHz, CDCl3) δ 8.19 (d, 1H, J = 9.0 Hz), 7.13 (d, 1H, J = 3.0 Hz), 6.91 (dd, 1H, J = 9.0, 
3.0 Hz), 4.89 (s, 2H), 3.93 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 163.9, 140.2, 134.9, 
128.1, 114.6, 113.2, 56.0, 52.4; MS (CI) m/z 209.0 (M+H)+.  
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Triazole derivative (212) 
 
OMe
NO2
N
N
N
 
 
A solution of 5-methoxy-2-nitrobenzyl azide 211 (122 mg, 0.586 mmol),  
phenylacetylene (120 mg, 1.17 mmol), CuSO4 (0.12 mL, 0.117 mmol, 1M in H2O) and 
sodium ascorbate (1.46 mL, 2.93 mmol, 2 M in H2O) in iPrOH (1.0 mL) was stirred at 
25 ºC for 24 h in dark.  Water (5 mL) was added to a reaction mixture and the aqueous 
layer was extracted with EtOAc (5 x 5 mL).  The combined organic layer was dried over 
Na2SO4 and concentrated under the reduced pressure to afford pure product as an off-
white solid (152 mg, 84 %).  Rf 0.5 (40 % EtOAc/hexanes).  1H NMR (300 MHz, 
CDCl3) δ 8.23 (d, 1H, J = 9.3 Hz), 7.95 (s, 1H), 7.84 (d, 2H, J = 7.2 Hz), 7.46-7.32 (m, 
3H), 6.94 (dd, 1H, J = 9.3, 2.7  Hz), 6.54 (d, 1H, J = 2.7 Hz), 6.01 (s, 2H), 3.81 (s, 3H); 
13C NMR (75 MHz, CDCl3) δ 164.4, 148.5, 140.5, 134.1, 130.5, 129.1, 128.63, 128.59, 
126.0, 120.9, 115.7, 114.2, 56.3, 51.8; MS (ESI) m/z 311.12 (M+H)+.  
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Phenyl-triazole derivative (214)173 
 
HN
N N  
 
A solution of sodium azide (131 mg, 2.01 mmol) in DMSO (2.0 mL) was heated at 
85 ºC.  Then, a solution of trans-β-nitrostyrene (150 mg, 1.01 mmol) in DMSO (7 mL) 
was added dropwise over a period of 4 h.  The reaction mixture was cooled to room 
temperature and water (10 mL) was added slowly.  The aqueous layer was extracted with 
EtOAc (3 x 5 mL) and the combined organic layer was dried over Na2SO4 and 
concentrated under the reduced pressure.  The residual material was purified by flash 
chromatography eluting with 100 % hexanes to 30 % EtOAc/hexanes to afford product 
as a colorless solid (119 mg, 82 %).  Rf 0.5 (50 % EtOAc/hexanes).  1H NMR (500 MHz, 
CD3OD) δ 8.18 (s, 1H), 7.86 (d, 2H, J = 7.5 Hz), 7.48-7.45 (m, 2H), 7.40-7.37 (m, 1H); 
13C NMR (125 MHz, CD3OD) δ 130.0, 129.5, 126.9 (3 carbons overlapping). 
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